id	sid	tid	token	lemma	pos
iajs-3742	1	1	79	79	NUM
iajs-3742	1	2	©	©	ADP
iajs-3742	1	3	2025	2025	NUM
iajs-3742	1	4	the	the	DET
iajs-3742	1	5	author(s	author(s	NOUN
iajs-3742	1	6	)	)	PUNCT
iajs-3742	1	7	.	.	PUNCT
iajs-3742	2	1	published	publish	VERB
iajs-3742	2	2	by	by	ADP
iajs-3742	2	3	college	college	NOUN
iajs-3742	2	4	of	of	ADP
iajs-3742	2	5	education	education	NOUN
iajs-3742	2	6	for	for	ADP
iajs-3742	2	7	pure	pure	ADJ
iajs-3742	2	8	science	science	NOUN
iajs-3742	2	9	(	(	PUNCT
iajs-3742	2	10	ibn	ibn	PROPN
iajs-3742	2	11	al	al	PROPN
iajs-3742	2	12	-	-	PUNCT
iajs-3742	2	13	haitham	haitham	PROPN
iajs-3742	2	14	)	)	PUNCT
iajs-3742	2	15	,	,	PUNCT
iajs-3742	2	16	university	university	NOUN
iajs-3742	2	17	of	of	ADP
iajs-3742	2	18	baghdad	baghdad	PROPN
iajs-3742	2	19	.	.	PUNCT
iajs-3742	3	1	this	this	PRON
iajs-3742	3	2	is	be	AUX
iajs-3742	3	3	an	an	DET
iajs-3742	3	4	open	open	ADJ
iajs-3742	3	5	-	-	PUNCT
iajs-3742	3	6	access	access	NOUN
iajs-3742	3	7	article	article	NOUN
iajs-3742	3	8	distributed	distribute	VERB
iajs-3742	3	9	under	under	ADP
iajs-3742	3	10	the	the	DET
iajs-3742	3	11	terms	term	NOUN
iajs-3742	3	12	of	of	ADP
iajs-3742	3	13	the	the	DET
iajs-3742	3	14	creative	creative	ADJ
iajs-3742	3	15	commons	common	NOUN
iajs-3742	3	16	attribution	attribution	NOUN
iajs-3742	3	17	4.0	4.0	NUM
iajs-3742	3	18	international	international	ADJ
iajs-3742	3	19	license	license	NOUN
iajs-3742	3	20	antiproliferative	antiproliferative	NOUN
iajs-3742	3	21	activity	activity	NOUN
iajs-3742	3	22	of	of	ADP
iajs-3742	3	23	crude	crude	ADJ
iajs-3742	3	24	marcescin	marcescin	NOUN
iajs-3742	3	25	on	on	ADP
iajs-3742	3	26	human	human	ADJ
iajs-3742	3	27	laryngx	laryngx	PROPN
iajs-3742	3	28	epidermoid	epidermoid	PROPN
iajs-3742	3	29	carcinoma	carcinoma	NOUN
iajs-3742	3	30	(	(	PUNCT
iajs-3742	3	31	hep-2	hep-2	NOUN
iajs-3742	3	32	)	)	PUNCT
iajs-3742	3	33	cell	cell	NOUN
iajs-3742	3	34	line	line	NOUN
iajs-3742	3	35	in	in	ADP
iajs-3742	3	36	vitro	vitro	X
iajs-3742	3	37	study	study	NOUN
iajs-3742	3	38	riad	riad	PROPN
iajs-3742	3	39	mohammed	mohammed	PROPN
iajs-3742	3	40	abdulredha	abdulredha	PROPN
iajs-3742	3	41	1	1	NUM
iajs-3742	3	42	*	*	NOUN
iajs-3742	3	43	and	and	CCONJ
iajs-3742	3	44	hind	hind	PROPN
iajs-3742	3	45	hussein	hussein	PROPN
iajs-3742	3	46	obaid	obaid	PROPN
iajs-3742	3	47	2	2	NUM
iajs-3742	3	48	1,2	1,2	NUM
iajs-3742	3	49	department	department	NOUN
iajs-3742	3	50	of	of	ADP
iajs-3742	3	51	biology	biology	NOUN
iajs-3742	3	52	,	,	PUNCT
iajs-3742	3	53	college	college	NOUN
iajs-3742	3	54	of	of	ADP
iajs-3742	3	55	science	science	NOUN
iajs-3742	3	56	,	,	PUNCT
iajs-3742	3	57	university	university	NOUN
iajs-3742	3	58	of	of	ADP
iajs-3742	3	59	baghdad	baghdad	PROPN
iajs-3742	3	60	,	,	PUNCT
iajs-3742	3	61	baghdad	baghdad	PROPN
iajs-3742	3	62	,	,	PUNCT
iajs-3742	3	63	iraq	iraq	PROPN
iajs-3742	3	64	.	.	PUNCT
iajs-3742	4	1	*	*	PUNCT
iajs-3742	4	2	corresponding	correspond	VERB
iajs-3742	4	3	author	author	NOUN
iajs-3742	4	4	.	.	PUNCT
iajs-3742	5	1	received	receive	VERB
iajs-3742	5	2	:	:	PUNCT
iajs-3742	5	3	19	19	NUM
iajs-3742	5	4	september	september	PROPN
iajs-3742	5	5	2023	2023	NUM
iajs-3742	5	6	accepted	accept	VERB
iajs-3742	5	7	:	:	PUNCT
iajs-3742	5	8	11	11	NUM
iajs-3742	5	9	december	december	PROPN
iajs-3742	5	10	2023	2023	NUM
iajs-3742	5	11	published	publish	VERB
iajs-3742	5	12	:	:	PUNCT
iajs-3742	5	13	20	20	NUM
iajs-3742	5	14	july	july	PROPN
iajs-3742	5	15	2025	2025	NUM
iajs-3742	5	16	doi.org/10.30526/38.3.3742	doi.org/10.30526/38.3.3742	PROPN
iajs-3742	5	17	abstract	abstract	ADJ
iajs-3742	5	18	marcescin	marcescin	PROPN
iajs-3742	5	19	is	be	AUX
iajs-3742	5	20	a	a	DET
iajs-3742	5	21	bacteriocin	bacteriocin	NOUN
iajs-3742	5	22	that	that	PRON
iajs-3742	5	23	is	be	AUX
iajs-3742	5	24	extracted	extract	VERB
iajs-3742	5	25	from	from	ADP
iajs-3742	5	26	isolates	isolate	NOUN
iajs-3742	5	27	of	of	ADP
iajs-3742	5	28	serratia	serratia	NOUN
iajs-3742	5	29	marcescens	marcescen	NOUN
iajs-3742	5	30	,	,	PUNCT
iajs-3742	5	31	which	which	PRON
iajs-3742	5	32	is	be	AUX
iajs-3742	5	33	a	a	DET
iajs-3742	5	34	gram	gram	NOUN
iajs-3742	5	35	-	-	PUNCT
iajs-3742	5	36	negative	negative	ADJ
iajs-3742	5	37	bacterium	bacterium	NOUN
iajs-3742	5	38	that	that	PRON
iajs-3742	5	39	belongs	belong	VERB
iajs-3742	5	40	to	to	ADP
iajs-3742	5	41	the	the	DET
iajs-3742	5	42	family	family	NOUN
iajs-3742	5	43	enterobacteraeaceae	enterobacteraeaceae	NOUN
iajs-3742	5	44	and	and	CCONJ
iajs-3742	5	45	is	be	AUX
iajs-3742	5	46	considered	consider	VERB
iajs-3742	5	47	a	a	DET
iajs-3742	5	48	nosocomial	nosocomial	ADJ
iajs-3742	5	49	pathogenic	pathogenic	ADJ
iajs-3742	5	50	bacteria	bacteria	NOUN
iajs-3742	5	51	.	.	PUNCT
iajs-3742	6	1	in	in	ADP
iajs-3742	6	2	this	this	DET
iajs-3742	6	3	research	research	NOUN
iajs-3742	6	4	,	,	PUNCT
iajs-3742	6	5	the	the	DET
iajs-3742	6	6	toxic	toxic	ADJ
iajs-3742	6	7	effect	effect	NOUN
iajs-3742	6	8	of	of	ADP
iajs-3742	6	9	crude	crude	ADJ
iajs-3742	6	10	marcescin	marcescin	NOUN
iajs-3742	6	11	extracted	extract	VERB
iajs-3742	6	12	from	from	ADP
iajs-3742	6	13	the	the	DET
iajs-3742	6	14	s.	s.	PROPN
iajs-3742	6	15	marcescens	marcescens	PROPN
iajs-3742	6	16	bacteria	bacteria	NOUN
iajs-3742	6	17	on	on	ADP
iajs-3742	6	18	the	the	DET
iajs-3742	6	19	human	human	ADJ
iajs-3742	6	20	laryngx	laryngx	PROPN
iajs-3742	6	21	epidermoid	epidermoid	PROPN
iajs-3742	6	22	carcinoma	carcinoma	NOUN
iajs-3742	6	23	(	(	PUNCT
iajs-3742	6	24	hep-2	hep-2	NOUN
iajs-3742	6	25	)	)	PUNCT
iajs-3742	6	26	cell	cell	NOUN
iajs-3742	6	27	line	line	NOUN
iajs-3742	6	28	was	be	AUX
iajs-3742	6	29	investigated	investigate	VERB
iajs-3742	6	30	.	.	PUNCT
iajs-3742	7	1	s.	s.	PROPN
iajs-3742	7	2	marcescens	marcescens	PROPN
iajs-3742	7	3	was	be	AUX
iajs-3742	7	4	isolated	isolate	VERB
iajs-3742	7	5	from	from	ADP
iajs-3742	7	6	blood	blood	NOUN
iajs-3742	7	7	,	,	PUNCT
iajs-3742	7	8	urine	urine	NOUN
iajs-3742	7	9	,	,	PUNCT
iajs-3742	7	10	and	and	CCONJ
iajs-3742	7	11	stool	stool	NOUN
iajs-3742	7	12	samples	sample	NOUN
iajs-3742	7	13	of	of	ADP
iajs-3742	7	14	patients	patient	NOUN
iajs-3742	7	15	from	from	ADP
iajs-3742	7	16	nursing	nurse	VERB
iajs-3742	7	17	house	house	NOUN
iajs-3742	7	18	hospital	hospital	NOUN
iajs-3742	7	19	,	,	PUNCT
iajs-3742	7	20	baghdad	baghdad	PROPN
iajs-3742	7	21	teaching	teaching	NOUN
iajs-3742	7	22	hospital	hospital	NOUN
iajs-3742	7	23	,	,	PUNCT
iajs-3742	7	24	and	and	CCONJ
iajs-3742	7	25	teaching	teach	VERB
iajs-3742	7	26	laboratories	laboratory	NOUN
iajs-3742	7	27	of	of	ADP
iajs-3742	7	28	medical	medical	ADJ
iajs-3742	7	29	city	city	NOUN
iajs-3742	7	30	by	by	ADP
iajs-3742	7	31	using	use	VERB
iajs-3742	7	32	a	a	DET
iajs-3742	7	33	series	series	NOUN
iajs-3742	7	34	of	of	ADP
iajs-3742	7	35	dilutions	dilution	NOUN
iajs-3742	7	36	to	to	ADP
iajs-3742	7	37	concentrations	concentration	NOUN
iajs-3742	7	38	of	of	ADP
iajs-3742	7	39	(	(	PUNCT
iajs-3742	7	40	0.00	0.00	NUM
iajs-3742	7	41	,	,	PUNCT
iajs-3742	7	42	1.95	1.95	NUM
iajs-3742	7	43	,	,	PUNCT
iajs-3742	7	44	3.9	3.9	NUM
iajs-3742	7	45	,	,	PUNCT
iajs-3742	7	46	7.8	7.8	NUM
iajs-3742	7	47	,	,	PUNCT
iajs-3742	7	48	15.62	15.62	NUM
iajs-3742	7	49	,	,	PUNCT
iajs-3742	7	50	31.25	31.25	NUM
iajs-3742	7	51	,	,	PUNCT
iajs-3742	7	52	62.5	62.5	NUM
iajs-3742	7	53	,	,	PUNCT
iajs-3742	7	54	125	125	NUM
iajs-3742	7	55	,	,	PUNCT
iajs-3742	7	56	250	250	NUM
iajs-3742	7	57	,	,	PUNCT
iajs-3742	7	58	500	500	NUM
iajs-3742	7	59	,	,	PUNCT
iajs-3742	7	60	and	and	CCONJ
iajs-3742	7	61	1000	1000	NUM
iajs-3742	7	62	)	)	PUNCT
iajs-3742	7	63	µg	µg	ADV
iajs-3742	7	64	/	/	SYM
iajs-3742	7	65	ml	ml	NOUN
iajs-3742	7	66	and	and	CCONJ
iajs-3742	7	67	an	an	DET
iajs-3742	7	68	exposure	exposure	NOUN
iajs-3742	7	69	time	time	NOUN
iajs-3742	7	70	of	of	ADP
iajs-3742	7	71	(	(	PUNCT
iajs-3742	7	72	24	24	NUM
iajs-3742	7	73	,	,	PUNCT
iajs-3742	7	74	48	48	NUM
iajs-3742	7	75	,	,	PUNCT
iajs-3742	7	76	and	and	CCONJ
iajs-3742	7	77	72	72	NUM
iajs-3742	7	78	)	)	PUNCT
iajs-3742	7	79	hours	hour	NOUN
iajs-3742	7	80	.	.	PUNCT
iajs-3742	8	1	the	the	DET
iajs-3742	8	2	results	result	NOUN
iajs-3742	8	3	showed	show	VERB
iajs-3742	8	4	significant	significant	ADJ
iajs-3742	8	5	differences	difference	NOUN
iajs-3742	8	6	(	(	PUNCT
iajs-3742	8	7	p≤0.05	p≤0.05	NOUN
iajs-3742	8	8	)	)	PUNCT
iajs-3742	8	9	in	in	ADP
iajs-3742	8	10	the	the	DET
iajs-3742	8	11	ir	ir	PROPN
iajs-3742	8	12	values	value	NOUN
iajs-3742	8	13	(	(	PUNCT
iajs-3742	8	14	100–2	100–2	NUM
iajs-3742	8	15	%	%	NOUN
iajs-3742	8	16	)	)	PUNCT
iajs-3742	8	17	at	at	ADP
iajs-3742	8	18	the	the	DET
iajs-3742	8	19	concentrations	concentration	NOUN
iajs-3742	8	20	(	(	PUNCT
iajs-3742	8	21	1000–1.95	1000–1.95	NOUN
iajs-3742	8	22	)	)	PUNCT
iajs-3742	8	23	µg	µg	NOUN
iajs-3742	8	24	/	/	SYM
iajs-3742	8	25	ml	ml	NOUN
iajs-3742	8	26	when	when	SCONJ
iajs-3742	8	27	compared	compare	VERB
iajs-3742	8	28	with	with	ADP
iajs-3742	8	29	the	the	DET
iajs-3742	8	30	control	control	NOUN
iajs-3742	8	31	(	(	PUNCT
iajs-3742	8	32	100	100	NUM
iajs-3742	8	33	%	%	NOUN
iajs-3742	8	34	)	)	PUNCT
iajs-3742	8	35	;	;	PUNCT
iajs-3742	8	36	there	there	PRON
iajs-3742	8	37	were	be	VERB
iajs-3742	8	38	also	also	ADV
iajs-3742	8	39	significant	significant	ADJ
iajs-3742	8	40	differences	difference	NOUN
iajs-3742	8	41	after	after	ADP
iajs-3742	8	42	48	48	NUM
iajs-3742	8	43	and	and	CCONJ
iajs-3742	8	44	72	72	NUM
iajs-3742	8	45	hours	hour	NOUN
iajs-3742	8	46	.	.	PUNCT
iajs-3742	9	1	the	the	DET
iajs-3742	9	2	results	result	NOUN
iajs-3742	9	3	showed	show	VERB
iajs-3742	9	4	that	that	SCONJ
iajs-3742	9	5	high	high	ADJ
iajs-3742	9	6	concentrations	concentration	NOUN
iajs-3742	9	7	caused	cause	VERB
iajs-3742	9	8	a	a	DET
iajs-3742	9	9	high	high	ADJ
iajs-3742	9	10	rate	rate	NOUN
iajs-3742	9	11	of	of	ADP
iajs-3742	9	12	inhibition	inhibition	NOUN
iajs-3742	9	13	at	at	ADP
iajs-3742	9	14	concentrations	concentration	NOUN
iajs-3742	9	15	(	(	PUNCT
iajs-3742	9	16	1000	1000	NUM
iajs-3742	9	17	,	,	PUNCT
iajs-3742	9	18	500	500	NUM
iajs-3742	9	19	,	,	PUNCT
iajs-3742	9	20	and	and	CCONJ
iajs-3742	9	21	250	250	NUM
iajs-3742	9	22	)	)	PUNCT
iajs-3742	9	23	µg	µg	ADV
iajs-3742	9	24	/	/	SYM
iajs-3742	9	25	m	m	PROPN
iajs-3742	9	26	where	where	SCONJ
iajs-3742	9	27	the	the	DET
iajs-3742	9	28	rate	rate	NOUN
iajs-3742	9	29	of	of	ADP
iajs-3742	9	30	inhibition	inhibition	NOUN
iajs-3742	9	31	was	be	AUX
iajs-3742	9	32	(	(	PUNCT
iajs-3742	9	33	100	100	NUM
iajs-3742	9	34	,	,	PUNCT
iajs-3742	9	35	67	67	NUM
iajs-3742	9	36	,	,	PUNCT
iajs-3742	9	37	and	and	CCONJ
iajs-3742	9	38	58	58	NUM
iajs-3742	9	39	)	)	PUNCT
iajs-3742	9	40	after	after	ADP
iajs-3742	9	41	24	24	NUM
iajs-3742	9	42	hours	hour	NOUN
iajs-3742	9	43	,	,	PUNCT
iajs-3742	9	44	then	then	ADV
iajs-3742	9	45	the	the	DET
iajs-3742	9	46	rate	rate	NOUN
iajs-3742	9	47	of	of	ADP
iajs-3742	9	48	inhibition	inhibition	NOUN
iajs-3742	9	49	began	begin	VERB
iajs-3742	9	50	to	to	PART
iajs-3742	9	51	decrease	decrease	VERB
iajs-3742	9	52	gradually	gradually	ADV
iajs-3742	9	53	,	,	PUNCT
iajs-3742	9	54	reaching	reach	VERB
iajs-3742	9	55	2	2	NUM
iajs-3742	9	56	%	%	NOUN
iajs-3742	9	57	at	at	ADP
iajs-3742	9	58	the	the	DET
iajs-3742	9	59	lowest	low	ADJ
iajs-3742	9	60	concentration	concentration	NOUN
iajs-3742	9	61	of	of	ADP
iajs-3742	9	62	1.95	1.95	NUM
iajs-3742	9	63	.	.	PUNCT
iajs-3742	10	1	it	it	PRON
iajs-3742	10	2	is	be	AUX
iajs-3742	10	3	clear	clear	ADJ
iajs-3742	10	4	that	that	SCONJ
iajs-3742	10	5	hep-2	hep-2	PUNCT
iajs-3742	10	6	cells	cell	NOUN
iajs-3742	10	7	are	be	AUX
iajs-3742	10	8	sensitive	sensitive	ADJ
iajs-3742	10	9	to	to	ADP
iajs-3742	10	10	marcescin	marcescin	NOUN
iajs-3742	10	11	,	,	PUNCT
iajs-3742	10	12	and	and	CCONJ
iajs-3742	10	13	their	their	PRON
iajs-3742	10	14	sensitivity	sensitivity	NOUN
iajs-3742	10	15	increases	increase	VERB
iajs-3742	10	16	exponentially	exponentially	ADV
iajs-3742	10	17	with	with	ADP
iajs-3742	10	18	increasing	increase	VERB
iajs-3742	10	19	concentration	concentration	NOUN
iajs-3742	10	20	and	and	CCONJ
iajs-3742	10	21	time	time	NOUN
iajs-3742	10	22	of	of	ADP
iajs-3742	10	23	exposure	exposure	NOUN
iajs-3742	10	24	.	.	PUNCT
iajs-3742	11	1	keywords	keyword	NOUN
iajs-3742	11	2	:	:	PUNCT
iajs-3742	11	3	serratia	serratia	PROPN
iajs-3742	11	4	marcescens	marcescen	NOUN
iajs-3742	11	5	,	,	PUNCT
iajs-3742	11	6	marcescin	marcescin	NOUN
iajs-3742	11	7	,	,	PUNCT
iajs-3742	11	8	cytotoxicity	cytotoxicity	NOUN
iajs-3742	11	9	,	,	PUNCT
iajs-3742	11	10	hep-2	hep-2	PUNCT
iajs-3742	11	11	cell	cell	NOUN
iajs-3742	11	12	line	line	NOUN
iajs-3742	11	13	,	,	PUNCT
iajs-3742	11	14	inhibition	inhibition	NOUN
iajs-3742	11	15	rate	rate	NOUN
iajs-3742	11	16	.	.	PUNCT
iajs-3742	12	1	1	1	X
iajs-3742	12	2	.	.	X
iajs-3742	12	3	introduction	introduction	NOUN
iajs-3742	12	4	despite	despite	SCONJ
iajs-3742	12	5	major	major	ADJ
iajs-3742	12	6	improvements	improvement	NOUN
iajs-3742	12	7	in	in	ADP
iajs-3742	12	8	diagnosis	diagnosis	NOUN
iajs-3742	12	9	and	and	CCONJ
iajs-3742	12	10	treatment	treatment	NOUN
iajs-3742	12	11	,	,	PUNCT
iajs-3742	12	12	cancer	cancer	NOUN
iajs-3742	12	13	remains	remain	VERB
iajs-3742	12	14	the	the	DET
iajs-3742	12	15	top	top	ADJ
iajs-3742	12	16	cause	cause	NOUN
iajs-3742	12	17	of	of	ADP
iajs-3742	12	18	death	death	NOUN
iajs-3742	12	19	in	in	ADP
iajs-3742	12	20	the	the	DET
iajs-3742	12	21	world	world	NOUN
iajs-3742	12	22	(	(	PUNCT
iajs-3742	12	23	1	1	NUM
iajs-3742	12	24	)	)	PUNCT
iajs-3742	12	25	.	.	PUNCT
iajs-3742	13	1	in	in	ADP
iajs-3742	13	2	2020	2020	NUM
iajs-3742	13	3	,	,	PUNCT
iajs-3742	13	4	10	10	NUM
iajs-3742	13	5	million	million	NUM
iajs-3742	13	6	people	people	NOUN
iajs-3742	13	7	worldwide	worldwide	ADV
iajs-3742	13	8	died	die	VERB
iajs-3742	13	9	from	from	ADP
iajs-3742	13	10	cancer	cancer	NOUN
iajs-3742	13	11	,	,	PUNCT
iajs-3742	13	12	one	one	NUM
iajs-3742	13	13	of	of	ADP
iajs-3742	13	14	the	the	DET
iajs-3742	13	15	major	major	ADJ
iajs-3742	13	16	causes	cause	NOUN
iajs-3742	13	17	of	of	ADP
iajs-3742	13	18	death	death	NOUN
iajs-3742	13	19	.	.	PUNCT
iajs-3742	14	1	the	the	DET
iajs-3742	14	2	most	most	ADV
iajs-3742	14	3	prevalent	prevalent	ADJ
iajs-3742	14	4	cancers	cancer	NOUN
iajs-3742	14	5	include	include	VERB
iajs-3742	14	6	melanoma	melanoma	NOUN
iajs-3742	14	7	,	,	PUNCT
iajs-3742	14	8	lymphoma	lymphoma	NOUN
iajs-3742	14	9	,	,	PUNCT
iajs-3742	14	10	leukemia	leukemia	NOUN
iajs-3742	14	11	,	,	PUNCT
iajs-3742	14	12	sarcoma	sarcoma	NOUN
iajs-3742	14	13	,	,	PUNCT
iajs-3742	14	14	and	and	CCONJ
iajs-3742	14	15	carcinoma	carcinoma	NOUN
iajs-3742	14	16	,	,	PUNCT
iajs-3742	14	17	which	which	PRON
iajs-3742	14	18	can	can	AUX
iajs-3742	14	19	originate	originate	VERB
iajs-3742	14	20	in	in	ADP
iajs-3742	14	21	a	a	DET
iajs-3742	14	22	variety	variety	NOUN
iajs-3742	14	23	of	of	ADP
iajs-3742	14	24	body	body	NOUN
iajs-3742	14	25	organs	organ	NOUN
iajs-3742	14	26	(	(	PUNCT
iajs-3742	14	27	2	2	NUM
iajs-3742	14	28	)	)	PUNCT
iajs-3742	14	29	.	.	PUNCT
iajs-3742	15	1	in	in	ADP
iajs-3742	15	2	men	man	NOUN
iajs-3742	15	3	,	,	PUNCT
iajs-3742	15	4	the	the	DET
iajs-3742	15	5	prostate	prostate	NOUN
iajs-3742	15	6	,	,	PUNCT
iajs-3742	15	7	lung	lung	NOUN
iajs-3742	15	8	and	and	CCONJ
iajs-3742	15	9	bronchus	bronchus	NOUN
iajs-3742	15	10	,	,	PUNCT
iajs-3742	15	11	colon	colon	NOUN
iajs-3742	15	12	and	and	CCONJ
iajs-3742	15	13	rectum	rectum	NOUN
iajs-3742	15	14	,	,	PUNCT
iajs-3742	15	15	and	and	CCONJ
iajs-3742	15	16	urinary	urinary	ADJ
iajs-3742	15	17	bladder	bladder	NOUN
iajs-3742	15	18	,	,	PUNCT
iajs-3742	15	19	respectively	respectively	ADV
iajs-3742	15	20	,	,	PUNCT
iajs-3742	15	21	have	have	VERB
iajs-3742	15	22	the	the	DET
iajs-3742	15	23	largest	large	ADJ
iajs-3742	15	24	percentages	percentage	NOUN
iajs-3742	15	25	of	of	ADP
iajs-3742	15	26	cancer	cancer	NOUN
iajs-3742	15	27	types	type	NOUN
iajs-3742	15	28	.	.	PUNCT
iajs-3742	16	1	breast	breast	NOUN
iajs-3742	16	2	,	,	PUNCT
iajs-3742	16	3	lung	lung	NOUN
iajs-3742	16	4	,	,	PUNCT
iajs-3742	16	5	and	and	CCONJ
iajs-3742	16	6	bronchus	bronchu	NOUN
iajs-3742	16	7	;	;	PUNCT
iajs-3742	16	8	colon	colon	NOUN
iajs-3742	16	9	and	and	CCONJ
iajs-3742	16	10	rectum	rectum	NOUN
iajs-3742	16	11	;	;	PUNCT
iajs-3742	16	12	uterine	uterine	ADJ
iajs-3742	16	13	corpus	corpus	NOUN
iajs-3742	16	14	;	;	PUNCT
iajs-3742	16	15	and	and	CCONJ
iajs-3742	16	16	thyroid	thyroid	NOUN
iajs-3742	16	17	cancer	cancer	NOUN
iajs-3742	16	18	prevalence	prevalence	NOUN
iajs-3742	16	19	are	be	AUX
iajs-3742	16	20	higher	high	ADJ
iajs-3742	16	21	in	in	ADP
iajs-3742	16	22	women	woman	NOUN
iajs-3742	16	23	,	,	PUNCT
iajs-3742	16	24	correspondingly	correspondingly	ADV
iajs-3742	16	25	(	(	PUNCT
iajs-3742	16	26	3	3	NUM
iajs-3742	16	27	)	)	PUNCT
iajs-3742	16	28	.	.	PUNCT
iajs-3742	17	1	today	today	NOUN
iajs-3742	17	2	's	's	PART
iajs-3742	17	3	anticancer	anticancer	NOUN
iajs-3742	17	4	agents	agent	NOUN
iajs-3742	17	5	fall	fall	VERB
iajs-3742	17	6	into	into	ADP
iajs-3742	17	7	several	several	ADJ
iajs-3742	17	8	groups	group	NOUN
iajs-3742	17	9	(	(	PUNCT
iajs-3742	17	10	4	4	NUM
iajs-3742	17	11	)	)	PUNCT
iajs-3742	17	12	.	.	PUNCT
iajs-3742	18	1	modern	modern	ADJ
iajs-3742	18	2	treatments	treatment	NOUN
iajs-3742	18	3	,	,	PUNCT
iajs-3742	18	4	including	include	VERB
iajs-3742	18	5	hormone-	hormone-	NOUN
iajs-3742	18	6	,	,	PUNCT
iajs-3742	18	7	immuno-	immuno-	X
iajs-3742	18	8	,	,	PUNCT
iajs-3742	18	9	and	and	CCONJ
iajs-3742	18	10	antibody	antibody	NOUN
iajs-3742	18	11	-	-	PUNCT
iajs-3742	18	12	based	base	VERB
iajs-3742	18	13	therapies	therapy	NOUN
iajs-3742	18	14	,	,	PUNCT
iajs-3742	18	15	are	be	AUX
iajs-3742	18	16	gaining	gain	VERB
iajs-3742	18	17	popularity	popularity	NOUN
iajs-3742	18	18	.	.	PUNCT
iajs-3742	19	1	toxins	toxin	NOUN
iajs-3742	19	2	,	,	PUNCT
iajs-3742	19	3	antibiotics	antibiotic	NOUN
iajs-3742	19	4	,	,	PUNCT
iajs-3742	19	5	bacteriocins	bacteriocin	NOUN
iajs-3742	19	6	,	,	PUNCT
iajs-3742	19	7	non	non	ADJ
iajs-3742	19	8	-	-	ADJ
iajs-3742	19	9	ribosomal	ribosomal	ADJ
iajs-3742	19	10	peptides	peptide	NOUN
iajs-3742	19	11	,	,	PUNCT
iajs-3742	19	12	polyketides	polyketide	NOUN
iajs-3742	19	13	,	,	PUNCT
iajs-3742	19	14	phenylpropanoids	phenylpropanoid	NOUN
iajs-3742	19	15	,	,	PUNCT
iajs-3742	19	16	phenylflavonoids	phenylflavonoid	NOUN
iajs-3742	19	17	,	,	PUNCT
iajs-3742	19	18	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	ADJ
iajs-3742	19	19	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	NOUN
iajs-3742	19	20	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	21	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	X
iajs-3742	19	22	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	PROPN
iajs-3742	19	23	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	NOUN
iajs-3742	19	24	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	25	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	X
iajs-3742	19	26	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	PROPN
iajs-3742	19	27	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	NOUN
iajs-3742	19	28	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	29	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	X
iajs-3742	19	30	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	PROPN
iajs-3742	19	31	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	NOUN
iajs-3742	19	32	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	33	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	X
iajs-3742	19	34	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	PROPN
iajs-3742	19	35	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	NOUN
iajs-3742	19	36	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	37	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	X
iajs-3742	19	38	https://orcid.org/0009-0007-7966-8458	https://orcid.org/0009-0007-7966-8458	PROPN
iajs-3742	19	39	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	mailto:email:riad.abd2102@sc.uobaghdad.edu.iq	PROPN
iajs-3742	19	40	https://orcid.org/0000-0002-2046-7834	https://orcid.org/0000-0002-2046-7834	PROPN
iajs-3742	19	41	mailto:hind_3000@yahoo.com	mailto:hind_3000@yahoo.com	PROPN
iajs-3742	19	42	ihjpas	ihjpas	PROPN
iajs-3742	19	43	.	.	PUNCT
iajs-3742	20	1	2025	2025	NUM
iajs-3742	20	2	,	,	PUNCT
iajs-3742	20	3	38(3	38(3	NUM
iajs-3742	20	4	)	)	PUNCT
iajs-3742	20	5	80	80	NUM
iajs-3742	20	6	purine	purine	NOUN
iajs-3742	20	7	nucleosides	nucleoside	NOUN
iajs-3742	20	8	,	,	PUNCT
iajs-3742	20	9	short	short	ADJ
iajs-3742	20	10	-	-	PUNCT
iajs-3742	20	11	chain	chain	NOUN
iajs-3742	20	12	fatty	fatty	NOUN
iajs-3742	20	13	acids	acid	NOUN
iajs-3742	20	14	(	(	PUNCT
iajs-3742	20	15	scfas	scfas	NOUN
iajs-3742	20	16	)	)	PUNCT
iajs-3742	20	17	,	,	PUNCT
iajs-3742	20	18	and	and	CCONJ
iajs-3742	20	19	enzymes	enzyme	NOUN
iajs-3742	20	20	that	that	PRON
iajs-3742	20	21	fight	fight	VERB
iajs-3742	20	22	cancer	cancer	NOUN
iajs-3742	20	23	have	have	AUX
iajs-3742	20	24	been	be	AUX
iajs-3742	20	25	the	the	DET
iajs-3742	20	26	focus	focus	NOUN
iajs-3742	20	27	of	of	ADP
iajs-3742	20	28	studies	study	NOUN
iajs-3742	20	29	.	.	PUNCT
iajs-3742	21	1	the	the	DET
iajs-3742	21	2	majority	majority	NOUN
iajs-3742	21	3	of	of	ADP
iajs-3742	21	4	these	these	DET
iajs-3742	21	5	compounds	compound	NOUN
iajs-3742	21	6	selectively	selectively	ADV
iajs-3742	21	7	target	target	VERB
iajs-3742	21	8	cancer	cancer	NOUN
iajs-3742	21	9	cells	cell	NOUN
iajs-3742	21	10	,	,	PUNCT
iajs-3742	21	11	either	either	CCONJ
iajs-3742	21	12	directly	directly	ADV
iajs-3742	21	13	or	or	CCONJ
iajs-3742	21	14	indirectly	indirectly	ADV
iajs-3742	21	15	via	via	ADP
iajs-3742	21	16	particular	particular	ADJ
iajs-3742	21	17	pathways	pathway	NOUN
iajs-3742	21	18	(	(	PUNCT
iajs-3742	21	19	5	5	NUM
iajs-3742	21	20	)	)	PUNCT
iajs-3742	21	21	.	.	PUNCT
iajs-3742	22	1	according	accord	VERB
iajs-3742	22	2	to	to	ADP
iajs-3742	22	3	reports	report	NOUN
iajs-3742	22	4	,	,	PUNCT
iajs-3742	22	5	the	the	DET
iajs-3742	22	6	use	use	NOUN
iajs-3742	22	7	of	of	ADP
iajs-3742	22	8	microorganisms	microorganism	NOUN
iajs-3742	22	9	or	or	CCONJ
iajs-3742	22	10	their	their	PRON
iajs-3742	22	11	products	product	NOUN
iajs-3742	22	12	to	to	PART
iajs-3742	22	13	treat	treat	VERB
iajs-3742	22	14	cancer	cancer	NOUN
iajs-3742	22	15	dates	date	NOUN
iajs-3742	22	16	back	back	ADV
iajs-3742	22	17	to	to	ADP
iajs-3742	22	18	the	the	DET
iajs-3742	22	19	eighteenth	eighteenth	ADJ
iajs-3742	22	20	century	century	NOUN
iajs-3742	22	21	.	.	PUNCT
iajs-3742	23	1	for	for	ADP
iajs-3742	23	2	example	example	NOUN
iajs-3742	23	3	,	,	PUNCT
iajs-3742	23	4	people	people	NOUN
iajs-3742	23	5	with	with	ADP
iajs-3742	23	6	tumors	tumor	NOUN
iajs-3742	23	7	that	that	PRON
iajs-3742	23	8	could	could	AUX
iajs-3742	23	9	n't	not	PART
iajs-3742	23	10	be	be	AUX
iajs-3742	23	11	removed	remove	VERB
iajs-3742	23	12	were	be	AUX
iajs-3742	23	13	given	give	VERB
iajs-3742	23	14	coley	coley	NOUN
iajs-3742	23	15	's	's	PART
iajs-3742	23	16	toxins	toxin	NOUN
iajs-3742	23	17	,	,	PUNCT
iajs-3742	23	18	which	which	PRON
iajs-3742	23	19	are	be	AUX
iajs-3742	23	20	made	make	VERB
iajs-3742	23	21	from	from	ADP
iajs-3742	23	22	the	the	DET
iajs-3742	23	23	culture	culture	NOUN
iajs-3742	23	24	fluids	fluid	NOUN
iajs-3742	23	25	of	of	ADP
iajs-3742	23	26	bacteria	bacteria	NOUN
iajs-3742	23	27	such	such	ADJ
iajs-3742	23	28	as	as	ADP
iajs-3742	23	29	streptococcus	streptococcus	NOUN
iajs-3742	23	30	pyogenes	pyogene	NOUN
iajs-3742	23	31	and	and	CCONJ
iajs-3742	23	32	s.	s.	PROPN
iajs-3742	23	33	marcescens	marcescens	PROPN
iajs-3742	23	34	.	.	PUNCT
iajs-3742	24	1	evidently	evidently	ADV
iajs-3742	24	2	,	,	PUNCT
iajs-3742	24	3	those	those	PRON
iajs-3742	24	4	who	who	PRON
iajs-3742	24	5	received	receive	VERB
iajs-3742	24	6	this	this	DET
iajs-3742	24	7	toxin	toxin	NOUN
iajs-3742	24	8	treatment	treatment	NOUN
iajs-3742	24	9	had	have	VERB
iajs-3742	24	10	their	their	PRON
iajs-3742	24	11	malignant	malignant	ADJ
iajs-3742	24	12	tumors	tumor	NOUN
iajs-3742	24	13	shrink	shrink	VERB
iajs-3742	24	14	,	,	PUNCT
iajs-3742	24	15	and	and	CCONJ
iajs-3742	24	16	they	they	PRON
iajs-3742	24	17	recovered	recover	VERB
iajs-3742	24	18	their	their	PRON
iajs-3742	24	19	health	health	NOUN
iajs-3742	24	20	(	(	PUNCT
iajs-3742	24	21	6	6	NUM
iajs-3742	24	22	,	,	PUNCT
iajs-3742	24	23	7	7	NUM
iajs-3742	24	24	)	)	PUNCT
iajs-3742	24	25	.	.	PUNCT
iajs-3742	25	1	we	we	PRON
iajs-3742	25	2	desperately	desperately	ADV
iajs-3742	25	3	need	need	VERB
iajs-3742	25	4	new	new	ADJ
iajs-3742	25	5	compounds	compound	NOUN
iajs-3742	25	6	with	with	ADP
iajs-3742	25	7	improved	improved	ADJ
iajs-3742	25	8	selectivity	selectivity	NOUN
iajs-3742	25	9	and	and	CCONJ
iajs-3742	25	10	specificity	specificity	NOUN
iajs-3742	25	11	against	against	ADP
iajs-3742	25	12	cancer	cancer	NOUN
iajs-3742	25	13	cells	cell	NOUN
iajs-3742	25	14	.	.	PUNCT
iajs-3742	26	1	numerous	numerous	ADJ
iajs-3742	26	2	proteins	protein	NOUN
iajs-3742	26	3	and	and	CCONJ
iajs-3742	26	4	peptides	peptide	NOUN
iajs-3742	26	5	having	have	VERB
iajs-3742	26	6	anticancer	anticancer	NOUN
iajs-3742	26	7	activities	activity	NOUN
iajs-3742	26	8	are	be	AUX
iajs-3742	26	9	present	present	ADJ
iajs-3742	26	10	in	in	ADP
iajs-3742	26	11	microorganisms	microorganism	NOUN
iajs-3742	26	12	,	,	PUNCT
iajs-3742	26	13	particularly	particularly	ADV
iajs-3742	26	14	bacteria	bacteria	NOUN
iajs-3742	26	15	.	.	PUNCT
iajs-3742	27	1	for	for	ADP
iajs-3742	27	2	example	example	NOUN
iajs-3742	27	3	,	,	PUNCT
iajs-3742	27	4	bacteriocins	bacteriocin	NOUN
iajs-3742	27	5	have	have	VERB
iajs-3742	27	6	biological	biological	ADJ
iajs-3742	27	7	effects	effect	NOUN
iajs-3742	27	8	because	because	SCONJ
iajs-3742	27	9	of	of	ADP
iajs-3742	27	10	their	their	PRON
iajs-3742	27	11	distinctive	distinctive	ADJ
iajs-3742	27	12	structural	structural	ADJ
iajs-3742	27	13	characteristics	characteristic	NOUN
iajs-3742	27	14	.	.	PUNCT
iajs-3742	28	1	initially	initially	ADV
iajs-3742	28	2	believed	believe	VERB
iajs-3742	28	3	to	to	PART
iajs-3742	28	4	be	be	AUX
iajs-3742	28	5	limited	limit	VERB
iajs-3742	28	6	to	to	ADP
iajs-3742	28	7	preventing	prevent	VERB
iajs-3742	28	8	bacterial	bacterial	ADJ
iajs-3742	28	9	growth	growth	NOUN
iajs-3742	28	10	,	,	PUNCT
iajs-3742	28	11	their	their	PRON
iajs-3742	28	12	roles	role	NOUN
iajs-3742	28	13	have	have	AUX
iajs-3742	28	14	since	since	ADV
iajs-3742	28	15	been	be	AUX
iajs-3742	28	16	expanded	expand	VERB
iajs-3742	28	17	to	to	PART
iajs-3742	28	18	include	include	VERB
iajs-3742	28	19	suppressing	suppress	VERB
iajs-3742	28	20	a	a	DET
iajs-3742	28	21	number	number	NOUN
iajs-3742	28	22	of	of	ADP
iajs-3742	28	23	cancer	cancer	NOUN
iajs-3742	28	24	cell	cell	NOUN
iajs-3742	28	25	lines	line	NOUN
iajs-3742	28	26	(	(	PUNCT
iajs-3742	28	27	8)	8)	NUM
iajs-3742	28	28	.	.	PUNCT
iajs-3742	29	1	several	several	ADJ
iajs-3742	29	2	bacteriocins	bacteriocin	NOUN
iajs-3742	29	3	have	have	AUX
iajs-3742	29	4	demonstrated	demonstrate	VERB
iajs-3742	29	5	specific	specific	ADJ
iajs-3742	29	6	cytotoxicity	cytotoxicity	NOUN
iajs-3742	29	7	against	against	ADP
iajs-3742	29	8	cancer	cancer	NOUN
iajs-3742	29	9	cells	cell	NOUN
iajs-3742	29	10	compared	compare	VERB
iajs-3742	29	11	to	to	ADP
iajs-3742	29	12	healthy	healthy	ADJ
iajs-3742	29	13	cells	cell	NOUN
iajs-3742	29	14	.	.	PUNCT
iajs-3742	30	1	due	due	ADP
iajs-3742	30	2	to	to	ADP
iajs-3742	30	3	this	this	PRON
iajs-3742	30	4	,	,	PUNCT
iajs-3742	30	5	they	they	PRON
iajs-3742	30	6	are	be	AUX
iajs-3742	30	7	viable	viable	ADJ
iajs-3742	30	8	candidates	candidate	NOUN
iajs-3742	30	9	for	for	ADP
iajs-3742	30	10	additional	additional	ADJ
iajs-3742	30	11	studies	study	NOUN
iajs-3742	30	12	and	and	CCONJ
iajs-3742	30	13	clinical	clinical	ADJ
iajs-3742	30	14	trials	trial	NOUN
iajs-3742	30	15	(	(	PUNCT
iajs-3742	30	16	9	9	NUM
iajs-3742	30	17	)	)	PUNCT
iajs-3742	30	18	.	.	PUNCT
iajs-3742	31	1	many	many	ADJ
iajs-3742	31	2	bacterial	bacterial	ADJ
iajs-3742	31	3	species	specie	NOUN
iajs-3742	31	4	synthesize	synthesize	VERB
iajs-3742	31	5	bioactive	bioactive	ADJ
iajs-3742	31	6	peptides	peptide	NOUN
iajs-3742	31	7	known	know	VERB
iajs-3742	31	8	as	as	ADP
iajs-3742	31	9	bacteriocins	bacteriocin	NOUN
iajs-3742	31	10	(	(	PUNCT
iajs-3742	31	11	10	10	NUM
iajs-3742	31	12	)	)	PUNCT
iajs-3742	31	13	.	.	PUNCT
iajs-3742	32	1	bacteriocins	bacteriocin	NOUN
iajs-3742	32	2	exist	exist	VERB
iajs-3742	32	3	in	in	ADP
iajs-3742	32	4	all	all	DET
iajs-3742	32	5	microbial	microbial	ADJ
iajs-3742	32	6	communities	community	NOUN
iajs-3742	32	7	,	,	PUNCT
iajs-3742	32	8	indicating	indicate	VERB
iajs-3742	32	9	their	their	PRON
iajs-3742	32	10	significance	significance	NOUN
iajs-3742	32	11	for	for	ADP
iajs-3742	32	12	bacterial	bacterial	ADJ
iajs-3742	32	13	survival	survival	NOUN
iajs-3742	32	14	in	in	ADP
iajs-3742	32	15	complex	complex	ADJ
iajs-3742	32	16	microbial	microbial	ADJ
iajs-3742	32	17	environments	environment	NOUN
iajs-3742	32	18	(	(	PUNCT
iajs-3742	32	19	11	11	NUM
iajs-3742	32	20	)	)	PUNCT
iajs-3742	32	21	.	.	PUNCT
iajs-3742	33	1	bacteriocin	bacteriocin	PRON
iajs-3742	33	2	can	can	AUX
iajs-3742	33	3	help	help	VERB
iajs-3742	33	4	with	with	ADP
iajs-3742	33	5	some	some	PRON
iajs-3742	33	6	of	of	ADP
iajs-3742	33	7	the	the	DET
iajs-3742	33	8	most	most	ADV
iajs-3742	33	9	difficult	difficult	ADJ
iajs-3742	33	10	issues	issue	NOUN
iajs-3742	33	11	with	with	ADP
iajs-3742	33	12	multidrug	multidrug	NOUN
iajs-3742	33	13	-	-	PUNCT
iajs-3742	33	14	resistant	resistant	ADJ
iajs-3742	33	15	organisms	organism	NOUN
iajs-3742	33	16	,	,	PUNCT
iajs-3742	33	17	which	which	PRON
iajs-3742	33	18	have	have	AUX
iajs-3742	33	19	become	become	VERB
iajs-3742	33	20	a	a	DET
iajs-3742	33	21	severe	severe	ADJ
iajs-3742	33	22	challenge	challenge	NOUN
iajs-3742	33	23	in	in	ADP
iajs-3742	33	24	disease	disease	NOUN
iajs-3742	33	25	control	control	NOUN
iajs-3742	33	26	(	(	PUNCT
iajs-3742	33	27	12	12	NUM
iajs-3742	33	28	)	)	PUNCT
iajs-3742	33	29	.	.	PUNCT
iajs-3742	34	1	a	a	DET
iajs-3742	34	2	class	class	NOUN
iajs-3742	34	3	of	of	ADP
iajs-3742	34	4	protein	protein	NOUN
iajs-3742	34	5	-	-	PUNCT
iajs-3742	34	6	based	base	VERB
iajs-3742	34	7	antibiotics	antibiotic	NOUN
iajs-3742	34	8	called	call	VERB
iajs-3742	34	9	marcescin	marcescin	NOUN
iajs-3742	34	10	destroys	destroy	VERB
iajs-3742	34	11	sensitive	sensitive	ADJ
iajs-3742	34	12	microorganisms	microorganism	NOUN
iajs-3742	34	13	.	.	PUNCT
iajs-3742	35	1	hamon	hamon	NOUN
iajs-3742	35	2	and	and	CCONJ
iajs-3742	35	3	peron	peron	PROPN
iajs-3742	35	4	reported	report	VERB
iajs-3742	35	5	that	that	SCONJ
iajs-3742	35	6	76	76	NUM
iajs-3742	35	7	of	of	ADP
iajs-3742	35	8	85	85	NUM
iajs-3742	35	9	isolates	isolate	NOUN
iajs-3742	35	10	of	of	ADP
iajs-3742	35	11	s.	s.	PROPN
iajs-3742	35	12	marcescens	marcescens	PROPN
iajs-3742	35	13	produced	produce	VERB
iajs-3742	35	14	the	the	DET
iajs-3742	35	15	bacteriocins	bacteriocin	NOUN
iajs-3742	35	16	known	know	VERB
iajs-3742	35	17	as	as	ADP
iajs-3742	35	18	marcescins	marcescin	NOUN
iajs-3742	35	19	over	over	ADP
iajs-3742	35	20	ten	ten	NUM
iajs-3742	35	21	years	year	NOUN
iajs-3742	35	22	ago	ago	ADV
iajs-3742	35	23	(	(	PUNCT
iajs-3742	35	24	13	13	NUM
iajs-3742	35	25	)	)	PUNCT
iajs-3742	35	26	.	.	PUNCT
iajs-3742	36	1	the	the	DET
iajs-3742	36	2	chromosome	chromosome	NOUN
iajs-3742	36	3	carries	carry	VERB
iajs-3742	36	4	the	the	DET
iajs-3742	36	5	marcescin	marcescin	NOUN
iajs-3742	36	6	genes	gene	NOUN
iajs-3742	36	7	(	(	PUNCT
iajs-3742	36	8	14	14	NUM
iajs-3742	36	9	)	)	PUNCT
iajs-3742	36	10	.	.	PUNCT
iajs-3742	37	1	research	research	NOUN
iajs-3742	37	2	has	have	AUX
iajs-3742	37	3	revealed	reveal	VERB
iajs-3742	37	4	the	the	DET
iajs-3742	37	5	existence	existence	NOUN
iajs-3742	37	6	of	of	ADP
iajs-3742	37	7	both	both	CCONJ
iajs-3742	37	8	broad	broad	ADJ
iajs-3742	37	9	-	-	PUNCT
iajs-3742	37	10	spectrum	spectrum	NOUN
iajs-3742	37	11	and	and	CCONJ
iajs-3742	37	12	targeted	target	VERB
iajs-3742	37	13	antibacterial	antibacterial	ADJ
iajs-3742	37	14	action	action	NOUN
iajs-3742	37	15	against	against	ADP
iajs-3742	37	16	unrelated	unrelated	ADJ
iajs-3742	37	17	pathogens	pathogen	NOUN
iajs-3742	37	18	.	.	PUNCT
iajs-3742	38	1	researchers	researcher	NOUN
iajs-3742	38	2	have	have	AUX
iajs-3742	38	3	also	also	ADV
iajs-3742	38	4	demonstrated	demonstrate	VERB
iajs-3742	38	5	that	that	SCONJ
iajs-3742	38	6	bacteriocins	bacteriocin	NOUN
iajs-3742	38	7	can	can	AUX
iajs-3742	38	8	stop	stop	VERB
iajs-3742	38	9	the	the	DET
iajs-3742	38	10	growth	growth	NOUN
iajs-3742	38	11	of	of	ADP
iajs-3742	38	12	certain	certain	ADJ
iajs-3742	38	13	cancer	cancer	NOUN
iajs-3742	38	14	cell	cell	NOUN
iajs-3742	38	15	lines	line	NOUN
iajs-3742	38	16	(	(	PUNCT
iajs-3742	38	17	15	15	NUM
iajs-3742	38	18	)	)	PUNCT
iajs-3742	38	19	.	.	PUNCT
iajs-3742	39	1	due	due	ADP
iajs-3742	39	2	to	to	ADP
iajs-3742	39	3	their	their	PRON
iajs-3742	39	4	capacity	capacity	NOUN
iajs-3742	39	5	to	to	PART
iajs-3742	39	6	distinguish	distinguish	VERB
iajs-3742	39	7	between	between	ADP
iajs-3742	39	8	cancerous	cancerous	ADJ
iajs-3742	39	9	and	and	CCONJ
iajs-3742	39	10	non	non	ADJ
iajs-3742	39	11	-	-	ADJ
iajs-3742	39	12	cancerous	cancerous	ADJ
iajs-3742	39	13	cells	cell	NOUN
iajs-3742	39	14	,	,	PUNCT
iajs-3742	39	15	bacteriocins	bacteriocin	NOUN
iajs-3742	39	16	have	have	VERB
iajs-3742	39	17	potent	potent	ADJ
iajs-3742	39	18	anticancer	anticancer	NOUN
iajs-3742	39	19	capabilities	capability	NOUN
iajs-3742	39	20	(	(	PUNCT
iajs-3742	39	21	16	16	NUM
iajs-3742	39	22	)	)	PUNCT
iajs-3742	39	23	.	.	PUNCT
iajs-3742	40	1	this	this	DET
iajs-3742	40	2	study	study	NOUN
iajs-3742	40	3	aims	aim	VERB
iajs-3742	40	4	to	to	PART
iajs-3742	40	5	provide	provide	VERB
iajs-3742	40	6	a	a	DET
iajs-3742	40	7	comprehensive	comprehensive	ADJ
iajs-3742	40	8	understanding	understanding	NOUN
iajs-3742	40	9	of	of	ADP
iajs-3742	40	10	the	the	DET
iajs-3742	40	11	anticancer	anticancer	NOUN
iajs-3742	40	12	activities	activity	NOUN
iajs-3742	40	13	of	of	ADP
iajs-3742	40	14	marcescin	marcescin	NOUN
iajs-3742	40	15	and	and	CCONJ
iajs-3742	40	16	their	their	PRON
iajs-3742	40	17	potential	potential	NOUN
iajs-3742	40	18	as	as	ADP
iajs-3742	40	19	therapeutic	therapeutic	ADJ
iajs-3742	40	20	agents	agent	NOUN
iajs-3742	40	21	for	for	ADP
iajs-3742	40	22	the	the	DET
iajs-3742	40	23	disease	disease	NOUN
iajs-3742	40	24	.	.	PUNCT
iajs-3742	41	1	2	2	X
iajs-3742	41	2	.	.	X
iajs-3742	41	3	materials	material	NOUN
iajs-3742	41	4	and	and	CCONJ
iajs-3742	41	5	methods	method	NOUN
iajs-3742	41	6	2.1	2.1	NUM
iajs-3742	41	7	.	.	PUNCT
iajs-3742	42	1	isolation	isolation	NOUN
iajs-3742	42	2	and	and	CCONJ
iajs-3742	42	3	identification	identification	NOUN
iajs-3742	42	4	of	of	ADP
iajs-3742	42	5	s.	s.	PROPN
iajs-3742	42	6	marcescens	marcescens	PROPN
iajs-3742	42	7	.	.	PUNCT
iajs-3742	43	1	two	two	NUM
iajs-3742	43	2	hundred	hundred	NUM
iajs-3742	43	3	samples	sample	NOUN
iajs-3742	43	4	were	be	AUX
iajs-3742	43	5	collected	collect	VERB
iajs-3742	43	6	from	from	ADP
iajs-3742	43	7	various	various	ADJ
iajs-3742	43	8	clinical	clinical	ADJ
iajs-3742	43	9	sources	source	NOUN
iajs-3742	43	10	,	,	PUNCT
iajs-3742	43	11	including	include	VERB
iajs-3742	43	12	blood	blood	NOUN
iajs-3742	43	13	,	,	PUNCT
iajs-3742	43	14	urine	urine	NOUN
iajs-3742	43	15	,	,	PUNCT
iajs-3742	43	16	and	and	CCONJ
iajs-3742	43	17	stool	stool	NOUN
iajs-3742	43	18	from	from	ADP
iajs-3742	43	19	patients	patient	NOUN
iajs-3742	43	20	in	in	ADP
iajs-3742	43	21	hospitals	hospital	NOUN
iajs-3742	43	22	of	of	ADP
iajs-3742	43	23	baghdad	baghdad	PROPN
iajs-3742	43	24	teaching	teaching	NOUN
iajs-3742	43	25	hospital	hospital	NOUN
iajs-3742	43	26	,	,	PUNCT
iajs-3742	43	27	private	private	ADJ
iajs-3742	43	28	nursing	nursing	NOUN
iajs-3742	43	29	home	home	NOUN
iajs-3742	43	30	hospital	hospital	NOUN
iajs-3742	43	31	,	,	PUNCT
iajs-3742	43	32	and	and	CCONJ
iajs-3742	43	33	teaching	teach	VERB
iajs-3742	43	34	laboratories	laboratory	NOUN
iajs-3742	43	35	of	of	ADP
iajs-3742	43	36	medical	medical	ADJ
iajs-3742	43	37	city	city	NOUN
iajs-3742	43	38	in	in	ADP
iajs-3742	43	39	baghdad	baghdad	PROPN
iajs-3742	43	40	city	city	NOUN
iajs-3742	43	41	,	,	PUNCT
iajs-3742	43	42	and	and	CCONJ
iajs-3742	43	43	then	then	ADV
iajs-3742	43	44	they	they	PRON
iajs-3742	43	45	were	be	AUX
iajs-3742	43	46	cultured	cultured	ADJ
iajs-3742	43	47	on	on	ADP
iajs-3742	43	48	culture	culture	NOUN
iajs-3742	43	49	media	medium	NOUN
iajs-3742	43	50	.	.	PUNCT
iajs-3742	44	1	the	the	DET
iajs-3742	44	2	bacteria	bacteria	NOUN
iajs-3742	44	3	were	be	AUX
iajs-3742	44	4	diagnosed	diagnose	VERB
iajs-3742	44	5	based	base	VERB
iajs-3742	44	6	on	on	ADP
iajs-3742	44	7	cultural	cultural	ADJ
iajs-3742	44	8	characteristics	characteristic	NOUN
iajs-3742	44	9	,	,	PUNCT
iajs-3742	44	10	microscopic	microscopic	ADJ
iajs-3742	44	11	examination	examination	NOUN
iajs-3742	44	12	,	,	PUNCT
iajs-3742	44	13	and	and	CCONJ
iajs-3742	44	14	biochemical	biochemical	ADJ
iajs-3742	44	15	tests	test	NOUN
iajs-3742	44	16	,	,	PUNCT
iajs-3742	44	17	and	and	CCONJ
iajs-3742	44	18	then	then	ADV
iajs-3742	44	19	the	the	DET
iajs-3742	44	20	vitek-2	vitek-2	NUM
iajs-3742	44	21	system	system	NOUN
iajs-3742	44	22	was	be	AUX
iajs-3742	44	23	used	use	VERB
iajs-3742	44	24	to	to	PART
iajs-3742	44	25	confirm	confirm	VERB
iajs-3742	44	26	their	their	PRON
iajs-3742	44	27	identity	identity	NOUN
iajs-3742	44	28	.	.	PUNCT
iajs-3742	45	1	2.2	2.2	NUM
iajs-3742	45	2	.	.	PUNCT
iajs-3742	45	3	extraction	extraction	NOUN
iajs-3742	45	4	of	of	ADP
iajs-3742	45	5	marcescin	marcescin	NOUN
iajs-3742	45	6	marcescin	marcescin	NOUN
iajs-3742	45	7	was	be	AUX
iajs-3742	45	8	extracted	extract	VERB
iajs-3742	45	9	from	from	ADP
iajs-3742	45	10	isolates	isolate	NOUN
iajs-3742	45	11	of	of	ADP
iajs-3742	45	12	s.	s.	PROPN
iajs-3742	45	13	marcescens	marcescens	PROPN
iajs-3742	45	14	from	from	ADP
iajs-3742	45	15	blood	blood	NOUN
iajs-3742	45	16	,	,	PUNCT
iajs-3742	45	17	urine	urine	NOUN
iajs-3742	45	18	,	,	PUNCT
iajs-3742	45	19	and	and	CCONJ
iajs-3742	45	20	stool	stool	NOUN
iajs-3742	45	21	samples	sample	NOUN
iajs-3742	45	22	of	of	ADP
iajs-3742	45	23	hospitalized	hospitalize	VERB
iajs-3742	45	24	patients	patient	NOUN
iajs-3742	45	25	(	(	PUNCT
iajs-3742	45	26	17	17	NUM
iajs-3742	45	27	)	)	PUNCT
iajs-3742	45	28	.	.	PUNCT
iajs-3742	46	1	as	as	SCONJ
iajs-3742	46	2	follows	follow	VERB
iajs-3742	46	3	:	:	PUNCT
iajs-3742	46	4	the	the	DET
iajs-3742	46	5	isolates	isolate	NOUN
iajs-3742	46	6	of	of	ADP
iajs-3742	46	7	s.	s.	PROPN
iajs-3742	46	8	marcescens	marcescens	PROPN
iajs-3742	46	9	were	be	AUX
iajs-3742	46	10	cultured	cultured	ADJ
iajs-3742	46	11	in	in	ADP
iajs-3742	46	12	test	test	NOUN
iajs-3742	46	13	tubes	tube	NOUN
iajs-3742	46	14	containing	contain	VERB
iajs-3742	46	15	6.5	6.5	NUM
iajs-3742	46	16	ml	ml	NOUN
iajs-3742	46	17	of	of	ADP
iajs-3742	46	18	sterile	sterile	ADJ
iajs-3742	46	19	bhi	bhi	NOUN
iajs-3742	46	20	broth	broth	NOUN
iajs-3742	46	21	medium	medium	NOUN
iajs-3742	46	22	at	at	ADP
iajs-3742	46	23	a	a	DET
iajs-3742	46	24	temperature	temperature	NOUN
iajs-3742	46	25	of	of	ADP
iajs-3742	46	26	37	37	NUM
iajs-3742	46	27	°	°	NOUN
iajs-3742	46	28	c	c	NOUN
iajs-3742	46	29	for	for	ADP
iajs-3742	46	30	18	18	NUM
iajs-3742	46	31	hours	hour	NOUN
iajs-3742	46	32	.	.	PUNCT
iajs-3742	47	1	we	we	PRON
iajs-3742	47	2	prepared	prepare	VERB
iajs-3742	47	3	the	the	DET
iajs-3742	47	4	b.h.i	b.h.i	NOUN
iajs-3742	47	5	.	.	PUNCT
iajs-3742	48	1	broth	broth	ADJ
iajs-3742	48	2	medium	medium	ADJ
iajs-3742	48	3	+	+	CCONJ
iajs-3742	48	4	5	5	NUM
iajs-3742	48	5	%	%	NOUN
iajs-3742	48	6	glycerol	glycerol	NOUN
iajs-3742	48	7	in	in	ADP
iajs-3742	48	8	suitable	suitable	ADJ
iajs-3742	48	9	flasks	flask	NOUN
iajs-3742	48	10	,	,	PUNCT
iajs-3742	48	11	each	each	PRON
iajs-3742	48	12	with	with	ADP
iajs-3742	48	13	a	a	DET
iajs-3742	48	14	capacity	capacity	NOUN
iajs-3742	48	15	of	of	ADP
iajs-3742	48	16	250	250	NUM
iajs-3742	48	17	ml	ml	NOUN
iajs-3742	48	18	,	,	PUNCT
iajs-3742	48	19	autoclaved	autoclave	VERB
iajs-3742	48	20	it	it	PRON
iajs-3742	48	21	,	,	PUNCT
iajs-3742	48	22	and	and	CCONJ
iajs-3742	48	23	then	then	ADV
iajs-3742	48	24	let	let	VERB
iajs-3742	48	25	it	it	PRON
iajs-3742	48	26	cool	cool	ADJ
iajs-3742	48	27	.	.	PUNCT
iajs-3742	49	1	the	the	DET
iajs-3742	49	2	next	next	ADJ
iajs-3742	49	3	day	day	NOUN
iajs-3742	49	4	,	,	PUNCT
iajs-3742	49	5	we	we	PRON
iajs-3742	49	6	inoculate	inoculate	VERB
iajs-3742	49	7	each	each	DET
iajs-3742	49	8	prepared	prepare	VERB
iajs-3742	49	9	medium	medium	NOUN
iajs-3742	49	10	with	with	ADP
iajs-3742	49	11	a	a	DET
iajs-3742	49	12	tube	tube	NOUN
iajs-3742	49	13	from	from	ADP
iajs-3742	49	14	the	the	DET
iajs-3742	49	15	bacterial	bacterial	ADJ
iajs-3742	49	16	isolate	isolate	NOUN
iajs-3742	49	17	.	.	PUNCT
iajs-3742	50	1	the	the	DET
iajs-3742	50	2	flasks	flask	NOUN
iajs-3742	50	3	are	be	AUX
iajs-3742	50	4	then	then	ADV
iajs-3742	50	5	incubated	incubate	VERB
iajs-3742	50	6	in	in	ADP
iajs-3742	50	7	a	a	DET
iajs-3742	50	8	shaking	shake	VERB
iajs-3742	50	9	incubator	incubator	NOUN
iajs-3742	50	10	for	for	ADP
iajs-3742	50	11	14	14	NUM
iajs-3742	50	12	hours	hour	NOUN
iajs-3742	50	13	at	at	ADP
iajs-3742	50	14	a	a	DET
iajs-3742	50	15	rate	rate	NOUN
iajs-3742	50	16	of	of	ADP
iajs-3742	50	17	150–200	150–200	NUM
iajs-3742	50	18	cycles	cycle	NOUN
iajs-3742	50	19	per	per	ADP
iajs-3742	50	20	minute	minute	NOUN
iajs-3742	50	21	to	to	PART
iajs-3742	50	22	reach	reach	VERB
iajs-3742	50	23	a	a	DET
iajs-3742	50	24	number	number	NOUN
iajs-3742	50	25	of	of	ADP
iajs-3742	50	26	cells	cell	NOUN
iajs-3742	50	27	of	of	ADP
iajs-3742	50	28	about	about	ADV
iajs-3742	50	29	3×10	3×10	NUM
iajs-3742	50	30	4	4	NUM
iajs-3742	50	31	.the	.the	PRON
iajs-3742	50	32	flasks	flask	NOUN
iajs-3742	50	33	receive	receive	VERB
iajs-3742	50	34	a	a	DET
iajs-3742	50	35	dose	dose	NOUN
iajs-3742	50	36	of	of	ADP
iajs-3742	50	37	2	2	NUM
iajs-3742	50	38	μg	μg	NOUN
iajs-3742	50	39	/	/	SYM
iajs-3742	50	40	ml	ml	PROPN
iajs-3742	50	41	of	of	ADP
iajs-3742	50	42	mitomycin	mitomycin	PROPN
iajs-3742	50	43	c	c	NOUN
iajs-3742	50	44	before	before	ADP
iajs-3742	50	45	being	be	AUX
iajs-3742	50	46	placed	place	VERB
iajs-3742	50	47	back	back	ADV
iajs-3742	50	48	in	in	ADP
iajs-3742	50	49	the	the	DET
iajs-3742	50	50	shaking	shake	VERB
iajs-3742	50	51	incubator	incubator	NOUN
iajs-3742	50	52	for	for	ADP
iajs-3742	50	53	an	an	DET
iajs-3742	50	54	additional	additional	ADJ
iajs-3742	50	55	3	3	NUM
iajs-3742	50	56	hours	hour	NOUN
iajs-3742	50	57	.	.	PUNCT
iajs-3742	51	1	we	we	PRON
iajs-3742	51	2	use	use	VERB
iajs-3742	51	3	a	a	DET
iajs-3742	51	4	cooled	cool	VERB
iajs-3742	51	5	centrifuge	centrifuge	NOUN
iajs-3742	51	6	for	for	ADP
iajs-3742	51	7	30	30	NUM
iajs-3742	51	8	minutes	minute	NOUN
iajs-3742	51	9	at	at	ADP
iajs-3742	51	10	ihjpas	ihjpas	PROPN
iajs-3742	51	11	.	.	PUNCT
iajs-3742	52	1	2025	2025	NUM
iajs-3742	52	2	,	,	PUNCT
iajs-3742	52	3	38(3	38(3	NUM
iajs-3742	52	4	)	)	PUNCT
iajs-3742	52	5	81	81	NUM
iajs-3742	52	6	a	a	DET
iajs-3742	52	7	speed	speed	NOUN
iajs-3742	52	8	of	of	ADP
iajs-3742	52	9	7000	7000	NUM
iajs-3742	52	10	cycles	cycle	NOUN
iajs-3742	52	11	per	per	ADP
iajs-3742	52	12	minute	minute	NOUN
iajs-3742	52	13	to	to	PART
iajs-3742	52	14	separate	separate	VERB
iajs-3742	52	15	the	the	DET
iajs-3742	52	16	bacteria	bacteria	NOUN
iajs-3742	52	17	in	in	ADP
iajs-3742	52	18	each	each	DET
iajs-3742	52	19	flask	flask	NOUN
iajs-3742	52	20	after	after	ADP
iajs-3742	52	21	incubation	incubation	NOUN
iajs-3742	52	22	.	.	PUNCT
iajs-3742	53	1	finally	finally	ADV
iajs-3742	53	2	,	,	PUNCT
iajs-3742	53	3	we	we	PRON
iajs-3742	53	4	separated	separate	VERB
iajs-3742	53	5	the	the	DET
iajs-3742	53	6	supernatant	supernatant	NOUN
iajs-3742	53	7	from	from	ADP
iajs-3742	53	8	the	the	DET
iajs-3742	53	9	precipitate	precipitate	NOUN
iajs-3742	53	10	for	for	ADP
iajs-3742	53	11	each	each	DET
iajs-3742	53	12	flask	flask	NOUN
iajs-3742	53	13	containing	contain	VERB
iajs-3742	53	14	marcescin	marcescin	NOUN
iajs-3742	53	15	.	.	PUNCT
iajs-3742	54	1	next	next	ADV
iajs-3742	54	2	,	,	PUNCT
iajs-3742	54	3	we	we	PRON
iajs-3742	54	4	used	use	VERB
iajs-3742	54	5	the	the	DET
iajs-3742	54	6	bradford	bradford	PROPN
iajs-3742	54	7	method	method	NOUN
iajs-3742	54	8	to	to	PART
iajs-3742	54	9	measure	measure	VERB
iajs-3742	54	10	the	the	DET
iajs-3742	54	11	concentration	concentration	NOUN
iajs-3742	54	12	of	of	ADP
iajs-3742	54	13	marcescin	marcescin	NOUN
iajs-3742	54	14	(	(	PUNCT
iajs-3742	54	15	18	18	NUM
iajs-3742	54	16	)	)	PUNCT
iajs-3742	54	17	.	.	PUNCT
iajs-3742	55	1	we	we	PRON
iajs-3742	55	2	measured	measure	VERB
iajs-3742	55	3	the	the	DET
iajs-3742	55	4	effectiveness	effectiveness	NOUN
iajs-3742	55	5	of	of	ADP
iajs-3742	55	6	marcescin	marcescin	NOUN
iajs-3742	55	7	using	use	VERB
iajs-3742	55	8	the	the	DET
iajs-3742	55	9	well	well	ADJ
iajs-3742	55	10	method	method	NOUN
iajs-3742	55	11	(	(	PUNCT
iajs-3742	55	12	19	19	NUM
iajs-3742	55	13	)	)	PUNCT
iajs-3742	55	14	.	.	PUNCT
iajs-3742	56	1	2.3	2.3	NUM
iajs-3742	56	2	.	.	PUNCT
iajs-3742	56	3	study	study	VERB
iajs-3742	56	4	the	the	DET
iajs-3742	56	5	toxic	toxic	ADJ
iajs-3742	56	6	effects	effect	NOUN
iajs-3742	56	7	of	of	ADP
iajs-3742	56	8	marcescin	marcescin	NOUN
iajs-3742	56	9	on	on	ADP
iajs-3742	56	10	the	the	DET
iajs-3742	56	11	hep-2	hep-2	PUNCT
iajs-3742	56	12	cancer	cancer	NOUN
iajs-3742	56	13	cell	cell	NOUN
iajs-3742	56	14	line	line	NOUN
iajs-3742	56	15	in	in	ADP
iajs-3742	56	16	vitro	vitro	X
iajs-3742	56	17	.	.	PUNCT
iajs-3742	57	1	the	the	DET
iajs-3742	57	2	study	study	NOUN
iajs-3742	57	3	of	of	ADP
iajs-3742	57	4	the	the	DET
iajs-3742	57	5	toxic	toxic	ADJ
iajs-3742	57	6	effect	effect	NOUN
iajs-3742	57	7	of	of	ADP
iajs-3742	57	8	marcescin	marcescin	NOUN
iajs-3742	57	9	in	in	ADP
iajs-3742	57	10	different	different	ADJ
iajs-3742	57	11	concentrations	concentration	NOUN
iajs-3742	57	12	(	(	PUNCT
iajs-3742	57	13	0.0	0.0	NUM
iajs-3742	57	14	,	,	PUNCT
iajs-3742	57	15	1.95	1.95	NUM
iajs-3742	57	16	,	,	PUNCT
iajs-3742	57	17	3.9	3.9	NUM
iajs-3742	57	18	,	,	PUNCT
iajs-3742	57	19	7.8	7.8	NUM
iajs-3742	57	20	,	,	PUNCT
iajs-3742	57	21	15.62	15.62	NUM
iajs-3742	57	22	,	,	PUNCT
iajs-3742	57	23	31.25	31.25	NUM
iajs-3742	57	24	,	,	PUNCT
iajs-3742	57	25	62.5	62.5	NUM
iajs-3742	57	26	,	,	PUNCT
iajs-3742	57	27	125	125	NUM
iajs-3742	57	28	,	,	PUNCT
iajs-3742	57	29	250	250	NUM
iajs-3742	57	30	,	,	PUNCT
iajs-3742	57	31	500	500	NUM
iajs-3742	57	32	,	,	PUNCT
iajs-3742	57	33	1000	1000	NUM
iajs-3742	57	34	μg	μg	NOUN
iajs-3742	57	35	/	/	SYM
iajs-3742	57	36	ml	ml	NOUN
iajs-3742	57	37	)	)	PUNCT
iajs-3742	57	38	on	on	ADP
iajs-3742	57	39	the	the	DET
iajs-3742	57	40	human	human	ADJ
iajs-3742	57	41	laryngx	laryngx	PROPN
iajs-3742	57	42	cancer	cancer	NOUN
iajs-3742	57	43	cell	cell	NOUN
iajs-3742	57	44	line	line	NOUN
iajs-3742	57	45	(	(	PUNCT
iajs-3742	57	46	hep2	hep2	PROPN
iajs-3742	57	47	)	)	PUNCT
iajs-3742	57	48	.	.	PUNCT
iajs-3742	58	1	it	it	PRON
iajs-3742	58	2	is	be	AUX
iajs-3742	58	3	grown	grow	VERB
iajs-3742	58	4	on	on	ADP
iajs-3742	58	5	rpmi-1640	rpmi-1640	ADJ
iajs-3742	58	6	medium	medium	NOUN
iajs-3742	58	7	supplemented	supplement	VERB
iajs-3742	58	8	with	with	ADP
iajs-3742	58	9	5	5	NUM
iajs-3742	58	10	%	%	NOUN
iajs-3742	58	11	fetal	fetal	ADJ
iajs-3742	58	12	calf	calf	NOUN
iajs-3742	58	13	serum	serum	NOUN
iajs-3742	58	14	(	(	PUNCT
iajs-3742	58	15	fcs	fcs	PROPN
iajs-3742	58	16	)	)	PUNCT
iajs-3742	58	17	.	.	PUNCT
iajs-3742	59	1	2.4	2.4	NUM
iajs-3742	59	2	.	.	PUNCT
iajs-3742	59	3	marcescins	marcescin	NOUN
iajs-3742	59	4	'	'	PART
iajs-3742	59	5	cytotoxic	cytotoxic	ADJ
iajs-3742	59	6	effects	effect	NOUN
iajs-3742	59	7	on	on	ADP
iajs-3742	59	8	cancer	cancer	NOUN
iajs-3742	59	9	cells	cell	NOUN
iajs-3742	59	10	the	the	DET
iajs-3742	59	11	study	study	NOUN
iajs-3742	59	12	was	be	AUX
iajs-3742	59	13	carried	carry	VERB
iajs-3742	59	14	out	out	ADP
iajs-3742	59	15	using	use	VERB
iajs-3742	59	16	96	96	NUM
iajs-3742	59	17	flat	flat	ADV
iajs-3742	59	18	-	-	PUNCT
iajs-3742	59	19	bottomed	bottom	VERB
iajs-3742	59	20	,	,	PUNCT
iajs-3742	59	21	multiple	multiple	ADJ
iajs-3742	59	22	-	-	PUNCT
iajs-3742	59	23	tissue	tissue	NOUN
iajs-3742	59	24	culture	culture	NOUN
iajs-3742	59	25	microtiter	microtiter	NOUN
iajs-3742	59	26	plates	plate	NOUN
iajs-3742	59	27	,	,	PUNCT
iajs-3742	59	28	which	which	PRON
iajs-3742	59	29	involved	involve	VERB
iajs-3742	59	30	three	three	NUM
iajs-3742	59	31	steps	step	NOUN
iajs-3742	59	32	:	:	PUNCT
iajs-3742	60	1	2.4.1	2.4.1	NUM
iajs-3742	60	2	.	.	PUNCT
iajs-3742	60	3	seeding	seed	VERB
iajs-3742	60	4	of	of	ADP
iajs-3742	60	5	cells	cell	NOUN
iajs-3742	60	6	.	.	PUNCT
iajs-3742	61	1	after	after	SCONJ
iajs-3742	61	2	the	the	DET
iajs-3742	61	3	cells	cell	NOUN
iajs-3742	61	4	had	have	AUX
iajs-3742	61	5	grown	grow	VERB
iajs-3742	61	6	and	and	CCONJ
iajs-3742	61	7	multiplied	multiply	VERB
iajs-3742	61	8	,	,	PUNCT
iajs-3742	61	9	the	the	DET
iajs-3742	61	10	monolayer	monolayer	NOUN
iajs-3742	61	11	-	-	PUNCT
iajs-3742	61	12	containing	contain	VERB
iajs-3742	61	13	containers	container	NOUN
iajs-3742	61	14	were	be	AUX
iajs-3742	61	15	taken	take	VERB
iajs-3742	61	16	out	out	ADP
iajs-3742	61	17	,	,	PUNCT
iajs-3742	61	18	and	and	CCONJ
iajs-3742	61	19	the	the	DET
iajs-3742	61	20	cells	cell	NOUN
iajs-3742	61	21	were	be	AUX
iajs-3742	61	22	then	then	ADV
iajs-3742	61	23	harvested	harvest	VERB
iajs-3742	61	24	using	use	VERB
iajs-3742	61	25	a	a	DET
iajs-3742	61	26	trypsin	trypsin	NOUN
iajs-3742	61	27	-	-	PUNCT
iajs-3742	61	28	versin	versin	NOUN
iajs-3742	61	29	(	(	PUNCT
iajs-3742	61	30	t.v	t.v	PROPN
iajs-3742	61	31	.	.	PUNCT
iajs-3742	61	32	)	)	PUNCT
iajs-3742	61	33	solution	solution	NOUN
iajs-3742	61	34	.	.	PUNCT
iajs-3742	62	1	each	each	DET
iajs-3742	62	2	container	container	NOUN
iajs-3742	62	3	received	receive	VERB
iajs-3742	62	4	20	20	NUM
iajs-3742	62	5	ml	ml	NOUN
iajs-3742	62	6	of	of	ADP
iajs-3742	62	7	the	the	DET
iajs-3742	62	8	culture	culture	NOUN
iajs-3742	62	9	medium	medium	NOUN
iajs-3742	62	10	,	,	PUNCT
iajs-3742	62	11	including	include	VERB
iajs-3742	62	12	serum	serum	NOUN
iajs-3742	62	13	,	,	PUNCT
iajs-3742	62	14	which	which	PRON
iajs-3742	62	15	was	be	AUX
iajs-3742	62	16	added	add	VERB
iajs-3742	62	17	and	and	CCONJ
iajs-3742	62	18	thoroughly	thoroughly	ADV
iajs-3742	62	19	mixed	mixed	ADJ
iajs-3742	62	20	.	.	PUNCT
iajs-3742	63	1	following	follow	VERB
iajs-3742	63	2	that	that	PRON
iajs-3742	63	3	,	,	PUNCT
iajs-3742	63	4	the	the	DET
iajs-3742	63	5	cells	cell	NOUN
iajs-3742	63	6	were	be	AUX
iajs-3742	63	7	counted	count	VERB
iajs-3742	63	8	using	use	VERB
iajs-3742	63	9	a	a	DET
iajs-3742	63	10	(	(	PUNCT
iajs-3742	63	11	haemocytometer	haemocytometer	NOUN
iajs-3742	63	12	)	)	PUNCT
iajs-3742	63	13	and	and	CCONJ
iajs-3742	63	14	1	1	NUM
iajs-3742	63	15	%	%	NOUN
iajs-3742	63	16	trypan	trypan	NOUN
iajs-3742	63	17	blue	blue	ADJ
iajs-3742	63	18	dye	dye	NOUN
iajs-3742	63	19	,	,	PUNCT
iajs-3742	63	20	as	as	SCONJ
iajs-3742	63	21	suggested	suggest	VERB
iajs-3742	63	22	by	by	ADP
iajs-3742	63	23	freshney	freshney	ADJ
iajs-3742	63	24	(	(	PUNCT
iajs-3742	63	25	20	20	NUM
iajs-3742	63	26	)	)	PUNCT
iajs-3742	63	27	.	.	PUNCT
iajs-3742	64	1	(	(	PUNCT
iajs-3742	64	2	0.1	0.1	NUM
iajs-3742	64	3	)	)	PUNCT
iajs-3742	64	4	ml	ml	NOUN
iajs-3742	64	5	of	of	ADP
iajs-3742	64	6	the	the	DET
iajs-3742	64	7	cell	cell	NOUN
iajs-3742	64	8	suspension	suspension	NOUN
iajs-3742	64	9	was	be	AUX
iajs-3742	64	10	pipetted	pipette	VERB
iajs-3742	64	11	into	into	ADP
iajs-3742	64	12	each	each	DET
iajs-3742	64	13	well	well	NOUN
iajs-3742	64	14	of	of	ADP
iajs-3742	64	15	the	the	DET
iajs-3742	64	16	plate	plate	NOUN
iajs-3742	64	17	using	use	VERB
iajs-3742	64	18	a	a	DET
iajs-3742	64	19	micropipette	micropipette	NOUN
iajs-3742	64	20	.	.	PUNCT
iajs-3742	65	1	(	(	PUNCT
iajs-3742	65	2	1	1	NUM
iajs-3742	65	3	×10	×10	NOUN
iajs-3742	65	4	4	4	NUM
iajs-3742	65	5	)	)	PUNCT
iajs-3742	65	6	cells	cell	NOUN
iajs-3742	65	7	/	/	SYM
iajs-3742	65	8	wells	well	NOUN
iajs-3742	65	9	were	be	AUX
iajs-3742	65	10	contained	contain	VERB
iajs-3742	65	11	in	in	ADP
iajs-3742	65	12	each	each	DET
iajs-3742	65	13	well	well	NOUN
iajs-3742	65	14	.	.	PUNCT
iajs-3742	66	1	in	in	ADP
iajs-3742	66	2	order	order	NOUN
iajs-3742	66	3	to	to	PART
iajs-3742	66	4	facilitate	facilitate	VERB
iajs-3742	66	5	cell	cell	NOUN
iajs-3742	66	6	attachment	attachment	NOUN
iajs-3742	66	7	,	,	PUNCT
iajs-3742	66	8	the	the	DET
iajs-3742	66	9	surface	surface	NOUN
iajs-3742	66	10	of	of	ADP
iajs-3742	66	11	the	the	DET
iajs-3742	66	12	plate	plate	NOUN
iajs-3742	66	13	was	be	AUX
iajs-3742	66	14	then	then	ADV
iajs-3742	66	15	covered	cover	VERB
iajs-3742	66	16	with	with	ADP
iajs-3742	66	17	a	a	DET
iajs-3742	66	18	specific	specific	ADJ
iajs-3742	66	19	kind	kind	NOUN
iajs-3742	66	20	of	of	ADP
iajs-3742	66	21	sterile	sterile	ADJ
iajs-3742	66	22	,	,	PUNCT
iajs-3742	66	23	transparent	transparent	ADJ
iajs-3742	66	24	adhesive	adhesive	ADJ
iajs-3742	66	25	paper	paper	NOUN
iajs-3742	66	26	.	.	PUNCT
iajs-3742	67	1	the	the	DET
iajs-3742	67	2	plate	plate	NOUN
iajs-3742	67	3	was	be	AUX
iajs-3742	67	4	then	then	ADV
iajs-3742	67	5	gently	gently	ADV
iajs-3742	67	6	rotated	rotate	VERB
iajs-3742	67	7	before	before	ADP
iajs-3742	67	8	being	be	AUX
iajs-3742	67	9	incubated	incubate	VERB
iajs-3742	67	10	at	at	ADP
iajs-3742	67	11	37	37	NUM
iajs-3742	67	12	°	°	NOUN
iajs-3742	67	13	c	c	NOUN
iajs-3742	67	14	overnight	overnight	ADV
iajs-3742	67	15	.	.	PUNCT
iajs-3742	68	1	2.4.2	2.4.2	NUM
iajs-3742	68	2	.	.	PUNCT
iajs-3742	68	3	exposure	exposure	NOUN
iajs-3742	68	4	of	of	ADP
iajs-3742	68	5	cancerous	cancerous	ADJ
iajs-3742	68	6	cells	cell	NOUN
iajs-3742	68	7	to	to	ADP
iajs-3742	68	8	the	the	DET
iajs-3742	68	9	marcescin	marcescin	NOUN
iajs-3742	68	10	serial	serial	ADJ
iajs-3742	68	11	concentrations	concentration	NOUN
iajs-3742	68	12	of	of	ADP
iajs-3742	68	13	marcescin	marcescin	NOUN
iajs-3742	68	14	were	be	AUX
iajs-3742	68	15	prepared	prepare	VERB
iajs-3742	68	16	using	use	VERB
iajs-3742	68	17	tissue	tissue	NOUN
iajs-3742	68	18	culture	culture	NOUN
iajs-3742	68	19	medium	medium	ADJ
iajs-3742	68	20	devoid	devoid	ADJ
iajs-3742	68	21	of	of	ADP
iajs-3742	68	22	(	(	PUNCT
iajs-3742	68	23	fcs	fc	NOUN
iajs-3742	68	24	)	)	PUNCT
iajs-3742	68	25	,	,	PUNCT
iajs-3742	68	26	and	and	CCONJ
iajs-3742	68	27	added	add	VERB
iajs-3742	68	28	to	to	ADP
iajs-3742	68	29	the	the	DET
iajs-3742	68	30	pits	pit	NOUN
iajs-3742	68	31	containing	contain	VERB
iajs-3742	68	32	adherent	adherent	ADJ
iajs-3742	68	33	cancer	cancer	NOUN
iajs-3742	68	34	cells	cell	NOUN
iajs-3742	68	35	,	,	PUNCT
iajs-3742	68	36	taking	take	VERB
iajs-3742	68	37	into	into	ADP
iajs-3742	68	38	account	account	NOUN
iajs-3742	68	39	the	the	DET
iajs-3742	68	40	preparation	preparation	NOUN
iajs-3742	68	41	of	of	ADP
iajs-3742	68	42	material	material	ADJ
iajs-3742	68	43	solutions	solution	NOUN
iajs-3742	68	44	immediately	immediately	ADV
iajs-3742	68	45	upon	upon	SCONJ
iajs-3742	68	46	use	use	NOUN
iajs-3742	68	47	,	,	PUNCT
iajs-3742	68	48	and	and	CCONJ
iajs-3742	68	49	using	use	VERB
iajs-3742	68	50	three	three	NUM
iajs-3742	68	51	replicates	replicate	NOUN
iajs-3742	68	52	for	for	ADP
iajs-3742	68	53	each	each	DET
iajs-3742	68	54	treatment	treatment	NOUN
iajs-3742	68	55	.	.	PUNCT
iajs-3742	69	1	after	after	ADP
iajs-3742	69	2	removing	remove	VERB
iajs-3742	69	3	the	the	DET
iajs-3742	69	4	adhesive	adhesive	ADJ
iajs-3742	69	5	paper	paper	NOUN
iajs-3742	69	6	,	,	PUNCT
iajs-3742	69	7	the	the	DET
iajs-3742	69	8	culture	culture	NOUN
iajs-3742	69	9	medium	medium	NOUN
iajs-3742	69	10	was	be	AUX
iajs-3742	69	11	emptied	empty	VERB
iajs-3742	69	12	from	from	ADP
iajs-3742	69	13	the	the	DET
iajs-3742	69	14	wells	well	NOUN
iajs-3742	69	15	.	.	PUNCT
iajs-3742	70	1	due	due	ADP
iajs-3742	70	2	to	to	ADP
iajs-3742	70	3	the	the	DET
iajs-3742	70	4	addition	addition	NOUN
iajs-3742	70	5	of	of	ADP
iajs-3742	70	6	0.2	0.2	NUM
iajs-3742	70	7	ml	ml	NOUN
iajs-3742	70	8	of	of	ADP
iajs-3742	70	9	serum	serum	NOUN
iajs-3742	70	10	-	-	PUNCT
iajs-3742	70	11	free	free	ADJ
iajs-3742	70	12	culture	culture	NOUN
iajs-3742	70	13	media	medium	NOUN
iajs-3742	70	14	,	,	PUNCT
iajs-3742	70	15	column	column	NOUN
iajs-3742	70	16	no	no	NOUN
iajs-3742	70	17	.	.	PROPN
iajs-3742	70	18	1	1	NUM
iajs-3742	70	19	was	be	AUX
iajs-3742	70	20	regarded	regard	VERB
iajs-3742	70	21	as	as	ADP
iajs-3742	70	22	a	a	DET
iajs-3742	70	23	negative	negative	ADJ
iajs-3742	70	24	control	control	NOUN
iajs-3742	70	25	.	.	PUNCT
iajs-3742	71	1	while	while	SCONJ
iajs-3742	71	2	the	the	DET
iajs-3742	71	3	dilutions	dilution	NOUN
iajs-3742	71	4	of	of	ADP
iajs-3742	71	5	the	the	DET
iajs-3742	71	6	marcescin	marcescin	NOUN
iajs-3742	71	7	,	,	PUNCT
iajs-3742	71	8	which	which	PRON
iajs-3742	71	9	were	be	AUX
iajs-3742	71	10	made	make	VERB
iajs-3742	71	11	as	as	ADP
iajs-3742	71	12	(	(	PUNCT
iajs-3742	71	13	0.2	0.2	NUM
iajs-3742	71	14	ml/	ml/	NOUN
iajs-3742	71	15	well/	well/	PUNCT
iajs-3742	71	16	concentration	concentration	NOUN
iajs-3742	71	17	)	)	PUNCT
iajs-3742	71	18	were	be	AUX
iajs-3742	71	19	applied	apply	VERB
iajs-3742	71	20	to	to	ADP
iajs-3742	71	21	the	the	DET
iajs-3742	71	22	columns	column	NOUN
iajs-3742	71	23	from	from	ADP
iajs-3742	71	24	2	2	NUM
iajs-3742	71	25	to	to	ADP
iajs-3742	71	26	12	12	NUM
iajs-3742	71	27	,	,	PUNCT
iajs-3742	71	28	a	a	DET
iajs-3742	71	29	new	new	ADJ
iajs-3742	71	30	piece	piece	NOUN
iajs-3742	71	31	of	of	ADP
iajs-3742	71	32	adhesive	adhesive	ADJ
iajs-3742	71	33	paper	paper	NOUN
iajs-3742	71	34	was	be	AUX
iajs-3742	71	35	then	then	ADV
iajs-3742	71	36	placed	place	VERB
iajs-3742	71	37	on	on	ADP
iajs-3742	71	38	the	the	DET
iajs-3742	71	39	plate	plate	NOUN
iajs-3742	71	40	's	's	PART
iajs-3742	71	41	surface	surface	NOUN
iajs-3742	71	42	.	.	PUNCT
iajs-3742	72	1	the	the	DET
iajs-3742	72	2	plates	plate	NOUN
iajs-3742	72	3	were	be	AUX
iajs-3742	72	4	exposed	expose	VERB
iajs-3742	72	5	for	for	ADP
iajs-3742	72	6	24	24	NUM
iajs-3742	72	7	,	,	PUNCT
iajs-3742	72	8	48	48	NUM
iajs-3742	72	9	,	,	PUNCT
iajs-3742	72	10	and	and	CCONJ
iajs-3742	72	11	72	72	NUM
iajs-3742	72	12	hours	hour	NOUN
iajs-3742	72	13	each	each	PRON
iajs-3742	72	14	at	at	ADP
iajs-3742	72	15	a	a	DET
iajs-3742	72	16	temperature	temperature	NOUN
iajs-3742	72	17	of	of	ADP
iajs-3742	72	18	37	37	NUM
iajs-3742	72	19	°	°	NOUN
iajs-3742	72	20	c	c	NOUN
iajs-3742	72	21	.	.	PUNCT
iajs-3742	73	1	2.4.3	2.4.3	X
iajs-3742	73	2	.	.	X
iajs-3742	73	3	cytotoxicity	cytotoxicity	NOUN
iajs-3742	73	4	assay	assay	VERB
iajs-3742	73	5	the	the	DET
iajs-3742	73	6	assay	assay	NOUN
iajs-3742	73	7	mtt	mtt	NOUN
iajs-3742	73	8	test	test	NOUN
iajs-3742	73	9	was	be	AUX
iajs-3742	73	10	used	use	VERB
iajs-3742	73	11	to	to	PART
iajs-3742	73	12	detect	detect	VERB
iajs-3742	73	13	the	the	DET
iajs-3742	73	14	cytotoxic	cytotoxic	ADJ
iajs-3742	73	15	effect	effect	NOUN
iajs-3742	73	16	of	of	ADP
iajs-3742	73	17	marcescin	marcescin	NOUN
iajs-3742	73	18	on	on	ADP
iajs-3742	73	19	cancer	cancer	NOUN
iajs-3742	73	20	cells	cell	NOUN
iajs-3742	73	21	,	,	PUNCT
iajs-3742	73	22	according	accord	VERB
iajs-3742	73	23	to	to	ADP
iajs-3742	73	24	the	the	DET
iajs-3742	73	25	following	following	ADJ
iajs-3742	73	26	steps	step	NOUN
iajs-3742	73	27	:	:	PUNCT
iajs-3742	73	28	in	in	ADP
iajs-3742	73	29	order	order	NOUN
iajs-3742	73	30	to	to	PART
iajs-3742	73	31	verify	verify	VERB
iajs-3742	73	32	that	that	SCONJ
iajs-3742	73	33	all	all	DET
iajs-3742	73	34	traces	trace	NOUN
iajs-3742	73	35	of	of	ADP
iajs-3742	73	36	the	the	DET
iajs-3742	73	37	test	test	NOUN
iajs-3742	73	38	material	material	NOUN
iajs-3742	73	39	and	and	CCONJ
iajs-3742	73	40	non	non	ADJ
iajs-3742	73	41	-	-	ADJ
iajs-3742	73	42	adherent	adherent	ADJ
iajs-3742	73	43	cells	cell	NOUN
iajs-3742	73	44	were	be	AUX
iajs-3742	73	45	eliminated	eliminate	VERB
iajs-3742	73	46	,	,	PUNCT
iajs-3742	73	47	the	the	DET
iajs-3742	73	48	culture	culture	NOUN
iajs-3742	73	49	media	medium	NOUN
iajs-3742	73	50	and	and	CCONJ
iajs-3742	73	51	suspended	suspend	VERB
iajs-3742	73	52	cells	cell	NOUN
iajs-3742	73	53	in	in	ADP
iajs-3742	73	54	the	the	DET
iajs-3742	73	55	plates	plate	NOUN
iajs-3742	73	56	were	be	AUX
iajs-3742	73	57	removed	remove	VERB
iajs-3742	73	58	after	after	ADP
iajs-3742	73	59	the	the	DET
iajs-3742	73	60	specified	specified	ADJ
iajs-3742	73	61	incubation	incubation	NOUN
iajs-3742	73	62	period	period	NOUN
iajs-3742	73	63	and	and	CCONJ
iajs-3742	73	64	then	then	ADV
iajs-3742	73	65	washed	wash	VERB
iajs-3742	73	66	three	three	NUM
iajs-3742	73	67	times	time	NOUN
iajs-3742	73	68	with	with	ADP
iajs-3742	73	69	phosphate	phosphate	NOUN
iajs-3742	73	70	-	-	PUNCT
iajs-3742	73	71	buffered	buffer	VERB
iajs-3742	73	72	saline	saline	NOUN
iajs-3742	73	73	.	.	PUNCT
iajs-3742	74	1	then	then	ADV
iajs-3742	74	2	,	,	PUNCT
iajs-3742	74	3	a	a	DET
iajs-3742	74	4	volume	volume	NOUN
iajs-3742	74	5	of	of	ADP
iajs-3742	74	6	10	10	NUM
iajs-3742	74	7	µl	µl	NOUN
iajs-3742	74	8	of	of	ADP
iajs-3742	74	9	mtt	mtt	NOUN
iajs-3742	74	10	dye	dye	NOUN
iajs-3742	74	11	solution	solution	NOUN
iajs-3742	74	12	(	(	PUNCT
iajs-3742	74	13	with	with	ADP
iajs-3742	74	14	a	a	DET
iajs-3742	74	15	final	final	ADJ
iajs-3742	74	16	concentration	concentration	NOUN
iajs-3742	74	17	of	of	ADP
iajs-3742	74	18	0.5	0.5	NUM
iajs-3742	74	19	mg	mg	NUM
iajs-3742	74	20	/	/	SYM
iajs-3742	74	21	ml	ml	NOUN
iajs-3742	74	22	)	)	PUNCT
iajs-3742	74	23	was	be	AUX
iajs-3742	74	24	added	add	VERB
iajs-3742	74	25	to	to	ADP
iajs-3742	74	26	each	each	DET
iajs-3742	74	27	well	well	ADV
iajs-3742	74	28	and	and	CCONJ
iajs-3742	74	29	left	leave	VERB
iajs-3742	74	30	for	for	ADP
iajs-3742	74	31	4	4	NUM
iajs-3742	74	32	hours	hour	NOUN
iajs-3742	74	33	at	at	ADP
iajs-3742	74	34	a	a	DET
iajs-3742	74	35	temperature	temperature	NOUN
iajs-3742	74	36	of	of	ADP
iajs-3742	74	37	37	37	NUM
iajs-3742	74	38	°	°	NOUN
iajs-3742	74	39	c	c	NOUN
iajs-3742	74	40	in	in	ADP
iajs-3742	74	41	a	a	DET
iajs-3742	74	42	carbon	carbon	NOUN
iajs-3742	74	43	dioxide	dioxide	NOUN
iajs-3742	74	44	incubator	incubator	NOUN
iajs-3742	74	45	.	.	PUNCT
iajs-3742	75	1	the	the	DET
iajs-3742	75	2	excess	excess	ADJ
iajs-3742	75	3	dye	dye	NOUN
iajs-3742	75	4	was	be	AUX
iajs-3742	75	5	removed	remove	VERB
iajs-3742	75	6	from	from	ADP
iajs-3742	75	7	the	the	DET
iajs-3742	75	8	cells	cell	NOUN
iajs-3742	75	9	by	by	ADP
iajs-3742	75	10	repeatedly	repeatedly	ADV
iajs-3742	75	11	washing	wash	VERB
iajs-3742	75	12	them	they	PRON
iajs-3742	75	13	in	in	ADP
iajs-3742	75	14	pbs	pbs	PROPN
iajs-3742	75	15	.	.	PUNCT
iajs-3742	76	1	to	to	PART
iajs-3742	76	2	ensure	ensure	VERB
iajs-3742	76	3	the	the	DET
iajs-3742	76	4	violet	violet	ADJ
iajs-3742	76	5	granules	granule	NOUN
iajs-3742	76	6	were	be	AUX
iajs-3742	76	7	totally	totally	ADV
iajs-3742	76	8	dissolved	dissolve	VERB
iajs-3742	76	9	,	,	PUNCT
iajs-3742	76	10	100	100	NUM
iajs-3742	76	11	µl	µl	NOUN
iajs-3742	76	12	of	of	ADP
iajs-3742	76	13	dmso	dmso	NOUN
iajs-3742	76	14	were	be	AUX
iajs-3742	76	15	added	add	VERB
iajs-3742	76	16	when	when	SCONJ
iajs-3742	76	17	the	the	DET
iajs-3742	76	18	dishes	dish	NOUN
iajs-3742	76	19	were	be	AUX
iajs-3742	76	20	completely	completely	ADV
iajs-3742	76	21	dry	dry	ADJ
iajs-3742	76	22	.	.	PUNCT
iajs-3742	77	1	at	at	ADP
iajs-3742	77	2	a	a	DET
iajs-3742	77	3	wavelength	wavelength	NOUN
iajs-3742	77	4	of	of	ADP
iajs-3742	77	5	500	500	NUM
iajs-3742	77	6	nanometers	nanometer	NOUN
iajs-3742	77	7	,	,	PUNCT
iajs-3742	77	8	results	result	NOUN
iajs-3742	77	9	were	be	AUX
iajs-3742	77	10	read	read	VERB
iajs-3742	77	11	using	use	VERB
iajs-3742	77	12	an	an	DET
iajs-3742	77	13	elisa	elisa	NOUN
iajs-3742	77	14	microplate	microplate	NOUN
iajs-3742	77	15	spectrophotometer	spectrophotometer	NOUN
iajs-3742	77	16	,	,	PUNCT
iajs-3742	77	17	keeping	keep	VERB
iajs-3742	77	18	in	in	ADP
iajs-3742	77	19	mind	mind	NOUN
iajs-3742	77	20	that	that	SCONJ
iajs-3742	77	21	the	the	DET
iajs-3742	77	22	work	work	NOUN
iajs-3742	77	23	should	should	AUX
iajs-3742	77	24	be	be	AUX
iajs-3742	77	25	done	do	VERB
iajs-3742	77	26	with	with	ADP
iajs-3742	77	27	mtt	mtt	NOUN
iajs-3742	77	28	dye	dye	NOUN
iajs-3742	77	29	away	away	ADV
iajs-3742	77	30	from	from	ADP
iajs-3742	77	31	light	light	NOUN
iajs-3742	77	32	(	(	PUNCT
iajs-3742	77	33	21	21	NUM
iajs-3742	77	34	,	,	PUNCT
iajs-3742	77	35	22	22	NUM
iajs-3742	77	36	)	)	PUNCT
iajs-3742	77	37	.	.	PUNCT
iajs-3742	78	1	the	the	DET
iajs-3742	78	2	rate	rate	NOUN
iajs-3742	78	3	of	of	ADP
iajs-3742	78	4	cancer	cancer	NOUN
iajs-3742	78	5	cell	cell	NOUN
iajs-3742	78	6	growth	growth	NOUN
iajs-3742	78	7	inhibition	inhibition	NOUN
iajs-3742	78	8	(	(	PUNCT
iajs-3742	78	9	inhibitory	inhibitory	ADJ
iajs-3742	78	10	rate	rate	NOUN
iajs-3742	78	11	)	)	PUNCT
iajs-3742	78	12	(	(	PUNCT
iajs-3742	78	13	i.r	i.r	PROPN
iajs-3742	78	14	)	)	PUNCT
iajs-3742	78	15	was	be	AUX
iajs-3742	78	16	calculated	calculate	VERB
iajs-3742	78	17	according	accord	VERB
iajs-3742	78	18	to	to	ADP
iajs-3742	78	19	the	the	DET
iajs-3742	78	20	equation	equation	NOUN
iajs-3742	78	21	indicated	indicate	VERB
iajs-3742	78	22	by	by	ADP
iajs-3742	78	23	(	(	PUNCT
iajs-3742	78	24	23	23	NUM
iajs-3742	78	25	)	)	PUNCT
iajs-3742	78	26	.	.	PUNCT
iajs-3742	79	1	(	(	PUNCT
iajs-3742	79	2	1	1	X
iajs-3742	79	3	)	)	PUNCT
iajs-3742	79	4	ihjpas	ihjpa	NOUN
iajs-3742	79	5	.	.	PUNCT
iajs-3742	80	1	2025	2025	NUM
iajs-3742	80	2	,	,	PUNCT
iajs-3742	80	3	38(3	38(3	NUM
iajs-3742	80	4	)	)	PUNCT
iajs-3742	80	5	82	82	NUM
iajs-3742	81	1	where	where	SCONJ
iajs-3742	81	2	:	:	PUNCT
iajs-3742	81	3	ir=	ir=	VERB
iajs-3742	81	4	inhibitory	inhibitory	ADJ
iajs-3742	81	5	rate	rate	NOUN
iajs-3742	81	6	a=	a=	NOUN
iajs-3742	81	7	absorbancy	absorbancy	NOUN
iajs-3742	81	8	for	for	ADP
iajs-3742	81	9	negative	negative	ADJ
iajs-3742	81	10	control	control	NOUN
iajs-3742	81	11	b=	b=	NOUN
iajs-3742	81	12	absorbancy	absorbancy	VERB
iajs-3742	81	13	for	for	ADP
iajs-3742	81	14	test	test	NOUN
iajs-3742	81	15	3	3	NUM
iajs-3742	81	16	.	.	PUNCT
iajs-3742	82	1	results	result	NOUN
iajs-3742	82	2	out	out	ADP
iajs-3742	82	3	of	of	ADP
iajs-3742	82	4	200	200	NUM
iajs-3742	82	5	samples	sample	NOUN
iajs-3742	82	6	,	,	PUNCT
iajs-3742	82	7	33	33	NUM
iajs-3742	82	8	isolates	isolate	NOUN
iajs-3742	82	9	of	of	ADP
iajs-3742	82	10	s.	s.	PROPN
iajs-3742	82	11	marcescens	marcescens	PROPN
iajs-3742	82	12	were	be	AUX
iajs-3742	82	13	identified	identify	VERB
iajs-3742	82	14	based	base	VERB
iajs-3742	82	15	on	on	ADP
iajs-3742	82	16	phenotypic	phenotypic	ADJ
iajs-3742	82	17	characteristics	characteristic	NOUN
iajs-3742	82	18	,	,	PUNCT
iajs-3742	82	19	microscopic	microscopic	ADJ
iajs-3742	82	20	examination	examination	NOUN
iajs-3742	82	21	,	,	PUNCT
iajs-3742	82	22	and	and	CCONJ
iajs-3742	82	23	biochemical	biochemical	ADJ
iajs-3742	82	24	tests	test	NOUN
iajs-3742	82	25	and	and	CCONJ
iajs-3742	82	26	confirmed	confirm	VERB
iajs-3742	82	27	using	use	VERB
iajs-3742	82	28	the	the	DET
iajs-3742	82	29	vitek-2	vitek-2	NUM
iajs-3742	82	30	system	system	NOUN
iajs-3742	82	31	.	.	PUNCT
iajs-3742	83	1	then	then	ADV
iajs-3742	83	2	the	the	DET
iajs-3742	83	3	efficient	efficient	ADJ
iajs-3742	83	4	isolates	isolate	NOUN
iajs-3742	83	5	produced	produce	VERB
iajs-3742	83	6	were	be	AUX
iajs-3742	83	7	selected	select	VERB
iajs-3742	83	8	using	use	VERB
iajs-3742	83	9	the	the	DET
iajs-3742	83	10	cap	cap	NOUN
iajs-3742	83	11	assay	assay	NOUN
iajs-3742	83	12	technique	technique	NOUN
iajs-3742	83	13	(	(	PUNCT
iajs-3742	83	14	24	24	NUM
iajs-3742	83	15	)	)	PUNCT
iajs-3742	83	16	,	,	PUNCT
iajs-3742	83	17	and	and	CCONJ
iajs-3742	83	18	isolate	isolate	VERB
iajs-3742	83	19	s23	s23	NOUN
iajs-3742	83	20	was	be	AUX
iajs-3742	83	21	chosen	choose	VERB
iajs-3742	83	22	as	as	ADP
iajs-3742	83	23	the	the	DET
iajs-3742	83	24	best	good	ADJ
iajs-3742	83	25	isolate	isolate	NOUN
iajs-3742	83	26	using	use	VERB
iajs-3742	83	27	the	the	DET
iajs-3742	83	28	well	well	ADJ
iajs-3742	83	29	method	method	NOUN
iajs-3742	83	30	(	(	PUNCT
iajs-3742	83	31	19	19	NUM
iajs-3742	83	32	)	)	PUNCT
iajs-3742	83	33	,	,	PUNCT
iajs-3742	83	34	as	as	SCONJ
iajs-3742	83	35	it	it	PRON
iajs-3742	83	36	gave	give	VERB
iajs-3742	83	37	the	the	DET
iajs-3742	83	38	highest	high	ADJ
iajs-3742	83	39	zone	zone	NOUN
iajs-3742	83	40	of	of	ADP
iajs-3742	83	41	inhibition	inhibition	NOUN
iajs-3742	83	42	,	,	PUNCT
iajs-3742	83	43	the	the	DET
iajs-3742	83	44	highest	high	ADJ
iajs-3742	83	45	activity	activity	NOUN
iajs-3742	83	46	,	,	PUNCT
iajs-3742	83	47	and	and	CCONJ
iajs-3742	83	48	the	the	DET
iajs-3742	83	49	highest	high	ADJ
iajs-3742	83	50	concentration	concentration	NOUN
iajs-3742	83	51	,	,	PUNCT
iajs-3742	83	52	which	which	PRON
iajs-3742	83	53	was	be	AUX
iajs-3742	83	54	used	use	VERB
iajs-3742	83	55	in	in	ADP
iajs-3742	83	56	this	this	DET
iajs-3742	83	57	research	research	NOUN
iajs-3742	83	58	.	.	PUNCT
iajs-3742	84	1	3.1	3.1	NUM
iajs-3742	84	2	.	.	PUNCT
iajs-3742	84	3	toxic	toxic	ADJ
iajs-3742	84	4	effect	effect	NOUN
iajs-3742	84	5	of	of	ADP
iajs-3742	84	6	marcescin	marcescin	NOUN
iajs-3742	84	7	after	after	ADP
iajs-3742	84	8	24	24	NUM
iajs-3742	84	9	hours	hour	NOUN
iajs-3742	84	10	.	.	PUNCT
iajs-3742	85	1	the	the	DET
iajs-3742	85	2	toxic	toxic	ADJ
iajs-3742	85	3	impact	impact	NOUN
iajs-3742	85	4	was	be	AUX
iajs-3742	85	5	studied	study	VERB
iajs-3742	85	6	in	in	ADP
iajs-3742	85	7	the	the	DET
iajs-3742	85	8	hep-2	hep-2	PUNCT
iajs-3742	85	9	cell	cell	NOUN
iajs-3742	85	10	line	line	NOUN
iajs-3742	85	11	.	.	PUNCT
iajs-3742	86	1	the	the	DET
iajs-3742	86	2	percentage	percentage	NOUN
iajs-3742	86	3	of	of	ADP
iajs-3742	86	4	cell	cell	NOUN
iajs-3742	86	5	growth	growth	NOUN
iajs-3742	86	6	inhibition	inhibition	NOUN
iajs-3742	86	7	was	be	AUX
iajs-3742	86	8	mostly	mostly	ADV
iajs-3742	86	9	determined	determine	VERB
iajs-3742	86	10	by	by	ADP
iajs-3742	86	11	the	the	DET
iajs-3742	86	12	concentration	concentration	NOUN
iajs-3742	86	13	utilized	utilize	VERB
iajs-3742	86	14	and	and	CCONJ
iajs-3742	86	15	the	the	DET
iajs-3742	86	16	exposure	exposure	NOUN
iajs-3742	86	17	time.the	time.the	DET
iajs-3742	86	18	maximum	maximum	ADJ
iajs-3742	86	19	percentage	percentage	NOUN
iajs-3742	86	20	of	of	ADP
iajs-3742	86	21	growth	growth	NOUN
iajs-3742	86	22	inhibition	inhibition	NOUN
iajs-3742	86	23	was	be	AUX
iajs-3742	86	24	reported	report	VERB
iajs-3742	86	25	at	at	ADP
iajs-3742	86	26	a	a	DET
iajs-3742	86	27	concentration	concentration	NOUN
iajs-3742	86	28	of	of	ADP
iajs-3742	86	29	1000	1000	NUM
iajs-3742	86	30	μg	μg	NOUN
iajs-3742	86	31	/	/	SYM
iajs-3742	86	32	ml	ml	NOUN
iajs-3742	86	33	,	,	PUNCT
iajs-3742	86	34	where	where	SCONJ
iajs-3742	86	35	the	the	DET
iajs-3742	86	36	effect	effect	NOUN
iajs-3742	86	37	was	be	AUX
iajs-3742	86	38	recognized	recognize	VERB
iajs-3742	86	39	when	when	SCONJ
iajs-3742	86	40	exposed	expose	VERB
iajs-3742	86	41	for	for	ADP
iajs-3742	86	42	the	the	DET
iajs-3742	86	43	first	first	ADJ
iajs-3742	86	44	24	24	NUM
iajs-3742	86	45	hours	hour	NOUN
iajs-3742	86	46	and	and	CCONJ
iajs-3742	86	47	reached	reach	VERB
iajs-3742	86	48	100	100	NUM
iajs-3742	86	49	%	%	NOUN
iajs-3742	86	50	before	before	ADP
iajs-3742	86	51	decreasing	decrease	VERB
iajs-3742	86	52	.	.	PUNCT
iajs-3742	87	1	when	when	SCONJ
iajs-3742	87	2	the	the	DET
iajs-3742	87	3	concentration	concentration	NOUN
iajs-3742	87	4	was	be	AUX
iajs-3742	87	5	gradually	gradually	ADV
iajs-3742	87	6	reduced	reduce	VERB
iajs-3742	87	7	,	,	PUNCT
iajs-3742	87	8	the	the	DET
iajs-3742	87	9	percentage	percentage	NOUN
iajs-3742	87	10	inhibition	inhibition	NOUN
iajs-3742	87	11	of	of	ADP
iajs-3742	87	12	cancer	cancer	NOUN
iajs-3742	87	13	cell	cell	NOUN
iajs-3742	87	14	growth	growth	NOUN
iajs-3742	87	15	reached	reach	VERB
iajs-3742	87	16	2	2	NUM
iajs-3742	87	17	%	%	NOUN
iajs-3742	87	18	at	at	ADP
iajs-3742	87	19	the	the	DET
iajs-3742	87	20	concentration	concentration	NOUN
iajs-3742	87	21	of	of	ADP
iajs-3742	87	22	1.95	1.95	NUM
iajs-3742	87	23	μg	μg	NOUN
iajs-3742	87	24	/	/	SYM
iajs-3742	87	25	ml	ml	PROPN
iajs-3742	87	26	.	.	PUNCT
iajs-3742	88	1	it	it	PRON
iajs-3742	88	2	was	be	AUX
iajs-3742	88	3	observed	observe	VERB
iajs-3742	88	4	that	that	SCONJ
iajs-3742	88	5	there	there	PRON
iajs-3742	88	6	are	be	VERB
iajs-3742	88	7	significant	significant	ADJ
iajs-3742	88	8	differences	difference	NOUN
iajs-3742	88	9	in	in	ADP
iajs-3742	88	10	the	the	DET
iajs-3742	88	11	first	first	ADJ
iajs-3742	88	12	24	24	NUM
iajs-3742	88	13	hours	hour	NOUN
iajs-3742	88	14	(	(	PUNCT
iajs-3742	88	15	p≤0.05	p≤0.05	NOUN
iajs-3742	88	16	)	)	PUNCT
iajs-3742	88	17	for	for	ADP
iajs-3742	88	18	concentrations	concentration	NOUN
iajs-3742	88	19	(	(	PUNCT
iajs-3742	88	20	1000–1.95	1000–1.95	NOUN
iajs-3742	88	21	)	)	PUNCT
iajs-3742	88	22	μg	μg	PROPN
iajs-3742	88	23	/	/	SYM
iajs-3742	88	24	ml	ml	NOUN
iajs-3742	88	25	,	,	PUNCT
iajs-3742	88	26	where	where	SCONJ
iajs-3742	88	27	the	the	DET
iajs-3742	88	28	inhibition	inhibition	NOUN
iajs-3742	88	29	rate	rate	NOUN
iajs-3742	88	30	starts	start	VERB
iajs-3742	88	31	from	from	ADP
iajs-3742	88	32	100	100	NUM
iajs-3742	88	33	%	%	NOUN
iajs-3742	88	34	until	until	SCONJ
iajs-3742	88	35	it	it	PRON
iajs-3742	88	36	reaches	reach	VERB
iajs-3742	88	37	2	2	NUM
iajs-3742	88	38	%	%	NOUN
iajs-3742	88	39	when	when	SCONJ
iajs-3742	88	40	compared	compare	VERB
iajs-3742	88	41	to	to	ADP
iajs-3742	88	42	the	the	DET
iajs-3742	88	43	control	control	NOUN
iajs-3742	88	44	's	's	PART
iajs-3742	88	45	100	100	NUM
iajs-3742	88	46	%	%	NOUN
iajs-3742	88	47	viability	viability	NOUN
iajs-3742	88	48	,	,	PUNCT
iajs-3742	88	49	while	while	SCONJ
iajs-3742	88	50	there	there	PRON
iajs-3742	88	51	are	be	VERB
iajs-3742	88	52	no	no	DET
iajs-3742	88	53	significant	significant	ADJ
iajs-3742	88	54	differences	difference	NOUN
iajs-3742	88	55	when	when	SCONJ
iajs-3742	88	56	compared	compare	VERB
iajs-3742	88	57	between	between	ADP
iajs-3742	88	58	the	the	DET
iajs-3742	88	59	values	value	NOUN
iajs-3742	88	60	of	of	ADP
iajs-3742	88	61	ir	ir	PROPN
iajs-3742	88	62	(	(	PUNCT
iajs-3742	88	63	figure	figure	NOUN
iajs-3742	88	64	1	1	NUM
iajs-3742	88	65	)	)	PUNCT
iajs-3742	88	66	.	.	PUNCT
iajs-3742	89	1	figure	figure	NOUN
iajs-3742	89	2	1	1	NUM
iajs-3742	89	3	.	.	PUNCT
iajs-3742	90	1	effect	effect	NOUN
iajs-3742	90	2	of	of	ADP
iajs-3742	90	3	marcescin	marcescin	NOUN
iajs-3742	90	4	on	on	ADP
iajs-3742	90	5	hep-2	hep-2	PUNCT
iajs-3742	90	6	cell	cell	NOUN
iajs-3742	90	7	line	line	NOUN
iajs-3742	90	8	after	after	ADP
iajs-3742	90	9	24	24	NUM
iajs-3742	90	10	hours	hour	NOUN
iajs-3742	90	11	.	.	PUNCT
iajs-3742	91	1	3.2	3.2	NUM
iajs-3742	91	2	.	.	PUNCT
iajs-3742	92	1	toxic	toxic	ADJ
iajs-3742	92	2	effect	effect	NOUN
iajs-3742	92	3	of	of	ADP
iajs-3742	92	4	marcescin	marcescin	NOUN
iajs-3742	92	5	after	after	ADP
iajs-3742	92	6	48	48	NUM
iajs-3742	92	7	hours	hour	NOUN
iajs-3742	92	8	with	with	ADP
iajs-3742	92	9	regard	regard	NOUN
iajs-3742	92	10	to	to	ADP
iajs-3742	92	11	the	the	DET
iajs-3742	92	12	effect	effect	NOUN
iajs-3742	92	13	of	of	ADP
iajs-3742	92	14	the	the	DET
iajs-3742	92	15	marcescin	marcescin	NOUN
iajs-3742	92	16	during	during	ADP
iajs-3742	92	17	48	48	NUM
iajs-3742	92	18	hours	hour	NOUN
iajs-3742	93	1	,	,	PUNCT
iajs-3742	93	2	it	it	PRON
iajs-3742	93	3	increased	increase	VERB
iajs-3742	93	4	more	more	ADV
iajs-3742	93	5	than	than	ADP
iajs-3742	93	6	in	in	ADP
iajs-3742	93	7	the	the	DET
iajs-3742	93	8	first	first	ADJ
iajs-3742	93	9	24	24	NUM
iajs-3742	93	10	hours	hour	NOUN
iajs-3742	93	11	,	,	PUNCT
iajs-3742	93	12	where	where	SCONJ
iajs-3742	93	13	the	the	DET
iajs-3742	93	14	effect	effect	NOUN
iajs-3742	93	15	(	(	PUNCT
iajs-3742	93	16	ir	ir	NOUN
iajs-3742	93	17	)	)	PUNCT
iajs-3742	93	18	was	be	AUX
iajs-3742	93	19	observed	observe	VERB
iajs-3742	93	20	when	when	SCONJ
iajs-3742	93	21	the	the	DET
iajs-3742	93	22	concentration	concentration	NOUN
iajs-3742	93	23	was	be	AUX
iajs-3742	93	24	1000	1000	NUM
iajs-3742	93	25	μg	μg	NOUN
iajs-3742	93	26	/	/	SYM
iajs-3742	93	27	ml	ml	PROPN
iajs-3742	93	28	is	be	AUX
iajs-3742	93	29	100	100	NUM
iajs-3742	93	30	%	%	NOUN
iajs-3742	93	31	,	,	PUNCT
iajs-3742	93	32	then	then	ADV
iajs-3742	93	33	the	the	DET
iajs-3742	93	34	decrease	decrease	NOUN
iajs-3742	93	35	in	in	ADP
iajs-3742	93	36	the	the	DET
iajs-3742	93	37	effect	effect	NOUN
iajs-3742	93	38	began	begin	VERB
iajs-3742	93	39	gradually	gradually	ADV
iajs-3742	93	40	with	with	ADP
iajs-3742	93	41	a	a	DET
iajs-3742	93	42	decrease	decrease	NOUN
iajs-3742	93	43	in	in	ADP
iajs-3742	93	44	the	the	DET
iajs-3742	93	45	concentration	concentration	NOUN
iajs-3742	93	46	,	,	PUNCT
iajs-3742	93	47	that	that	SCONJ
iajs-3742	93	48	it	it	PRON
iajs-3742	93	49	was	be	AUX
iajs-3742	93	50	more	more	ADJ
iajs-3742	93	51	than	than	ADP
iajs-3742	93	52	the	the	DET
iajs-3742	93	53	effect	effect	NOUN
iajs-3742	93	54	in	in	ADP
iajs-3742	93	55	the	the	DET
iajs-3742	93	56	first	first	ADJ
iajs-3742	93	57	24	24	NUM
iajs-3742	93	58	hours	hour	NOUN
iajs-3742	93	59	,	,	PUNCT
iajs-3742	93	60	where	where	SCONJ
iajs-3742	93	61	the	the	DET
iajs-3742	93	62	inhibition	inhibition	NOUN
iajs-3742	93	63	was	be	AUX
iajs-3742	93	64	during	during	ADP
iajs-3742	93	65	the	the	DET
iajs-3742	93	66	first	first	ADJ
iajs-3742	93	67	24	24	NUM
iajs-3742	93	68	hours	hour	NOUN
iajs-3742	93	69	when	when	SCONJ
iajs-3742	93	70	the	the	DET
iajs-3742	93	71	concentration	concentration	NOUN
iajs-3742	93	72	was	be	AUX
iajs-3742	93	73	500	500	NUM
iajs-3742	93	74	μg	μg	NOUN
iajs-3742	93	75	/	/	SYM
iajs-3742	93	76	ml	ml	PROPN
iajs-3742	93	77	is	be	AUX
iajs-3742	93	78	67	67	NUM
iajs-3742	93	79	%	%	NOUN
iajs-3742	93	80	,	,	PUNCT
iajs-3742	93	81	while	while	SCONJ
iajs-3742	93	82	the	the	DET
iajs-3742	93	83	inhibition	inhibition	NOUN
iajs-3742	93	84	is	be	AUX
iajs-3742	93	85	73	73	NUM
iajs-3742	93	86	%	%	NOUN
iajs-3742	93	87	at	at	ADP
iajs-3742	93	88	the	the	DET
iajs-3742	93	89	same	same	ADJ
iajs-3742	93	90	concentration	concentration	NOUN
iajs-3742	93	91	after	after	ADP
iajs-3742	93	92	48	48	NUM
iajs-3742	93	93	hours	hour	NOUN
iajs-3742	93	94	.	.	PUNCT
iajs-3742	94	1	even	even	ADV
iajs-3742	94	2	in	in	ADP
iajs-3742	94	3	low	low	ADJ
iajs-3742	94	4	concentrations	concentration	NOUN
iajs-3742	94	5	,	,	PUNCT
iajs-3742	94	6	it	it	PRON
iajs-3742	94	7	was	be	AUX
iajs-3742	94	8	observed	observe	VERB
iajs-3742	94	9	that	that	SCONJ
iajs-3742	94	10	inhibition	inhibition	NOUN
iajs-3742	94	11	in	in	ADP
iajs-3742	94	12	48	48	NUM
iajs-3742	94	13	hours	hour	NOUN
iajs-3742	94	14	was	be	AUX
iajs-3742	94	15	greater	great	ADJ
iajs-3742	94	16	than	than	ADP
iajs-3742	94	17	inhibition	inhibition	NOUN
iajs-3742	94	18	in	in	ADP
iajs-3742	94	19	the	the	DET
iajs-3742	94	20	first	first	ADJ
iajs-3742	94	21	24	24	NUM
iajs-3742	94	22	hours	hour	NOUN
iajs-3742	94	23	.	.	PUNCT
iajs-3742	95	1	it	it	PRON
iajs-3742	95	2	was	be	AUX
iajs-3742	95	3	observed	observe	VERB
iajs-3742	95	4	that	that	SCONJ
iajs-3742	95	5	there	there	PRON
iajs-3742	95	6	are	be	VERB
iajs-3742	95	7	ihjpas	ihjpa	NOUN
iajs-3742	95	8	.	.	PUNCT
iajs-3742	96	1	2025	2025	NUM
iajs-3742	96	2	,	,	PUNCT
iajs-3742	96	3	38(3	38(3	NUM
iajs-3742	96	4	)	)	PUNCT
iajs-3742	96	5	83	83	NUM
iajs-3742	96	6	significant	significant	ADJ
iajs-3742	96	7	differences	difference	NOUN
iajs-3742	96	8	in	in	ADP
iajs-3742	96	9	the	the	DET
iajs-3742	96	10	48	48	NUM
iajs-3742	96	11	hours	hour	NOUN
iajs-3742	96	12	(	(	PUNCT
iajs-3742	96	13	p≤0.05	p≤0.05	NOUN
iajs-3742	96	14	)	)	PUNCT
iajs-3742	96	15	for	for	ADP
iajs-3742	96	16	concentrations	concentration	NOUN
iajs-3742	96	17	(	(	PUNCT
iajs-3742	96	18	1000–1.95	1000–1.95	NOUN
iajs-3742	96	19	)	)	PUNCT
iajs-3742	96	20	μg	μg	PROPN
iajs-3742	96	21	/	/	SYM
iajs-3742	96	22	ml	ml	NOUN
iajs-3742	96	23	,	,	PUNCT
iajs-3742	96	24	where	where	SCONJ
iajs-3742	96	25	the	the	DET
iajs-3742	96	26	inhibition	inhibition	NOUN
iajs-3742	96	27	rate	rate	NOUN
iajs-3742	96	28	starts	start	VERB
iajs-3742	96	29	from	from	ADP
iajs-3742	96	30	100	100	NUM
iajs-3742	96	31	%	%	NOUN
iajs-3742	96	32	until	until	SCONJ
iajs-3742	96	33	it	it	PRON
iajs-3742	96	34	reaches	reach	VERB
iajs-3742	96	35	6	6	NUM
iajs-3742	96	36	%	%	NOUN
iajs-3742	96	37	when	when	SCONJ
iajs-3742	96	38	compared	compare	VERB
iajs-3742	96	39	to	to	ADP
iajs-3742	96	40	the	the	DET
iajs-3742	96	41	control	control	NOUN
iajs-3742	96	42	100	100	NUM
iajs-3742	96	43	%	%	NOUN
iajs-3742	96	44	viability	viability	NOUN
iajs-3742	96	45	.	.	PUNCT
iajs-3742	97	1	also	also	ADV
iajs-3742	97	2	,	,	PUNCT
iajs-3742	97	3	there	there	PRON
iajs-3742	97	4	are	be	VERB
iajs-3742	97	5	significant	significant	ADJ
iajs-3742	97	6	differences	difference	NOUN
iajs-3742	97	7	between	between	ADP
iajs-3742	97	8	the	the	DET
iajs-3742	97	9	concentrations	concentration	NOUN
iajs-3742	97	10	(	(	PUNCT
iajs-3742	97	11	500–250	500–250	NUM
iajs-3742	97	12	and	and	CCONJ
iajs-3742	97	13	7.8–3.8	7.8–3.8	NUM
iajs-3742	97	14	)	)	PUNCT
iajs-3742	97	15	μg	μg	PROPN
iajs-3742	97	16	/	/	SYM
iajs-3742	97	17	ml	ml	PROPN
iajs-3742	97	18	,	,	PUNCT
iajs-3742	97	19	while	while	SCONJ
iajs-3742	97	20	there	there	PRON
iajs-3742	97	21	are	be	VERB
iajs-3742	97	22	no	no	DET
iajs-3742	97	23	significant	significant	ADJ
iajs-3742	97	24	differences	difference	NOUN
iajs-3742	97	25	between	between	ADP
iajs-3742	97	26	the	the	DET
iajs-3742	97	27	rest	rest	NOUN
iajs-3742	97	28	of	of	ADP
iajs-3742	97	29	the	the	DET
iajs-3742	97	30	concentrations	concentration	NOUN
iajs-3742	97	31	(	(	PUNCT
iajs-3742	97	32	figure	figure	NOUN
iajs-3742	97	33	2	2	NUM
iajs-3742	97	34	)	)	PUNCT
iajs-3742	97	35	.	.	PUNCT
iajs-3742	98	1	figure	figure	NOUN
iajs-3742	98	2	2	2	NUM
iajs-3742	98	3	.	.	PUNCT
iajs-3742	98	4	effect	effect	NOUN
iajs-3742	98	5	of	of	ADP
iajs-3742	98	6	marcescin	marcescin	NOUN
iajs-3742	98	7	on	on	ADP
iajs-3742	98	8	hep-2	hep-2	PUNCT
iajs-3742	98	9	cell	cell	NOUN
iajs-3742	98	10	line	line	NOUN
iajs-3742	98	11	after	after	ADP
iajs-3742	98	12	48	48	NUM
iajs-3742	98	13	hours	hour	NOUN
iajs-3742	98	14	.	.	PUNCT
iajs-3742	99	1	3.3	3.3	NUM
iajs-3742	99	2	.	.	PUNCT
iajs-3742	100	1	toxic	toxic	ADJ
iajs-3742	100	2	effect	effect	NOUN
iajs-3742	100	3	of	of	ADP
iajs-3742	100	4	marcescin	marcescin	NOUN
iajs-3742	100	5	after	after	ADP
iajs-3742	100	6	72	72	NUM
iajs-3742	100	7	hours	hour	NOUN
iajs-3742	100	8	the	the	DET
iajs-3742	100	9	inhibitory	inhibitory	ADJ
iajs-3742	100	10	effect	effect	NOUN
iajs-3742	100	11	of	of	ADP
iajs-3742	100	12	marcescin	marcescin	NOUN
iajs-3742	100	13	in	in	ADP
iajs-3742	100	14	the	the	DET
iajs-3742	100	15	72	72	NUM
iajs-3742	100	16	hours	hour	NOUN
iajs-3742	100	17	was	be	AUX
iajs-3742	100	18	greater	great	ADJ
iajs-3742	100	19	than	than	ADP
iajs-3742	100	20	the	the	DET
iajs-3742	100	21	inhibition	inhibition	NOUN
iajs-3742	100	22	in	in	ADP
iajs-3742	100	23	the	the	DET
iajs-3742	100	24	48	48	NUM
iajs-3742	100	25	hours	hour	NOUN
iajs-3742	100	26	and	and	CCONJ
iajs-3742	100	27	24	24	NUM
iajs-3742	100	28	hours	hour	NOUN
iajs-3742	100	29	.	.	PUNCT
iajs-3742	101	1	the	the	DET
iajs-3742	101	2	inhibition	inhibition	NOUN
iajs-3742	101	3	was	be	AUX
iajs-3742	101	4	noticed	notice	VERB
iajs-3742	101	5	at	at	ADP
iajs-3742	101	6	the	the	DET
iajs-3742	101	7	concentration	concentration	NOUN
iajs-3742	101	8	of	of	ADP
iajs-3742	101	9	1000	1000	NUM
iajs-3742	101	10	,	,	PUNCT
iajs-3742	101	11	which	which	PRON
iajs-3742	101	12	was	be	AUX
iajs-3742	101	13	100	100	NUM
iajs-3742	101	14	%	%	NOUN
iajs-3742	101	15	,	,	PUNCT
iajs-3742	101	16	and	and	CCONJ
iajs-3742	101	17	at	at	ADP
iajs-3742	101	18	the	the	DET
iajs-3742	101	19	concentration	concentration	NOUN
iajs-3742	101	20	of	of	ADP
iajs-3742	101	21	500	500	NUM
iajs-3742	101	22	in	in	ADP
iajs-3742	101	23	the	the	DET
iajs-3742	101	24	72	72	NUM
iajs-3742	101	25	hours	hour	NOUN
iajs-3742	101	26	,	,	PUNCT
iajs-3742	101	27	it	it	PRON
iajs-3742	101	28	was	be	AUX
iajs-3742	101	29	78	78	NUM
iajs-3742	101	30	%	%	NOUN
iajs-3742	101	31	,	,	PUNCT
iajs-3742	101	32	which	which	PRON
iajs-3742	101	33	is	be	AUX
iajs-3742	101	34	greater	great	ADJ
iajs-3742	101	35	than	than	ADP
iajs-3742	101	36	the	the	DET
iajs-3742	101	37	inhibition	inhibition	NOUN
iajs-3742	101	38	in	in	ADP
iajs-3742	101	39	the	the	DET
iajs-3742	101	40	48	48	NUM
iajs-3742	101	41	hours	hour	NOUN
iajs-3742	101	42	,	,	PUNCT
iajs-3742	101	43	which	which	PRON
iajs-3742	101	44	was	be	AUX
iajs-3742	101	45	73	73	NUM
iajs-3742	101	46	at	at	ADP
iajs-3742	101	47	the	the	DET
iajs-3742	101	48	same	same	ADJ
iajs-3742	101	49	concentration	concentration	NOUN
iajs-3742	101	50	,	,	PUNCT
iajs-3742	101	51	where	where	SCONJ
iajs-3742	101	52	it	it	PRON
iajs-3742	101	53	was	be	AUX
iajs-3742	101	54	67	67	NUM
iajs-3742	101	55	%	%	NOUN
iajs-3742	101	56	at	at	ADP
iajs-3742	101	57	the	the	DET
iajs-3742	101	58	24	24	NUM
iajs-3742	101	59	hours	hour	NOUN
iajs-3742	101	60	.	.	PUNCT
iajs-3742	102	1	the	the	DET
iajs-3742	102	2	inhibition	inhibition	NOUN
iajs-3742	102	3	rate	rate	NOUN
iajs-3742	102	4	decreased	decrease	VERB
iajs-3742	102	5	by	by	ADP
iajs-3742	102	6	gradually	gradually	ADV
iajs-3742	102	7	decreasing	decrease	VERB
iajs-3742	102	8	the	the	DET
iajs-3742	102	9	concentration	concentration	NOUN
iajs-3742	102	10	to	to	PART
iajs-3742	102	11	reach	reach	VERB
iajs-3742	102	12	an	an	DET
iajs-3742	102	13	inhibition	inhibition	NOUN
iajs-3742	102	14	rate	rate	NOUN
iajs-3742	102	15	of	of	ADP
iajs-3742	102	16	14	14	NUM
iajs-3742	102	17	%	%	NOUN
iajs-3742	102	18	at	at	ADP
iajs-3742	102	19	a	a	DET
iajs-3742	102	20	concentration	concentration	NOUN
iajs-3742	102	21	of	of	ADP
iajs-3742	102	22	1.95	1.95	NUM
iajs-3742	102	23	μg	μg	NOUN
iajs-3742	102	24	/	/	SYM
iajs-3742	102	25	ml	ml	NOUN
iajs-3742	102	26	,	,	PUNCT
iajs-3742	102	27	which	which	PRON
iajs-3742	102	28	is	be	AUX
iajs-3742	102	29	greater	great	ADJ
iajs-3742	102	30	than	than	ADP
iajs-3742	102	31	the	the	DET
iajs-3742	102	32	inhibition	inhibition	NOUN
iajs-3742	102	33	rate	rate	NOUN
iajs-3742	102	34	at	at	ADP
iajs-3742	102	35	the	the	DET
iajs-3742	102	36	same	same	ADJ
iajs-3742	102	37	concentration	concentration	NOUN
iajs-3742	102	38	at	at	ADP
iajs-3742	102	39	24	24	NUM
iajs-3742	102	40	and	and	CCONJ
iajs-3742	102	41	48	48	NUM
iajs-3742	102	42	hours	hour	NOUN
iajs-3742	102	43	.	.	PUNCT
iajs-3742	103	1	it	it	PRON
iajs-3742	103	2	was	be	AUX
iajs-3742	103	3	observed	observe	VERB
iajs-3742	103	4	that	that	SCONJ
iajs-3742	103	5	there	there	PRON
iajs-3742	103	6	are	be	VERB
iajs-3742	103	7	significant	significant	ADJ
iajs-3742	103	8	differences	difference	NOUN
iajs-3742	103	9	in	in	ADP
iajs-3742	103	10	the	the	DET
iajs-3742	103	11	72	72	NUM
iajs-3742	103	12	hours	hour	NOUN
iajs-3742	103	13	(	(	PUNCT
iajs-3742	103	14	p≤0.05	p≤0.05	NOUN
iajs-3742	103	15	)	)	PUNCT
iajs-3742	103	16	for	for	ADP
iajs-3742	103	17	concentrations	concentration	NOUN
iajs-3742	103	18	(	(	PUNCT
iajs-3742	103	19	1000–1.95	1000–1.95	NOUN
iajs-3742	103	20	)	)	PUNCT
iajs-3742	103	21	μg	μg	PROPN
iajs-3742	103	22	/	/	SYM
iajs-3742	103	23	ml	ml	NOUN
iajs-3742	103	24	,	,	PUNCT
iajs-3742	103	25	where	where	SCONJ
iajs-3742	103	26	the	the	DET
iajs-3742	103	27	inhibition	inhibition	NOUN
iajs-3742	103	28	rate	rate	NOUN
iajs-3742	103	29	starts	start	VERB
iajs-3742	103	30	from	from	ADP
iajs-3742	103	31	100	100	NUM
iajs-3742	103	32	%	%	NOUN
iajs-3742	103	33	until	until	SCONJ
iajs-3742	103	34	it	it	PRON
iajs-3742	103	35	reaches	reach	VERB
iajs-3742	103	36	14	14	NUM
iajs-3742	103	37	%	%	NOUN
iajs-3742	103	38	when	when	SCONJ
iajs-3742	103	39	compared	compare	VERB
iajs-3742	103	40	to	to	ADP
iajs-3742	103	41	the	the	DET
iajs-3742	103	42	control	control	NOUN
iajs-3742	103	43	's	's	PART
iajs-3742	103	44	100	100	NUM
iajs-3742	103	45	%	%	NOUN
iajs-3742	103	46	viability	viability	NOUN
iajs-3742	103	47	(	(	PUNCT
iajs-3742	103	48	figure	figure	NOUN
iajs-3742	103	49	3	3	NUM
iajs-3742	103	50	)	)	PUNCT
iajs-3742	103	51	.	.	PUNCT
iajs-3742	104	1	figure	figure	VERB
iajs-3742	104	2	3	3	NUM
iajs-3742	104	3	.	.	PUNCT
iajs-3742	104	4	effect	effect	NOUN
iajs-3742	104	5	of	of	ADP
iajs-3742	104	6	marcescin	marcescin	NOUN
iajs-3742	104	7	on	on	ADP
iajs-3742	104	8	hep-2	hep-2	PUNCT
iajs-3742	104	9	cell	cell	NOUN
iajs-3742	104	10	line	line	NOUN
iajs-3742	104	11	after	after	ADP
iajs-3742	104	12	72	72	NUM
iajs-3742	104	13	hours	hour	NOUN
iajs-3742	104	14	.	.	PUNCT
iajs-3742	105	1	ihjpas	ihjpas	PROPN
iajs-3742	105	2	.	.	PUNCT
iajs-3742	106	1	2025	2025	NUM
iajs-3742	106	2	,	,	PUNCT
iajs-3742	106	3	38(3	38(3	NUM
iajs-3742	106	4	)	)	PUNCT
iajs-3742	106	5	84	84	NUM
iajs-3742	106	6	3.4	3.4	NUM
iajs-3742	106	7	.	.	PUNCT
iajs-3742	107	1	comparative	comparative	ADJ
iajs-3742	107	2	between	between	ADP
iajs-3742	107	3	effect	effect	NOUN
iajs-3742	107	4	of	of	ADP
iajs-3742	107	5	marcescin	marcescin	NOUN
iajs-3742	107	6	on	on	ADP
iajs-3742	107	7	hep-2	hep-2	PUNCT
iajs-3742	107	8	cell	cell	NOUN
iajs-3742	107	9	line	line	NOUN
iajs-3742	107	10	in	in	ADP
iajs-3742	107	11	different	different	ADJ
iajs-3742	107	12	exposure	exposure	NOUN
iajs-3742	107	13	time	time	NOUN
iajs-3742	107	14	.	.	PUNCT
iajs-3742	108	1	the	the	DET
iajs-3742	108	2	effect	effect	NOUN
iajs-3742	108	3	of	of	ADP
iajs-3742	108	4	marcescin	marcescin	NOUN
iajs-3742	108	5	on	on	ADP
iajs-3742	108	6	the	the	DET
iajs-3742	108	7	hep-2	hep-2	PUNCT
iajs-3742	108	8	cell	cell	NOUN
iajs-3742	108	9	line	line	NOUN
iajs-3742	108	10	at	at	ADP
iajs-3742	108	11	48	48	NUM
iajs-3742	108	12	hours	hour	NOUN
iajs-3742	108	13	is	be	AUX
iajs-3742	108	14	higher	high	ADJ
iajs-3742	108	15	than	than	ADP
iajs-3742	108	16	at	at	ADP
iajs-3742	108	17	24	24	NUM
iajs-3742	108	18	hours	hour	NOUN
iajs-3742	108	19	,	,	PUNCT
iajs-3742	108	20	and	and	CCONJ
iajs-3742	108	21	at	at	ADP
iajs-3742	108	22	72	72	NUM
iajs-3742	108	23	hours	hour	NOUN
iajs-3742	108	24	;	;	PUNCT
iajs-3742	108	25	it	it	PRON
iajs-3742	108	26	is	be	AUX
iajs-3742	108	27	higher	high	ADJ
iajs-3742	108	28	than	than	ADP
iajs-3742	108	29	at	at	ADP
iajs-3742	108	30	48	48	NUM
iajs-3742	108	31	and	and	CCONJ
iajs-3742	108	32	24	24	NUM
iajs-3742	108	33	hours	hour	NOUN
iajs-3742	108	34	.	.	PUNCT
iajs-3742	109	1	significant	significant	ADJ
iajs-3742	109	2	differences	difference	NOUN
iajs-3742	109	3	were	be	AUX
iajs-3742	109	4	found	find	VERB
iajs-3742	109	5	when	when	SCONJ
iajs-3742	109	6	comparing	compare	VERB
iajs-3742	109	7	the	the	DET
iajs-3742	109	8	concentrations	concentration	NOUN
iajs-3742	109	9	at	at	ADP
iajs-3742	109	10	different	different	ADJ
iajs-3742	109	11	exposure	exposure	NOUN
iajs-3742	109	12	times	time	NOUN
iajs-3742	109	13	.	.	PUNCT
iajs-3742	110	1	therefore	therefore	ADV
iajs-3742	110	2	,	,	PUNCT
iajs-3742	110	3	the	the	DET
iajs-3742	110	4	effect	effect	NOUN
iajs-3742	110	5	of	of	ADP
iajs-3742	110	6	marcicin	marcicin	NOUN
iajs-3742	110	7	on	on	ADP
iajs-3742	110	8	the	the	DET
iajs-3742	110	9	hep-2	hep-2	PUNCT
iajs-3742	110	10	cell	cell	NOUN
iajs-3742	110	11	line	line	NOUN
iajs-3742	110	12	after	after	ADP
iajs-3742	110	13	72	72	NUM
iajs-3742	110	14	hours	hour	NOUN
iajs-3742	110	15	of	of	ADP
iajs-3742	110	16	exposure	exposure	NOUN
iajs-3742	110	17	was	be	AUX
iajs-3742	110	18	the	the	DET
iajs-3742	110	19	highest	high	ADJ
iajs-3742	110	20	because	because	SCONJ
iajs-3742	110	21	the	the	DET
iajs-3742	110	22	inhibition	inhibition	NOUN
iajs-3742	110	23	rate	rate	NOUN
iajs-3742	110	24	was	be	AUX
iajs-3742	110	25	highest	high	ADJ
iajs-3742	110	26	at	at	ADP
iajs-3742	110	27	the	the	DET
iajs-3742	110	28	concentration	concentration	NOUN
iajs-3742	110	29	of	of	ADP
iajs-3742	110	30	500	500	NUM
iajs-3742	110	31	µg	µg	NOUN
iajs-3742	110	32	/	/	SYM
iajs-3742	110	33	ml	ml	NOUN
iajs-3742	110	34	,	,	PUNCT
iajs-3742	110	35	where	where	SCONJ
iajs-3742	110	36	it	it	PRON
iajs-3742	110	37	was	be	AUX
iajs-3742	110	38	78	78	NUM
iajs-3742	110	39	%	%	NOUN
iajs-3742	110	40	,	,	PUNCT
iajs-3742	110	41	while	while	SCONJ
iajs-3742	110	42	at	at	ADP
iajs-3742	110	43	the	the	DET
iajs-3742	110	44	same	same	ADJ
iajs-3742	110	45	concentration	concentration	NOUN
iajs-3742	110	46	after	after	ADP
iajs-3742	110	47	24	24	NUM
iajs-3742	110	48	and	and	CCONJ
iajs-3742	110	49	48	48	NUM
iajs-3742	110	50	hours	hour	NOUN
iajs-3742	110	51	it	it	PRON
iajs-3742	110	52	was	be	AUX
iajs-3742	110	53	67	67	NUM
iajs-3742	110	54	%	%	NOUN
iajs-3742	110	55	and	and	CCONJ
iajs-3742	110	56	73	73	NUM
iajs-3742	110	57	%	%	NOUN
iajs-3742	110	58	,	,	PUNCT
iajs-3742	110	59	respectively	respectively	ADV
iajs-3742	110	60	(	(	PUNCT
iajs-3742	110	61	figure	figure	NOUN
iajs-3742	110	62	4	4	NUM
iajs-3742	110	63	)	)	PUNCT
iajs-3742	110	64	.	.	PUNCT
iajs-3742	111	1	figure	figure	VERB
iajs-3742	111	2	4	4	NUM
iajs-3742	111	3	.	.	NOUN
iajs-3742	111	4	comparative	comparative	ADJ
iajs-3742	111	5	between	between	ADP
iajs-3742	111	6	effect	effect	NOUN
iajs-3742	111	7	of	of	ADP
iajs-3742	111	8	marcescin	marcescin	NOUN
iajs-3742	111	9	on	on	ADP
iajs-3742	111	10	hep-2	hep-2	PUNCT
iajs-3742	111	11	cell	cell	NOUN
iajs-3742	111	12	line	line	NOUN
iajs-3742	111	13	after	after	ADP
iajs-3742	111	14	different	different	ADJ
iajs-3742	111	15	exposure	exposure	NOUN
iajs-3742	111	16	time	time	NOUN
iajs-3742	111	17	.	.	PUNCT
iajs-3742	112	1	4	4	X
iajs-3742	112	2	.	.	X
iajs-3742	112	3	discussion	discussion	NOUN
iajs-3742	112	4	studies	study	NOUN
iajs-3742	112	5	(	(	PUNCT
iajs-3742	112	6	25	25	NUM
iajs-3742	112	7	,	,	PUNCT
iajs-3742	112	8	26	26	NUM
iajs-3742	112	9	and	and	CCONJ
iajs-3742	112	10	27	27	NUM
iajs-3742	112	11	)	)	PUNCT
iajs-3742	112	12	showed	show	VERB
iajs-3742	112	13	that	that	SCONJ
iajs-3742	112	14	bacteriocins	bacteriocin	NOUN
iajs-3742	112	15	can	can	AUX
iajs-3742	112	16	inhibit	inhibit	VERB
iajs-3742	112	17	the	the	DET
iajs-3742	112	18	division	division	NOUN
iajs-3742	112	19	of	of	ADP
iajs-3742	112	20	different	different	ADJ
iajs-3742	112	21	types	type	NOUN
iajs-3742	112	22	of	of	ADP
iajs-3742	112	23	cancer	cancer	NOUN
iajs-3742	112	24	cells	cell	NOUN
iajs-3742	112	25	,	,	PUNCT
iajs-3742	112	26	but	but	CCONJ
iajs-3742	112	27	it	it	PRON
iajs-3742	112	28	depends	depend	VERB
iajs-3742	112	29	on	on	ADP
iajs-3742	112	30	the	the	DET
iajs-3742	112	31	dose	dose	NOUN
iajs-3742	112	32	and	and	CCONJ
iajs-3742	112	33	time	time	NOUN
iajs-3742	112	34	and	and	CCONJ
iajs-3742	112	35	increases	increase	VERB
iajs-3742	112	36	exponentially	exponentially	ADV
iajs-3742	112	37	.	.	PUNCT
iajs-3742	113	1	another	another	DET
iajs-3742	113	2	study	study	NOUN
iajs-3742	113	3	by	by	ADP
iajs-3742	113	4	(	(	PUNCT
iajs-3742	113	5	28	28	NUM
iajs-3742	113	6	)	)	PUNCT
iajs-3742	113	7	the	the	DET
iajs-3742	113	8	results	result	NOUN
iajs-3742	113	9	of	of	ADP
iajs-3742	113	10	this	this	DET
iajs-3742	113	11	study	study	NOUN
iajs-3742	113	12	were	be	AUX
iajs-3742	113	13	consistent	consistent	ADJ
iajs-3742	113	14	with	with	ADP
iajs-3742	113	15	the	the	DET
iajs-3742	113	16	results	result	NOUN
iajs-3742	113	17	of	of	ADP
iajs-3742	113	18	the	the	DET
iajs-3742	113	19	research	research	NOUN
iajs-3742	113	20	,	,	PUNCT
iajs-3742	113	21	as	as	SCONJ
iajs-3742	113	22	this	this	DET
iajs-3742	113	23	study	study	NOUN
iajs-3742	113	24	confirmed	confirm	VERB
iajs-3742	113	25	that	that	SCONJ
iajs-3742	113	26	the	the	DET
iajs-3742	113	27	bacteriocins	bacteriocin	NOUN
iajs-3742	113	28	cause	cause	VERB
iajs-3742	113	29	inhibition	inhibition	NOUN
iajs-3742	113	30	of	of	ADP
iajs-3742	113	31	the	the	DET
iajs-3742	113	32	growth	growth	NOUN
iajs-3742	113	33	of	of	ADP
iajs-3742	113	34	cancer	cancer	NOUN
iajs-3742	113	35	cells	cell	NOUN
iajs-3742	113	36	depending	depend	VERB
iajs-3742	113	37	on	on	ADP
iajs-3742	113	38	the	the	DET
iajs-3742	113	39	concentration	concentration	NOUN
iajs-3742	113	40	of	of	ADP
iajs-3742	113	41	the	the	DET
iajs-3742	113	42	bacteriocin	bacteriocin	NOUN
iajs-3742	113	43	and	and	CCONJ
iajs-3742	113	44	the	the	DET
iajs-3742	113	45	periods	period	NOUN
iajs-3742	113	46	of	of	ADP
iajs-3742	113	47	exposure	exposure	NOUN
iajs-3742	113	48	to	to	ADP
iajs-3742	113	49	the	the	DET
iajs-3742	113	50	bacteriocin	bacteriocin	NOUN
iajs-3742	113	51	.	.	PUNCT
iajs-3742	114	1	the	the	DET
iajs-3742	114	2	results	result	NOUN
iajs-3742	114	3	of	of	ADP
iajs-3742	114	4	the	the	DET
iajs-3742	114	5	research	research	NOUN
iajs-3742	114	6	were	be	AUX
iajs-3742	114	7	consistent	consistent	ADJ
iajs-3742	114	8	with	with	ADP
iajs-3742	114	9	the	the	DET
iajs-3742	114	10	study	study	NOUN
iajs-3742	114	11	(	(	PUNCT
iajs-3742	114	12	29	29	NUM
iajs-3742	114	13	)	)	PUNCT
iajs-3742	114	14	,	,	PUNCT
iajs-3742	114	15	the	the	DET
iajs-3742	114	16	period	period	NOUN
iajs-3742	114	17	of	of	ADP
iajs-3742	114	18	exposure	exposure	NOUN
iajs-3742	114	19	,	,	PUNCT
iajs-3742	114	20	and	and	CCONJ
iajs-3742	114	21	the	the	DET
iajs-3742	114	22	type	type	NOUN
iajs-3742	114	23	of	of	ADP
iajs-3742	114	24	extract	extract	NOUN
iajs-3742	114	25	.	.	PUNCT
iajs-3742	115	1	the	the	DET
iajs-3742	115	2	highest	high	ADJ
iajs-3742	115	3	rate	rate	NOUN
iajs-3742	115	4	of	of	ADP
iajs-3742	115	5	inhibition	inhibition	NOUN
iajs-3742	115	6	was	be	AUX
iajs-3742	115	7	recorded	record	VERB
iajs-3742	115	8	at	at	ADP
iajs-3742	115	9	a	a	DET
iajs-3742	115	10	concentration	concentration	NOUN
iajs-3742	115	11	of	of	ADP
iajs-3742	115	12	400	400	NUM
iajs-3742	115	13	µg	µg	NOUN
iajs-3742	115	14	/	/	SYM
iajs-3742	115	15	ml	ml	NOUN
iajs-3742	115	16	for	for	ADP
iajs-3742	115	17	the	the	DET
iajs-3742	115	18	four	four	NUM
iajs-3742	115	19	types	type	NOUN
iajs-3742	115	20	of	of	ADP
iajs-3742	115	21	extracts	extract	NOUN
iajs-3742	115	22	,	,	PUNCT
iajs-3742	115	23	and	and	CCONJ
iajs-3742	115	24	it	it	PRON
iajs-3742	115	25	decreases	decrease	VERB
iajs-3742	115	26	as	as	SCONJ
iajs-3742	115	27	the	the	DET
iajs-3742	115	28	concentration	concentration	NOUN
iajs-3742	115	29	decreases	decrease	VERB
iajs-3742	115	30	from	from	ADP
iajs-3742	115	31	the	the	DET
iajs-3742	115	32	first	first	ADJ
iajs-3742	115	33	day	day	NOUN
iajs-3742	115	34	of	of	ADP
iajs-3742	115	35	exposure	exposure	NOUN
iajs-3742	115	36	(	(	PUNCT
iajs-3742	115	37	24	24	NUM
iajs-3742	115	38	hours	hour	NOUN
iajs-3742	115	39	)	)	PUNCT
iajs-3742	115	40	and	and	CCONJ
iajs-3742	115	41	increases	increase	NOUN
iajs-3742	115	42	to	to	PART
iajs-3742	115	43	give	give	VERB
iajs-3742	115	44	the	the	DET
iajs-3742	115	45	highest	high	ADJ
iajs-3742	115	46	percentage	percentage	NOUN
iajs-3742	115	47	of	of	ADP
iajs-3742	115	48	inhibition	inhibition	NOUN
iajs-3742	115	49	after	after	ADP
iajs-3742	115	50	72	72	NUM
iajs-3742	115	51	hours	hour	NOUN
iajs-3742	115	52	.	.	PUNCT
iajs-3742	116	1	according	accord	VERB
iajs-3742	116	2	to	to	ADP
iajs-3742	116	3	(	(	PUNCT
iajs-3742	116	4	30	30	NUM
iajs-3742	116	5	)	)	PUNCT
iajs-3742	116	6	and	and	CCONJ
iajs-3742	116	7	(	(	PUNCT
iajs-3742	116	8	31	31	NUM
iajs-3742	116	9	)	)	PUNCT
iajs-3742	116	10	,	,	PUNCT
iajs-3742	116	11	the	the	DET
iajs-3742	116	12	effect	effect	NOUN
iajs-3742	116	13	of	of	ADP
iajs-3742	116	14	bacteriocins	bacteriocin	NOUN
iajs-3742	116	15	(	(	PUNCT
iajs-3742	116	16	colicin	colicin	PROPN
iajs-3742	116	17	,	,	PUNCT
iajs-3742	116	18	pyocin	pyocin	VERB
iajs-3742	116	19	,	,	PUNCT
iajs-3742	116	20	and	and	CCONJ
iajs-3742	116	21	vibriocin	vibriocin	VERB
iajs-3742	116	22	)	)	PUNCT
iajs-3742	116	23	on	on	ADP
iajs-3742	116	24	cancer	cancer	NOUN
iajs-3742	116	25	cells	cell	NOUN
iajs-3742	116	26	is	be	AUX
iajs-3742	116	27	not	not	PART
iajs-3742	116	28	restricted	restrict	VERB
iajs-3742	116	29	to	to	ADP
iajs-3742	116	30	concentration	concentration	NOUN
iajs-3742	116	31	alone	alone	ADV
iajs-3742	116	32	,	,	PUNCT
iajs-3742	116	33	and	and	CCONJ
iajs-3742	116	34	the	the	DET
iajs-3742	116	35	cell	cell	NOUN
iajs-3742	116	36	growth	growth	NOUN
iajs-3742	116	37	phase	phase	NOUN
iajs-3742	116	38	also	also	ADV
iajs-3742	116	39	has	have	VERB
iajs-3742	116	40	a	a	DET
iajs-3742	116	41	significant	significant	ADJ
iajs-3742	116	42	impact	impact	NOUN
iajs-3742	116	43	on	on	ADP
iajs-3742	116	44	survival	survival	NOUN
iajs-3742	116	45	.	.	PUNCT
iajs-3742	117	1	marcescin	marcescin	PROPN
iajs-3742	117	2	destroys	destroy	VERB
iajs-3742	117	3	the	the	DET
iajs-3742	117	4	cancer	cancer	NOUN
iajs-3742	117	5	cells	cell	NOUN
iajs-3742	117	6	by	by	ADP
iajs-3742	117	7	forming	form	VERB
iajs-3742	117	8	pores	pore	NOUN
iajs-3742	117	9	in	in	ADP
iajs-3742	117	10	the	the	DET
iajs-3742	117	11	cell	cell	NOUN
iajs-3742	117	12	wall	wall	NOUN
iajs-3742	117	13	that	that	PRON
iajs-3742	117	14	lead	lead	VERB
iajs-3742	117	15	to	to	ADP
iajs-3742	117	16	cell	cell	NOUN
iajs-3742	117	17	death	death	NOUN
iajs-3742	117	18	.	.	PUNCT
iajs-3742	118	1	this	this	PRON
iajs-3742	118	2	agrees	agree	VERB
iajs-3742	118	3	with	with	ADP
iajs-3742	118	4	the	the	DET
iajs-3742	118	5	study	study	NOUN
iajs-3742	118	6	by	by	ADP
iajs-3742	118	7	(	(	PUNCT
iajs-3742	118	8	32	32	NUM
iajs-3742	118	9	)	)	PUNCT
iajs-3742	118	10	.	.	PUNCT
iajs-3742	119	1	the	the	DET
iajs-3742	119	2	formation	formation	NOUN
iajs-3742	119	3	of	of	ADP
iajs-3742	119	4	pores	pore	NOUN
iajs-3742	119	5	in	in	ADP
iajs-3742	119	6	the	the	DET
iajs-3742	119	7	cytoplasmic	cytoplasmic	ADJ
iajs-3742	119	8	membrane	membrane	NOUN
iajs-3742	119	9	of	of	ADP
iajs-3742	119	10	cancer	cancer	NOUN
iajs-3742	119	11	cells	cell	NOUN
iajs-3742	119	12	affects	affect	VERB
iajs-3742	119	13	the	the	DET
iajs-3742	119	14	efflux	efflux	NOUN
iajs-3742	119	15	of	of	ADP
iajs-3742	119	16	intracellular	intracellular	ADJ
iajs-3742	119	17	substances	substance	NOUN
iajs-3742	119	18	,	,	PUNCT
iajs-3742	119	19	including	include	VERB
iajs-3742	119	20	potassium	potassium	NOUN
iajs-3742	119	21	and	and	CCONJ
iajs-3742	119	22	amino	amino	NOUN
iajs-3742	119	23	acids	acid	NOUN
iajs-3742	119	24	.	.	PUNCT
iajs-3742	120	1	cancer	cancer	NOUN
iajs-3742	120	2	cell	cell	NOUN
iajs-3742	120	3	death	death	NOUN
iajs-3742	120	4	results	result	VERB
iajs-3742	120	5	from	from	ADP
iajs-3742	120	6	this	this	DET
iajs-3742	120	7	depolarization	depolarization	NOUN
iajs-3742	120	8	of	of	ADP
iajs-3742	120	9	the	the	DET
iajs-3742	120	10	membrane	membrane	NOUN
iajs-3742	120	11	.	.	PUNCT
iajs-3742	121	1	another	another	DET
iajs-3742	121	2	investigation	investigation	NOUN
iajs-3742	121	3	revealed	reveal	VERB
iajs-3742	121	4	that	that	SCONJ
iajs-3742	121	5	the	the	DET
iajs-3742	121	6	s.	s.	PROPN
iajs-3742	121	7	marcessens	marcessen	VERB
iajs-3742	121	8	bacteriocin	bacteriocin	PRON
iajs-3742	121	9	28b	28b	NUM
iajs-3742	121	10	has	have	VERB
iajs-3742	121	11	the	the	DET
iajs-3742	121	12	ability	ability	NOUN
iajs-3742	121	13	to	to	PART
iajs-3742	121	14	generate	generate	VERB
iajs-3742	121	15	pores	pore	NOUN
iajs-3742	121	16	,	,	PUNCT
iajs-3742	121	17	suggesting	suggest	VERB
iajs-3742	121	18	that	that	SCONJ
iajs-3742	121	19	this	this	PRON
iajs-3742	121	20	may	may	AUX
iajs-3742	121	21	be	be	AUX
iajs-3742	121	22	the	the	DET
iajs-3742	121	23	bacteriocin	bacteriocin	NOUN
iajs-3742	121	24	's	's	PART
iajs-3742	121	25	mode	mode	NOUN
iajs-3742	121	26	of	of	ADP
iajs-3742	121	27	action	action	NOUN
iajs-3742	121	28	for	for	ADP
iajs-3742	121	29	killing	kill	VERB
iajs-3742	121	30	(	(	PUNCT
iajs-3742	121	31	33	33	NUM
iajs-3742	121	32	)	)	PUNCT
iajs-3742	121	33	.	.	PUNCT
iajs-3742	122	1	it	it	PRON
iajs-3742	122	2	was	be	AUX
iajs-3742	122	3	found	find	VERB
iajs-3742	122	4	that	that	SCONJ
iajs-3742	122	5	partially	partially	ADV
iajs-3742	122	6	purified	purify	VERB
iajs-3742	122	7	bacteriocin	bacteriocin	NOUN
iajs-3742	122	8	causes	cause	VERB
iajs-3742	122	9	the	the	DET
iajs-3742	122	10	death	death	NOUN
iajs-3742	122	11	of	of	ADP
iajs-3742	122	12	cancer	cancer	NOUN
iajs-3742	122	13	cells	cell	NOUN
iajs-3742	122	14	through	through	ADP
iajs-3742	122	15	programmed	program	VERB
iajs-3742	122	16	cell	cell	NOUN
iajs-3742	122	17	death	death	NOUN
iajs-3742	122	18	by	by	ADP
iajs-3742	122	19	affecting	affect	VERB
iajs-3742	122	20	the	the	DET
iajs-3742	122	21	dna	dna	NOUN
iajs-3742	122	22	and	and	CCONJ
iajs-3742	122	23	breaking	break	VERB
iajs-3742	122	24	it	it	PRON
iajs-3742	122	25	into	into	ADP
iajs-3742	122	26	pieces	piece	NOUN
iajs-3742	122	27	.	.	PUNCT
iajs-3742	123	1	this	this	DET
iajs-3742	123	2	effect	effect	NOUN
iajs-3742	123	3	begins	begin	VERB
iajs-3742	123	4	after	after	ADP
iajs-3742	123	5	the	the	DET
iajs-3742	123	6	first	first	ADJ
iajs-3742	123	7	hour	hour	NOUN
iajs-3742	123	8	of	of	ADP
iajs-3742	123	9	exposure	exposure	NOUN
iajs-3742	123	10	and	and	CCONJ
iajs-3742	123	11	reaches	reach	VERB
iajs-3742	123	12	its	its	PRON
iajs-3742	123	13	highest	high	ADJ
iajs-3742	123	14	peak	peak	NOUN
iajs-3742	123	15	after	after	ADP
iajs-3742	123	16	six	six	NUM
iajs-3742	123	17	hours	hour	NOUN
iajs-3742	123	18	(	(	PUNCT
iajs-3742	123	19	43	43	NUM
iajs-3742	123	20	)	)	PUNCT
iajs-3742	123	21	.	.	PUNCT
iajs-3742	124	1	some	some	DET
iajs-3742	124	2	colicins	colicin	NOUN
iajs-3742	124	3	,	,	PUNCT
iajs-3742	124	4	including	include	VERB
iajs-3742	124	5	hsc10	hsc10	NOUN
iajs-3742	124	6	,	,	PUNCT
iajs-3742	124	7	affect	affect	VERB
iajs-3742	124	8	the	the	DET
iajs-3742	124	9	cell	cell	NOUN
iajs-3742	124	10	cycle	cycle	NOUN
iajs-3742	124	11	of	of	ADP
iajs-3742	124	12	cancer	cancer	NOUN
iajs-3742	124	13	cells	cell	NOUN
iajs-3742	124	14	(	(	PUNCT
iajs-3742	124	15	t	t	NOUN
iajs-3742	124	16	-	-	PUNCT
iajs-3742	124	17	cell	cell	NOUN
iajs-3742	124	18	leukemia	leukemia	NOUN
iajs-3742	124	19	)	)	PUNCT
iajs-3742	124	20	,	,	PUNCT
iajs-3742	124	21	causing	cause	VERB
iajs-3742	124	22	their	their	PRON
iajs-3742	124	23	division	division	NOUN
iajs-3742	124	24	to	to	PART
iajs-3742	124	25	be	be	AUX
iajs-3742	124	26	inhibited	inhibit	VERB
iajs-3742	124	27	,	,	PUNCT
iajs-3742	124	28	making	make	VERB
iajs-3742	124	29	them	they	PRON
iajs-3742	124	30	unable	unable	ADJ
iajs-3742	124	31	to	to	PART
iajs-3742	124	32	reach	reach	VERB
iajs-3742	124	33	phases	phase	NOUN
iajs-3742	124	34	(	(	PUNCT
iajs-3742	124	35	s	s	X
iajs-3742	124	36	,	,	PUNCT
iajs-3742	124	37	g2	g2	PROPN
iajs-3742	124	38	,	,	PUNCT
iajs-3742	124	39	m	m	PROPN
iajs-3742	124	40	)	)	PUNCT
iajs-3742	124	41	,	,	PUNCT
iajs-3742	124	42	and	and	CCONJ
iajs-3742	124	43	congregating	congregate	VERB
iajs-3742	124	44	in	in	ADP
iajs-3742	124	45	the	the	DET
iajs-3742	124	46	g1	g1	PROPN
iajs-3742	124	47	phase	phase	NOUN
iajs-3742	124	48	(	(	PUNCT
iajs-3742	124	49	43	43	NUM
iajs-3742	124	50	)	)	PUNCT
iajs-3742	124	51	.	.	PUNCT
iajs-3742	125	1	ihjpas	ihjpas	PROPN
iajs-3742	125	2	.	.	PUNCT
iajs-3742	126	1	2025	2025	NUM
iajs-3742	126	2	,	,	PUNCT
iajs-3742	126	3	38(3	38(3	NUM
iajs-3742	126	4	)	)	PUNCT
iajs-3742	126	5	85	85	NUM
iajs-3742	126	6	5	5	NUM
iajs-3742	126	7	.	.	PUNCT
iajs-3742	126	8	conclusions	conclusion	NOUN
iajs-3742	126	9	the	the	DET
iajs-3742	126	10	results	result	NOUN
iajs-3742	126	11	showed	show	VERB
iajs-3742	126	12	that	that	SCONJ
iajs-3742	126	13	hep-2	hep-2	PUNCT
iajs-3742	126	14	cell	cell	NOUN
iajs-3742	126	15	lines	line	NOUN
iajs-3742	126	16	are	be	AUX
iajs-3742	126	17	sensitive	sensitive	ADJ
iajs-3742	126	18	to	to	ADP
iajs-3742	126	19	marcescin	marcescin	NOUN
iajs-3742	126	20	,	,	PUNCT
iajs-3742	126	21	and	and	CCONJ
iajs-3742	126	22	this	this	DET
iajs-3742	126	23	sensitivity	sensitivity	NOUN
iajs-3742	126	24	increases	increase	VERB
iajs-3742	126	25	with	with	ADP
iajs-3742	126	26	increasing	increase	VERB
iajs-3742	126	27	concentration	concentration	NOUN
iajs-3742	126	28	and	and	CCONJ
iajs-3742	126	29	the	the	PRON
iajs-3742	126	30	longer	long	ADJ
iajs-3742	126	31	the	the	DET
iajs-3742	126	32	exposure	exposure	NOUN
iajs-3742	126	33	period	period	NOUN
iajs-3742	126	34	to	to	ADP
iajs-3742	126	35	marcescin	marcescin	PROPN
iajs-3742	126	36	.	.	PUNCT
iajs-3742	127	1	marcescin	marcescin	PROPN
iajs-3742	127	2	does	do	AUX
iajs-3742	127	3	not	not	PART
iajs-3742	127	4	promote	promote	VERB
iajs-3742	127	5	the	the	DET
iajs-3742	127	6	proliferation	proliferation	NOUN
iajs-3742	127	7	of	of	ADP
iajs-3742	127	8	cancer	cancer	NOUN
iajs-3742	127	9	cells	cell	NOUN
iajs-3742	127	10	.	.	PUNCT
iajs-3742	128	1	so	so	ADV
iajs-3742	128	2	this	this	DET
iajs-3742	128	3	bacteriocin	bacteriocin	PRON
iajs-3742	128	4	may	may	AUX
iajs-3742	128	5	be	be	AUX
iajs-3742	128	6	used	use	VERB
iajs-3742	128	7	to	to	PART
iajs-3742	128	8	treat	treat	VERB
iajs-3742	128	9	cancer	cancer	NOUN
iajs-3742	128	10	.	.	PUNCT
iajs-3742	129	1	acknowledgment	acknowledgment	NOUN
iajs-3742	129	2	the	the	DET
iajs-3742	129	3	authors	author	NOUN
iajs-3742	129	4	would	would	AUX
iajs-3742	129	5	like	like	VERB
iajs-3742	129	6	to	to	PART
iajs-3742	129	7	thank	thank	VERB
iajs-3742	129	8	the	the	DET
iajs-3742	129	9	nursing	nursing	NOUN
iajs-3742	129	10	home	home	NOUN
iajs-3742	129	11	hospital	hospital	NOUN
iajs-3742	129	12	staff	staff	NOUN
iajs-3742	129	13	for	for	ADP
iajs-3742	129	14	their	their	PRON
iajs-3742	129	15	assistance	assistance	NOUN
iajs-3742	129	16	in	in	ADP
iajs-3742	129	17	collecting	collect	VERB
iajs-3742	129	18	samples	sample	NOUN
iajs-3742	129	19	.	.	PUNCT
iajs-3742	130	1	conflict	conflict	NOUN
iajs-3742	130	2	of	of	ADP
iajs-3742	130	3	interest	interest	NOUN
iajs-3742	130	4	the	the	DET
iajs-3742	130	5	authors	author	NOUN
iajs-3742	130	6	declare	declare	VERB
iajs-3742	130	7	that	that	SCONJ
iajs-3742	130	8	they	they	PRON
iajs-3742	130	9	have	have	VERB
iajs-3742	130	10	no	no	DET
iajs-3742	130	11	conflicts	conflict	NOUN
iajs-3742	130	12	of	of	ADP
iajs-3742	130	13	interest	interest	NOUN
iajs-3742	130	14	.	.	PUNCT
iajs-3742	131	1	funding	fund	VERB
iajs-3742	131	2	no	no	DET
iajs-3742	131	3	funding	funding	NOUN
iajs-3742	131	4	.	.	PUNCT
iajs-3742	132	1	ethical	ethical	ADJ
iajs-3742	132	2	approval	approval	NOUN
iajs-3742	132	3	the	the	DET
iajs-3742	132	4	study	study	NOUN
iajs-3742	132	5	was	be	AUX
iajs-3742	132	6	conducted	conduct	VERB
iajs-3742	132	7	in	in	ADP
iajs-3742	132	8	accordance	accordance	NOUN
iajs-3742	132	9	with	with	ADP
iajs-3742	132	10	the	the	DET
iajs-3742	132	11	ethical	ethical	ADJ
iajs-3742	132	12	principles	principle	NOUN
iajs-3742	132	13	.	.	PUNCT
iajs-3742	133	1	it	it	PRON
iajs-3742	133	2	was	be	AUX
iajs-3742	133	3	carried	carry	VERB
iajs-3742	133	4	out	out	ADP
iajs-3742	133	5	with	with	ADP
iajs-3742	133	6	patients	patient	NOUN
iajs-3742	133	7	verbal	verbal	ADJ
iajs-3742	133	8	and	and	CCONJ
iajs-3742	133	9	analytical	analytical	ADJ
iajs-3742	133	10	approval	approval	NOUN
iajs-3742	133	11	before	before	SCONJ
iajs-3742	133	12	the	the	DET
iajs-3742	133	13	sample	sample	NOUN
iajs-3742	133	14	was	be	AUX
iajs-3742	133	15	taken	take	VERB
iajs-3742	133	16	.	.	PUNCT
iajs-3742	134	1	the	the	DET
iajs-3742	134	2	university	university	PROPN
iajs-3742	134	3	of	of	ADP
iajs-3742	134	4	baghdad	baghdad	PROPN
iajs-3742	134	5	college	college	PROPN
iajs-3742	134	6	of	of	ADP
iajs-3742	134	7	science	science	NOUN
iajs-3742	134	8	,	,	PUNCT
iajs-3742	134	9	a	a	DET
iajs-3742	134	10	local	local	ADJ
iajs-3742	134	11	ethics	ethic	NOUN
iajs-3742	134	12	committee	committee	NOUN
iajs-3742	134	13	,	,	PUNCT
iajs-3742	134	14	reviewed	review	VERB
iajs-3742	134	15	and	and	CCONJ
iajs-3742	134	16	approved	approve	VERB
iajs-3742	134	17	the	the	DET
iajs-3742	134	18	study	study	NOUN
iajs-3742	134	19	protocol	protocol	NOUN
iajs-3742	134	20	,	,	PUNCT
iajs-3742	134	21	subject	subject	ADJ
iajs-3742	134	22	information	information	NOUN
iajs-3742	134	23	,	,	PUNCT
iajs-3742	134	24	and	and	CCONJ
iajs-3742	134	25	consent	consent	VERB
iajs-3742	134	26	form	form	NOUN
iajs-3742	134	27	on	on	ADP
iajs-3742	134	28	26	26	NUM
iajs-3742	134	29	september	september	PROPN
iajs-3742	134	30	2022	2022	NUM
iajs-3742	134	31	,	,	PUNCT
iajs-3742	134	32	using	use	VERB
iajs-3742	134	33	the	the	DET
iajs-3742	134	34	document	document	NOUN
iajs-3742	134	35	number	number	NOUN
iajs-3742	134	36	csec/0922/0089	csec/0922/0089	NOUN
iajs-3742	134	37	.	.	PUNCT
iajs-3742	135	1	references	reference	NOUN
iajs-3742	135	2	1	1	NUM
iajs-3742	135	3	.	.	PUNCT
iajs-3742	136	1	baindara	baindara	PROPN
iajs-3742	136	2	p	p	X
iajs-3742	136	3	,	,	PUNCT
iajs-3742	136	4	mandal	mandal	PROPN
iajs-3742	136	5	sm	sm	PROPN
iajs-3742	136	6	.	.	PUNCT
iajs-3742	136	7	bacteria	bacteria	NOUN
iajs-3742	136	8	and	and	CCONJ
iajs-3742	136	9	bacterial	bacterial	ADJ
iajs-3742	136	10	anticancer	anticancer	NOUN
iajs-3742	136	11	agents	agent	NOUN
iajs-3742	136	12	as	as	ADP
iajs-3742	136	13	a	a	DET
iajs-3742	136	14	promising	promising	ADJ
iajs-3742	136	15	alternative	alternative	NOUN
iajs-3742	136	16	for	for	ADP
iajs-3742	136	17	cancer	cancer	NOUN
iajs-3742	136	18	therapeutics	therapeutic	NOUN
iajs-3742	136	19	.	.	PUNCT
iajs-3742	137	1	biochimie	biochimie	PROPN
iajs-3742	137	2	 	 	SPACE
iajs-3742	137	3	2020;177:164–189	2020;177:164–189	NUM
iajs-3742	137	4	.	.	PUNCT
iajs-3742	137	5	https://doi.org/10.1016/j.biochi.2020.07.020	https://doi.org/10.1016/j.biochi.2020.07.020	NOUN
iajs-3742	137	6	2	2	NUM
iajs-3742	137	7	.	.	PUNCT
iajs-3742	138	1	kaur	kaur	PROPN
iajs-3742	138	2	b	b	PROPN
iajs-3742	138	3	,	,	PUNCT
iajs-3742	138	4	kumar	kumar	PROPN
iajs-3742	138	5	s	s	PROPN
iajs-3742	138	6	,	,	PUNCT
iajs-3742	138	7	kaushik	kaushik	PROPN
iajs-3742	138	8	bk	bk	PROPN
iajs-3742	138	9	.	.	PUNCT
iajs-3742	139	1	recent	recent	ADJ
iajs-3742	139	2	advancements	advancement	NOUN
iajs-3742	139	3	in	in	ADP
iajs-3742	139	4	optical	optical	ADJ
iajs-3742	139	5	biosensors	biosensor	NOUN
iajs-3742	139	6	for	for	ADP
iajs-3742	139	7	cancer	cancer	NOUN
iajs-3742	139	8	detection	detection	NOUN
iajs-3742	139	9	.	.	PUNCT
iajs-3742	140	1	biosens	biosen	NOUN
iajs-3742	140	2	bioelectron	bioelectron	VERB
iajs-3742	140	3	 	 	SPACE
iajs-3742	140	4	2022;197:113805	2022;197:113805	NUM
iajs-3742	140	5	.	.	PUNCT
iajs-3742	141	1	https://doi.org/10.1016/j.bios.2021.113805	https://doi.org/10.1016/j.bios.2021.113805	PROPN
iajs-3742	141	2	3	3	NUM
iajs-3742	141	3	.	.	X
iajs-3742	141	4	hassanpour	hassanpour	PROPN
iajs-3742	141	5	sh	sh	PROPN
iajs-3742	141	6	,	,	PUNCT
iajs-3742	141	7	dehghani	dehghani	PROPN
iajs-3742	141	8	m.	m.	PROPN
iajs-3742	141	9	review	review	PROPN
iajs-3742	141	10	of	of	ADP
iajs-3742	141	11	cancer	cancer	NOUN
iajs-3742	141	12	from	from	ADP
iajs-3742	141	13	perspective	perspective	NOUN
iajs-3742	141	14	of	of	ADP
iajs-3742	141	15	molecular	molecular	NOUN
iajs-3742	141	16	.	.	PUNCT
iajs-3742	142	1	j	j	PROPN
iajs-3742	142	2	cancer	cancer	NOUN
iajs-3742	142	3	res	re	NOUN
iajs-3742	142	4	pract	pract	PROPN
iajs-3742	142	5	 	 	SPACE
iajs-3742	142	6	2017;4(4):127–129	2017;4(4):127–129	PROPN
iajs-3742	142	7	.	.	PUNCT
iajs-3742	143	1	https://doi.org/10.1016/j.jcrpr.2017.07.001	https://doi.org/10.1016/j.jcrpr.2017.07.001	PROPN
iajs-3742	143	2	4	4	NUM
iajs-3742	143	3	.	.	PUNCT
iajs-3742	143	4	mahdi	mahdi	PROPN
iajs-3742	143	5	rh	rh	PROPN
iajs-3742	143	6	,	,	PUNCT
iajs-3742	143	7	hasan	hasan	PROPN
iajs-3742	143	8	sa	sa	PROPN
iajs-3742	143	9	,	,	PUNCT
iajs-3742	143	10	hasan	hasan	PROPN
iajs-3742	143	11	jm	jm	PROPN
iajs-3742	143	12	.	.	PUNCT
iajs-3742	144	1	the	the	DET
iajs-3742	144	2	effect	effect	NOUN
iajs-3742	144	3	of	of	ADP
iajs-3742	144	4	serratia	serratia	NOUN
iajs-3742	144	5	marcescens	marcescen	NOUN
iajs-3742	144	6	protease	protease	NOUN
iajs-3742	144	7	on	on	ADP
iajs-3742	144	8	human	human	ADJ
iajs-3742	144	9	lymphocytes	lymphocyte	NOUN
iajs-3742	144	10	transformation	transformation	NOUN
iajs-3742	144	11	.	.	PUNCT
iajs-3742	145	1	iraqi	iraqi	ADJ
iajs-3742	145	2	j	j	PROPN
iajs-3742	145	3	sci	sci	PROPN
iajs-3742	145	4	 	 	SPACE
iajs-3742	145	5	2013;54(3):531–535	2013;54(3):531–535	NUM
iajs-3742	145	6	.	.	PUNCT
iajs-3742	145	7	531535	531535	NUM
iajs-3742	145	8	.	.	PUNCT
iajs-3742	146	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/12113	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/12113	ADJ
iajs-3742	146	2	.	.	PROPN
iajs-3742	147	1	5	5	X
iajs-3742	147	2	.	.	X
iajs-3742	147	3	dicks	dick	NOUN
iajs-3742	147	4	lm	lm	PROPN
iajs-3742	147	5	,	,	PUNCT
iajs-3742	147	6	vermeulen	vermeulen	PROPN
iajs-3742	147	7	w.	w.	PROPN
iajs-3742	147	8	do	do	AUX
iajs-3742	147	9	bacteria	bacteria	NOUN
iajs-3742	147	10	provide	provide	VERB
iajs-3742	147	11	an	an	DET
iajs-3742	147	12	alternative	alternative	NOUN
iajs-3742	147	13	to	to	ADP
iajs-3742	147	14	cancer	cancer	NOUN
iajs-3742	147	15	treatment	treatment	NOUN
iajs-3742	147	16	and	and	CCONJ
iajs-3742	147	17	what	what	DET
iajs-3742	147	18	role	role	NOUN
iajs-3742	147	19	does	do	AUX
iajs-3742	147	20	lactic	lactic	ADJ
iajs-3742	147	21	acid	acid	NOUN
iajs-3742	147	22	bacteria	bacteria	NOUN
iajs-3742	147	23	play	play	NOUN
iajs-3742	147	24	?	?	PUNCT
iajs-3742	148	1	microorganisms	microorganism	NOUN
iajs-3742	148	2	 	 	SPACE
iajs-3742	148	3	2022;10(9):1733	2022;10(9):1733	NUM
iajs-3742	148	4	.	.	PUNCT
iajs-3742	149	1	https://doi.org/10.3390/microorganisms10091733	https://doi.org/10.3390/microorganisms10091733	PROPN
iajs-3742	149	2	.	.	PUNCT
iajs-3742	150	1	6	6	NUM
iajs-3742	150	2	.	.	X
iajs-3742	150	3	coley	coley	PROPN
iajs-3742	150	4	wb	wb	PROPN
iajs-3742	150	5	.	.	PUNCT
iajs-3742	151	1	the	the	DET
iajs-3742	151	2	treatment	treatment	NOUN
iajs-3742	151	3	of	of	ADP
iajs-3742	151	4	inoperable	inoperable	ADJ
iajs-3742	151	5	sarcoma	sarcoma	NOUN
iajs-3742	151	6	by	by	ADP
iajs-3742	151	7	bacterial	bacterial	ADJ
iajs-3742	151	8	toxins	toxin	NOUN
iajs-3742	151	9	(	(	PUNCT
iajs-3742	151	10	the	the	DET
iajs-3742	151	11	mixed	mixed	ADJ
iajs-3742	151	12	toxins	toxin	NOUN
iajs-3742	151	13	of	of	ADP
iajs-3742	151	14	the	the	DET
iajs-3742	151	15	streptococcus	streptococcus	NOUN
iajs-3742	151	16	erysipelas	erysipela	NOUN
iajs-3742	151	17	and	and	CCONJ
iajs-3742	151	18	the	the	DET
iajs-3742	151	19	bacillus	bacillus	NOUN
iajs-3742	151	20	prodigiosus	prodigiosus	NOUN
iajs-3742	151	21	)	)	PUNCT
iajs-3742	151	22	.	.	PUNCT
iajs-3742	152	1	proc	proc	NOUN
iajs-3742	152	2	r	r	PROPN
iajs-3742	152	3	soc	soc	NOUN
iajs-3742	152	4	med	me	VERB
iajs-3742	152	5	 	 	SPACE
iajs-3742	152	6	1910;3(surg	1910;3(surg	NUM
iajs-3742	152	7	sect):1–48	sect):1–48	NOUN
iajs-3742	152	8	.	.	PUNCT
iajs-3742	153	1	7	7	NUM
iajs-3742	153	2	.	.	X
iajs-3742	153	3	wiemann	wiemann	PROPN
iajs-3742	153	4	b	b	PROPN
iajs-3742	153	5	,	,	PUNCT
iajs-3742	153	6	starnes	starnes	PROPN
iajs-3742	153	7	co.	co.	PROPN
iajs-3742	153	8	coley	coley	NOUN
iajs-3742	153	9	’s	’s	PART
iajs-3742	153	10	toxins	toxin	NOUN
iajs-3742	153	11	,	,	PUNCT
iajs-3742	153	12	tumor	tumor	NOUN
iajs-3742	153	13	necrosis	necrosis	NOUN
iajs-3742	153	14	factor	factor	NOUN
iajs-3742	153	15	and	and	CCONJ
iajs-3742	153	16	cancer	cancer	NOUN
iajs-3742	153	17	research	research	NOUN
iajs-3742	153	18	:	:	PUNCT
iajs-3742	153	19	a	a	DET
iajs-3742	153	20	historical	historical	ADJ
iajs-3742	153	21	perspective	perspective	NOUN
iajs-3742	153	22	.	.	PUNCT
iajs-3742	154	1	pharmacol	pharmacol	VERB
iajs-3742	154	2	ther	ther	ADV
iajs-3742	154	3	 	 	SPACE
iajs-3742	154	4	1994;64(3):529–564	1994;64(3):529–564	NUM
iajs-3742	154	5	.	.	PUNCT
iajs-3742	155	1	https://doi.org/10.1016/0163-7258(94)90023-x	https://doi.org/10.1016/0163-7258(94)90023-x	PROPN
iajs-3742	155	2	.	.	PROPN
iajs-3742	155	3	8	8	NUM
iajs-3742	155	4	.	.	X
iajs-3742	155	5	molujin	molujin	NOUN
iajs-3742	155	6	am	am	PROPN
iajs-3742	155	7	,	,	PUNCT
iajs-3742	155	8	abbasiliasi	abbasiliasi	PROPN
iajs-3742	155	9	s	s	PROPN
iajs-3742	155	10	,	,	PUNCT
iajs-3742	155	11	nurdin	nurdin	VERB
iajs-3742	155	12	a	a	PRON
iajs-3742	155	13	,	,	PUNCT
iajs-3742	155	14	lee	lee	PROPN
iajs-3742	155	15	pc	pc	PROPN
iajs-3742	155	16	,	,	PUNCT
iajs-3742	155	17	gansau	gansau	PROPN
iajs-3742	155	18	ja	ja	PROPN
iajs-3742	155	19	,	,	PUNCT
iajs-3742	155	20	jawan	jawan	PROPN
iajs-3742	155	21	r.	r.	PROPN
iajs-3742	155	22	bacteriocins	bacteriocin	NOUN
iajs-3742	155	23	as	as	ADP
iajs-3742	155	24	potential	potential	ADJ
iajs-3742	155	25	therapeutic	therapeutic	ADJ
iajs-3742	155	26	approaches	approach	NOUN
iajs-3742	155	27	in	in	ADP
iajs-3742	155	28	the	the	DET
iajs-3742	155	29	treatment	treatment	NOUN
iajs-3742	155	30	of	of	ADP
iajs-3742	155	31	various	various	ADJ
iajs-3742	155	32	cancers	cancer	NOUN
iajs-3742	155	33	:	:	PUNCT
iajs-3742	155	34	a	a	DET
iajs-3742	155	35	review	review	NOUN
iajs-3742	155	36	of	of	ADP
iajs-3742	155	37	in	in	ADP
iajs-3742	155	38	vitro	vitro	X
iajs-3742	155	39	studies	study	NOUN
iajs-3742	155	40	.	.	PUNCT
iajs-3742	156	1	cancers	cancer	NOUN
iajs-3742	156	2	 	 	SPACE
iajs-3742	156	3	2022;14(19):4758	2022;14(19):4758	NUM
iajs-3742	156	4	.	.	PUNCT
iajs-3742	157	1	https://doi.org/10.3390/cancers14194758	https://doi.org/10.3390/cancers14194758	PROPN
iajs-3742	157	2	.	.	PUNCT
iajs-3742	158	1	9	9	X
iajs-3742	158	2	.	.	X
iajs-3742	158	3	kaur	kaur	PROPN
iajs-3742	158	4	s	s	PROPN
iajs-3742	158	5	,	,	PUNCT
iajs-3742	158	6	kaur	kaur	PROPN
iajs-3742	158	7	s.	s.	PROPN
iajs-3742	158	8	bacteriocins	bacteriocin	NOUN
iajs-3742	158	9	as	as	ADP
iajs-3742	158	10	potential	potential	ADJ
iajs-3742	158	11	anticancer	anticancer	NOUN
iajs-3742	158	12	agents	agent	NOUN
iajs-3742	158	13	.	.	PUNCT
iajs-3742	159	1	front	front	ADJ
iajs-3742	159	2	pharmacol	pharmacol	PROPN
iajs-3742	159	3	 	 	SPACE
iajs-3742	159	4	2015;6:272	2015;6:272	NUM
iajs-3742	159	5	.	.	PUNCT
iajs-3742	160	1	https://doi.org/10.3389/fphar.2015.00272	https://doi.org/10.3389/fphar.2015.00272	PROPN
iajs-3742	160	2	.	.	PROPN
iajs-3742	160	3	10	10	NUM
iajs-3742	160	4	.	.	PUNCT
iajs-3742	160	5	hussein	hussein	PROPN
iajs-3742	160	6	ar	ar	PROPN
iajs-3742	160	7	,	,	PUNCT
iajs-3742	160	8	khalaf	khalaf	PROPN
iajs-3742	160	9	zz	zz	PROPN
iajs-3742	160	10	,	,	PUNCT
iajs-3742	160	11	samir	samir	PROPN
iajs-3742	160	12	z	z	PROPN
iajs-3742	160	13	,	,	PUNCT
iajs-3742	160	14	samir	samir	PROPN
iajs-3742	160	15	r.	r.	PROPN
iajs-3742	160	16	the	the	DET
iajs-3742	160	17	antibacterial	antibacterial	ADJ
iajs-3742	160	18	activity	activity	NOUN
iajs-3742	160	19	of	of	ADP
iajs-3742	160	20	crude	crude	ADJ
iajs-3742	160	21	bacteriocin	bacteriocin	NOUN
iajs-3742	160	22	-	-	PUNCT
iajs-3742	160	23	like	like	ADJ
iajs-3742	160	24	substance	substance	NOUN
iajs-3742	160	25	against	against	ADP
iajs-3742	160	26	food	food	NOUN
iajs-3742	160	27	borne	bear	VERB
iajs-3742	160	28	bacterial	bacterial	ADJ
iajs-3742	160	29	pathogens	pathogen	NOUN
iajs-3742	160	30	.	.	PUNCT
iajs-3742	161	1	iraqi	iraqi	PROPN
iajs-3742	161	2	j	j	PROPN
iajs-3742	161	3	sci	sci	PROPN
iajs-3742	161	4	 	 	SPACE
iajs-3742	161	5	2018	2018	NUM
iajs-3742	161	6	;	;	PUNCT
iajs-3742	161	7	59(1a	59(1a	NUM
iajs-3742	161	8	):	):	PUNCT
iajs-3742	161	9	16	16	NUM
iajs-3742	161	10	-	-	SYM
iajs-3742	161	11	24	24	NUM
iajs-3742	161	12	.	.	PUNCT
iajs-3742	162	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/152	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/152	PROPN
iajs-3742	162	2	.	.	PROPN
iajs-3742	162	3	https://doi.org/10.1016/j.biochi.2020.07.020	https://doi.org/10.1016/j.biochi.2020.07.020	AUX
iajs-3742	162	4	https://doi.org/10.1016/j.bios.2021.113805	https://doi.org/10.1016/j.bios.2021.113805	PROPN
iajs-3742	162	5	https://doi.org/10.1016/j.jcrpr.2017.07.001	https://doi.org/10.1016/j.jcrpr.2017.07.001	PROPN
iajs-3742	162	6	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/12113	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/12113	PROPN
iajs-3742	162	7	https://doi.org/10.3390/microorganisms10091733	https://doi.org/10.3390/microorganisms10091733	PROPN
iajs-3742	162	8	https://doi.org/10.1016/0163-7258(94)90023-x	https://doi.org/10.1016/0163-7258(94)90023-x	PROPN
iajs-3742	162	9	https://doi.org/10.3390/cancers14194758	https://doi.org/10.3390/cancers14194758	PROPN
iajs-3742	162	10	https://doi.org/10.3389/fphar.2015.00272	https://doi.org/10.3389/fphar.2015.00272	PROPN
iajs-3742	162	11	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/152	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/152	PROPN
iajs-3742	162	12	ihjpas	ihjpa	NOUN
iajs-3742	162	13	.	.	PUNCT
iajs-3742	163	1	2025	2025	NUM
iajs-3742	163	2	,	,	PUNCT
iajs-3742	163	3	38(3	38(3	NUM
iajs-3742	163	4	)	)	PUNCT
iajs-3742	163	5	86	86	NUM
iajs-3742	163	6	11	11	NUM
iajs-3742	163	7	.	.	PUNCT
iajs-3742	164	1	salman	salman	PROPN
iajs-3742	164	2	sm	sm	PROPN
iajs-3742	164	3	,	,	PUNCT
iajs-3742	164	4	obaid	obaid	PROPN
iajs-3742	164	5	hh	hh	PROPN
iajs-3742	164	6	.	.	PROPN
iajs-3742	164	7	assessment	assessment	PROPN
iajs-3742	164	8	resistance	resistance	NOUN
iajs-3742	164	9	of	of	ADP
iajs-3742	164	10	gram	gram	NOUN
iajs-3742	164	11	negative	negative	ADJ
iajs-3742	164	12	gut	gut	NOUN
iajs-3742	164	13	microbiota	microbiota	NOUN
iajs-3742	164	14	for	for	ADP
iajs-3742	164	15	antibiotics	antibiotic	NOUN
iajs-3742	164	16	.	.	PUNCT
iajs-3742	165	1	bioinfolet	bioinfolet	PROPN
iajs-3742	165	2	 	 	SPACE
iajs-3742	165	3	2023;20(2a):147–152	2023;20(2a):147–152	NUM
iajs-3742	165	4	.	.	PROPN
iajs-3742	165	5	12	12	NUM
iajs-3742	165	6	.	.	PUNCT
iajs-3742	166	1	al	al	PROPN
iajs-3742	166	2	-	-	PUNCT
iajs-3742	166	3	saeedi	saeedi	PROPN
iajs-3742	166	4	bsm	bsm	PROPN
iajs-3742	166	5	,	,	PUNCT
iajs-3742	166	6	luti	luti	PROPN
iajs-3742	166	7	kjk	kjk	PROPN
iajs-3742	166	8	.	.	PUNCT
iajs-3742	167	1	bacteriocin	bacteriocin	PROPN
iajs-3742	167	2	from	from	ADP
iajs-3742	167	3	streptococcus	streptococcus	NOUN
iajs-3742	167	4	salivarius	salivarius	NOUN
iajs-3742	167	5	optimized	optimize	VERB
iajs-3742	167	6	statistically	statistically	ADV
iajs-3742	167	7	by	by	ADP
iajs-3742	167	8	response	response	NOUN
iajs-3742	167	9	surface	surface	NOUN
iajs-3742	167	10	methodology	methodology	NOUN
iajs-3742	167	11	active	active	ADJ
iajs-3742	167	12	against	against	ADP
iajs-3742	167	13	different	different	ADJ
iajs-3742	167	14	clinical	clinical	ADJ
iajs-3742	167	15	oral	oral	ADJ
iajs-3742	167	16	pathogenic	pathogenic	ADJ
iajs-3742	167	17	streptococci	streptococci	NOUN
iajs-3742	167	18	.	.	PUNCT
iajs-3742	168	1	iraqi	iraqi	ADJ
iajs-3742	168	2	j	j	PROPN
iajs-3742	168	3	sci	sci	PROPN
iajs-3742	168	4	 	 	SPACE
iajs-3742	168	5	2018;59(1c	2018;59(1c	NUM
iajs-3742	168	6	):	):	PUNCT
iajs-3742	168	7	463	463	NUM
iajs-3742	168	8	-	-	SYM
iajs-3742	168	9	475	475	NUM
iajs-3742	168	10	.	.	PUNCT
iajs-3742	169	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/271	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/271	NOUN
iajs-3742	169	2	.	.	PROPN
iajs-3742	170	1	13	13	NUM
iajs-3742	170	2	.	.	PUNCT
iajs-3742	170	3	traub	traub	PROPN
iajs-3742	170	4	wh	wh	PROPN
iajs-3742	170	5	,	,	PUNCT
iajs-3742	170	6	raymond	raymond	PROPN
iajs-3742	170	7	ea	ea	PROPN
iajs-3742	170	8	,	,	PUNCT
iajs-3742	170	9	startsman	startsman	NOUN
iajs-3742	170	10	ts	ts	PROPN
iajs-3742	170	11	.	.	PUNCT
iajs-3742	171	1	bacteriocin	bacteriocin	PROPN
iajs-3742	171	2	(	(	PUNCT
iajs-3742	171	3	marcescin	marcescin	PROPN
iajs-3742	171	4	)	)	PUNCT
iajs-3742	171	5	typing	typing	NOUN
iajs-3742	171	6	of	of	ADP
iajs-3742	171	7	clinical	clinical	ADJ
iajs-3742	171	8	isolates	isolate	NOUN
iajs-3742	171	9	of	of	ADP
iajs-3742	171	10	serratia	serratia	PROPN
iajs-3742	171	11	marcescens	marcescens	PROPN
iajs-3742	171	12	.	.	PUNCT
iajs-3742	172	1	appl	appl	PROPN
iajs-3742	172	2	microbiol	microbiol	PROPN
iajs-3742	172	3	 	 	SPACE
iajs-3742	172	4	1971;21(5):837–840	1971;21(5):837–840	PROPN
iajs-3742	172	5	.	.	PUNCT
iajs-3742	172	6	https://doi.org/10.1128/am.21.5.837840.1971	https://doi.org/10.1128/am.21.5.837840.1971	NOUN
iajs-3742	172	7	.	.	PUNCT
iajs-3742	173	1	14	14	NUM
iajs-3742	173	2	.	.	PUNCT
iajs-3742	174	1	šmajs	šmajs	PROPN
iajs-3742	174	2	d	d	PROPN
iajs-3742	174	3	,	,	PUNCT
iajs-3742	174	4	weinstock	weinstock	PROPN
iajs-3742	174	5	gm	gm	PROPN
iajs-3742	174	6	.	.	PUNCT
iajs-3742	175	1	the	the	DET
iajs-3742	175	2	iron	iron	NOUN
iajs-3742	175	3	and	and	CCONJ
iajs-3742	175	4	temperature	temperature	NOUN
iajs-3742	175	5	regulated	regulate	VERB
iajs-3742	175	6	cjrbc	cjrbc	ADJ
iajs-3742	175	7	genes	gene	NOUN
iajs-3742	175	8	of	of	ADP
iajs-3742	175	9	shigella	shigella	PROPN
iajs-3742	175	10	and	and	CCONJ
iajs-3742	175	11	enteroinvasive	enteroinvasive	ADJ
iajs-3742	175	12	escherichia	escherichia	NOUN
iajs-3742	175	13	coli	coli	NOUN
iajs-3742	175	14	strains	strain	VERB
iajs-3742	175	15	code	code	NOUN
iajs-3742	175	16	for	for	ADP
iajs-3742	175	17	colicin	colicin	NOUN
iajs-3742	175	18	js	js	ADP
iajs-3742	175	19	uptake	uptake	ADJ
iajs-3742	175	20	.	.	PUNCT
iajs-3742	176	1	j	j	PROPN
iajs-3742	176	2	bacteriol	bacteriol	NOUN
iajs-3742	176	3	 	 	SPACE
iajs-3742	176	4	2001;183(13):3958	2001;183(13):3958	NUM
iajs-3742	176	5	–	–	PUNCT
iajs-3742	176	6	3966	3966	NUM
iajs-3742	176	7	.	.	PUNCT
iajs-3742	177	1	https://doi.org/10.1128/jb.183.13.3958-3966.2001	https://doi.org/10.1128/jb.183.13.3958-3966.2001	INTJ
iajs-3742	177	2	.	.	PUNCT
iajs-3742	178	1	15	15	X
iajs-3742	178	2	.	.	PUNCT
iajs-3742	179	1	baindara	baindara	PROPN
iajs-3742	179	2	p	p	NOUN
iajs-3742	179	3	,	,	PUNCT
iajs-3742	179	4	korpole	korpole	PROPN
iajs-3742	179	5	s	s	PROPN
iajs-3742	179	6	,	,	PUNCT
iajs-3742	179	7	grover	grover	PROPN
iajs-3742	179	8	v.	v.	PROPN
iajs-3742	179	9	bacteriocins	bacteriocin	NOUN
iajs-3742	179	10	:	:	PUNCT
iajs-3742	179	11	perspective	perspective	NOUN
iajs-3742	179	12	for	for	ADP
iajs-3742	179	13	the	the	DET
iajs-3742	179	14	development	development	NOUN
iajs-3742	179	15	of	of	ADP
iajs-3742	179	16	novel	novel	ADJ
iajs-3742	179	17	anticancer	anticancer	NOUN
iajs-3742	179	18	drugs	drug	NOUN
iajs-3742	179	19	.	.	PUNCT
iajs-3742	180	1	appl	appl	PROPN
iajs-3742	180	2	microbiol	microbiol	PROPN
iajs-3742	180	3	biotechnol	biotechnol	PROPN
iajs-3742	180	4	 	 	SPACE
iajs-3742	180	5	2018;102:10393–10408	2018;102:10393–10408	PRON
iajs-3742	180	6	.	.	PUNCT
iajs-3742	181	1	https://doi.org/10.1007/s00253-018-9420-8	https://doi.org/10.1007/s00253-018-9420-8	PROPN
iajs-3742	181	2	.	.	PUNCT
iajs-3742	182	1	16	16	NUM
iajs-3742	182	2	.	.	PUNCT
iajs-3742	183	1	al	al	PROPN
iajs-3742	183	2	madboly	madboly	PROPN
iajs-3742	183	3	la	la	PROPN
iajs-3742	183	4	,	,	PUNCT
iajs-3742	183	5	el	el	PROPN
iajs-3742	183	6	deeb	deeb	PROPN
iajs-3742	183	7	nm	nm	PROPN
iajs-3742	183	8	,	,	PUNCT
iajs-3742	183	9	kabbash	kabbash	VERB
iajs-3742	183	10	a	a	PRON
iajs-3742	183	11	,	,	PUNCT
iajs-3742	183	12	nael	nael	PROPN
iajs-3742	183	13	ma	ma	PROPN
iajs-3742	183	14	,	,	PUNCT
iajs-3742	183	15	kenawy	kenawy	PROPN
iajs-3742	183	16	am	be	AUX
iajs-3742	183	17	,	,	PUNCT
iajs-3742	183	18	ragab	ragab	VERB
iajs-3742	183	19	ae	ae	PROPN
iajs-3742	183	20	.	.	PUNCT
iajs-3742	184	1	purification	purification	NOUN
iajs-3742	184	2	,	,	PUNCT
iajs-3742	184	3	characterization	characterization	NOUN
iajs-3742	184	4	,	,	PUNCT
iajs-3742	184	5	identification	identification	NOUN
iajs-3742	184	6	,	,	PUNCT
iajs-3742	184	7	and	and	CCONJ
iajs-3742	184	8	anticancer	anticancer	NOUN
iajs-3742	184	9	activity	activity	NOUN
iajs-3742	184	10	of	of	ADP
iajs-3742	184	11	a	a	DET
iajs-3742	184	12	circular	circular	ADJ
iajs-3742	184	13	bacteriocin	bacteriocin	NOUN
iajs-3742	184	14	from	from	ADP
iajs-3742	184	15	enterococcus	enterococcus	PROPN
iajs-3742	184	16	thailandicus	thailandicus	PROPN
iajs-3742	184	17	.	.	PUNCT
iajs-3742	185	1	front	front	ADJ
iajs-3742	185	2	bioeng	bioeng	PROPN
iajs-3742	185	3	biotechnol	biotechnol	NOUN
iajs-3742	185	4	 	 	SPACE
iajs-3742	185	5	2020;8:450	2020;8:450	NUM
iajs-3742	185	6	.	.	PUNCT
iajs-3742	186	1	https://doi.org/10.3389/fbioe.2020.00450	https://doi.org/10.3389/fbioe.2020.00450	NOUN
iajs-3742	186	2	.	.	PROPN
iajs-3742	187	1	17	17	NUM
iajs-3742	187	2	.	.	X
iajs-3742	188	1	herschman	herschman	PROPN
iajs-3742	188	2	hr	hr	PROPN
iajs-3742	188	3	,	,	PUNCT
iajs-3742	188	4	helinski	helinski	PROPN
iajs-3742	188	5	dr	dr	PROPN
iajs-3742	188	6	.	.	PROPN
iajs-3742	188	7	purification	purification	NOUN
iajs-3742	188	8	and	and	CCONJ
iajs-3742	188	9	characterization	characterization	NOUN
iajs-3742	188	10	of	of	ADP
iajs-3742	188	11	colicin	colicin	PROPN
iajs-3742	188	12	e2	e2	PROPN
iajs-3742	188	13	and	and	CCONJ
iajs-3742	188	14	colicin	colicin	PROPN
iajs-3742	188	15	e3	e3	PROPN
iajs-3742	188	16	.	.	PUNCT
iajs-3742	189	1	j	j	PROPN
iajs-3742	189	2	biol	biol	PROPN
iajs-3742	189	3	chem	chem	PROPN
iajs-3742	189	4	 	 	SPACE
iajs-3742	189	5	1967;242(22):5360–5368	1967;242(22):5360–5368	NUM
iajs-3742	189	6	.	.	PUNCT
iajs-3742	190	1	https://doi.org/10.1016/s0021-9258(18)99436-6	https://doi.org/10.1016/s0021-9258(18)99436-6	PROPN
iajs-3742	190	2	.	.	PUNCT
iajs-3742	191	1	18	18	NUM
iajs-3742	191	2	.	.	PUNCT
iajs-3742	192	1	bradford	bradford	PROPN
iajs-3742	192	2	mm	mm	PROPN
iajs-3742	192	3	.	.	PUNCT
iajs-3742	193	1	a	a	DET
iajs-3742	193	2	rapid	rapid	ADJ
iajs-3742	193	3	and	and	CCONJ
iajs-3742	193	4	sensitive	sensitive	ADJ
iajs-3742	193	5	method	method	NOUN
iajs-3742	193	6	for	for	ADP
iajs-3742	193	7	the	the	DET
iajs-3742	193	8	quantitation	quantitation	NOUN
iajs-3742	193	9	of	of	ADP
iajs-3742	193	10	microgram	microgram	ADJ
iajs-3742	193	11	quantities	quantity	NOUN
iajs-3742	193	12	of	of	ADP
iajs-3742	193	13	protein	protein	NOUN
iajs-3742	193	14	utilizing	utilize	VERB
iajs-3742	193	15	the	the	DET
iajs-3742	193	16	principle	principle	NOUN
iajs-3742	193	17	of	of	ADP
iajs-3742	193	18	protein	protein	NOUN
iajs-3742	193	19	dye	dye	NOUN
iajs-3742	193	20	binding	bind	VERB
iajs-3742	193	21	.	.	PUNCT
iajs-3742	194	1	anal	anal	ADJ
iajs-3742	194	2	biochem	biochem	PROPN
iajs-3742	194	3	 	 	SPACE
iajs-3742	194	4	1976;72(1–2):248–254	1976;72(1–2):248–254	NUM
iajs-3742	194	5	.	.	PUNCT
iajs-3742	195	1	https://doi.org/10.1016/0003-2697(76)90527-3	https://doi.org/10.1016/0003-2697(76)90527-3	PROPN
iajs-3742	195	2	.	.	PUNCT
iajs-3742	196	1	19	19	NUM
iajs-3742	196	2	.	.	PUNCT
iajs-3742	197	1	šmajs	šmajs	PROPN
iajs-3742	197	2	d	d	PROPN
iajs-3742	197	3	,	,	PUNCT
iajs-3742	197	4	pilsl	pilsl	NOUN
iajs-3742	197	5	h	h	PROPN
iajs-3742	197	6	,	,	PUNCT
iajs-3742	197	7	braun	braun	PROPN
iajs-3742	197	8	v.	v.	ADP
iajs-3742	197	9	colicin	colicin	PROPN
iajs-3742	197	10	u	u	PROPN
iajs-3742	197	11	,	,	PUNCT
iajs-3742	197	12	a	a	DET
iajs-3742	197	13	novel	novel	NOUN
iajs-3742	197	14	colicin	colicin	NOUN
iajs-3742	197	15	produced	produce	VERB
iajs-3742	197	16	by	by	ADP
iajs-3742	197	17	shigella	shigella	PROPN
iajs-3742	197	18	boydii	boydii	PROPN
iajs-3742	197	19	.	.	PUNCT
iajs-3742	198	1	j	j	PROPN
iajs-3742	198	2	bacteriol	bacteriol	NOUN
iajs-3742	198	3	 	 	SPACE
iajs-3742	198	4	1997;179(15):4919–4928	1997;179(15):4919–4928	NUM
iajs-3742	198	5	.	.	PUNCT
iajs-3742	198	6	https://doi.org/10.1128/jb.179.15.4919-4928.1997	https://doi.org/10.1128/jb.179.15.4919-4928.1997	NOUN
iajs-3742	198	7	.	.	PROPN
iajs-3742	199	1	20	20	NUM
iajs-3742	199	2	.	.	PUNCT
iajs-3742	199	3	freshney	freshney	PROPN
iajs-3742	199	4	ri	ri	PROPN
iajs-3742	199	5	.	.	PUNCT
iajs-3742	200	1	culture	culture	NOUN
iajs-3742	200	2	of	of	ADP
iajs-3742	200	3	animal	animal	NOUN
iajs-3742	200	4	cells	cell	NOUN
iajs-3742	200	5	:	:	PUNCT
iajs-3742	200	6	a	a	DET
iajs-3742	200	7	manual	manual	NOUN
iajs-3742	200	8	for	for	ADP
iajs-3742	200	9	basic	basic	ADJ
iajs-3742	200	10	technique	technique	NOUN
iajs-3742	200	11	.	.	PUNCT
iajs-3742	201	1	4	4	NUM
iajs-3742	201	2	th	th	NUM
iajs-3742	201	3	ed	ed	NOUN
iajs-3742	201	4	.	.	PUNCT
iajs-3742	202	1	new	new	PROPN
iajs-3742	202	2	york	york	PROPN
iajs-3742	202	3	:	:	PUNCT
iajs-3742	202	4	wileyliss	wileyliss	PROPN
iajs-3742	202	5	;	;	PUNCT
iajs-3742	202	6	2000	2000	NUM
iajs-3742	202	7	.	.	PUNCT
iajs-3742	203	1	21	21	NUM
iajs-3742	203	2	.	.	X
iajs-3742	203	3	betancur	betancur	VERB
iajs-3742	203	4	galvis	galvis	ADJ
iajs-3742	203	5	la	la	PROPN
iajs-3742	203	6	,	,	PUNCT
iajs-3742	203	7	saez	saez	PROPN
iajs-3742	203	8	j	j	PROPN
iajs-3742	203	9	,	,	PUNCT
iajs-3742	203	10	granados	granados	PROPN
iajs-3742	203	11	h	h	PROPN
iajs-3742	203	12	,	,	PUNCT
iajs-3742	203	13	salazar	salazar	NOUN
iajs-3742	203	14	a	a	PRON
iajs-3742	203	15	,	,	PUNCT
iajs-3742	203	16	ossa	ossa	PROPN
iajs-3742	203	17	je	je	PROPN
iajs-3742	203	18	.	.	PUNCT
iajs-3742	204	1	antitumor	antitumor	PROPN
iajs-3742	204	2	and	and	CCONJ
iajs-3742	204	3	antiviral	antiviral	ADJ
iajs-3742	204	4	activity	activity	NOUN
iajs-3742	204	5	of	of	ADP
iajs-3742	204	6	colombian	colombian	ADJ
iajs-3742	204	7	medicinal	medicinal	ADJ
iajs-3742	204	8	plant	plant	NOUN
iajs-3742	204	9	extracts	extract	NOUN
iajs-3742	204	10	.	.	PUNCT
iajs-3742	205	1	mem	mem	PROPN
iajs-3742	205	2	inst	inst	PROPN
iajs-3742	205	3	oswaldo	oswaldo	PROPN
iajs-3742	205	4	cruz	cruz	PROPN
iajs-3742	205	5	 	 	SPACE
iajs-3742	205	6	1999;94:531–535	1999;94:531–535	NUM
iajs-3742	205	7	.	.	PUNCT
iajs-3742	205	8	https://doi.org/10.1590/s0074-02761999000400011	https://doi.org/10.1590/s0074-02761999000400011	PROPN
iajs-3742	205	9	.	.	PUNCT
iajs-3742	206	1	22	22	NUM
iajs-3742	206	2	.	.	X
iajs-3742	207	1	betancur	betancur	VERB
iajs-3742	207	2	galvis	galvis	ADJ
iajs-3742	207	3	la	la	PROPN
iajs-3742	207	4	,	,	PUNCT
iajs-3742	207	5	morales	morales	PROPN
iajs-3742	207	6	ge	ge	PROPN
iajs-3742	207	7	,	,	PUNCT
iajs-3742	207	8	forero	forero	PROPN
iajs-3742	207	9	je	je	PROPN
iajs-3742	207	10	,	,	PUNCT
iajs-3742	207	11	roldan	roldan	PROPN
iajs-3742	207	12	j.	j.	PROPN
iajs-3742	207	13	cytotoxic	cytotoxic	PROPN
iajs-3742	207	14	and	and	CCONJ
iajs-3742	207	15	antiviral	antiviral	ADJ
iajs-3742	207	16	activities	activity	NOUN
iajs-3742	207	17	of	of	ADP
iajs-3742	207	18	colombian	colombian	ADJ
iajs-3742	207	19	medicinal	medicinal	ADJ
iajs-3742	207	20	plant	plant	NOUN
iajs-3742	207	21	extracts	extract	NOUN
iajs-3742	207	22	of	of	ADP
iajs-3742	207	23	the	the	DET
iajs-3742	207	24	euphorbia	euphorbia	ADJ
iajs-3742	207	25	genus	genus	NOUN
iajs-3742	207	26	.	.	PUNCT
iajs-3742	208	1	mem	mem	PROPN
iajs-3742	208	2	inst	inst	PROPN
iajs-3742	208	3	oswaldo	oswaldo	PROPN
iajs-3742	208	4	cruz	cruz	PROPN
iajs-3742	208	5	 	 	SPACE
iajs-3742	208	6	2002;97:541–546	2002;97:541–546	NUM
iajs-3742	208	7	.	.	PUNCT
iajs-3742	209	1	https://doi.org/10.1590/s0074-02762002000400024	https://doi.org/10.1590/s0074-02762002000400024	NOUN
iajs-3742	209	2	.	.	PUNCT
iajs-3742	210	1	23	23	NUM
iajs-3742	210	2	.	.	PUNCT
iajs-3742	211	1	gao	gao	PROPN
iajs-3742	211	2	s	s	PROPN
iajs-3742	211	3	,	,	PUNCT
iajs-3742	211	4	yu	yu	PROPN
iajs-3742	211	5	bp	bp	PROPN
iajs-3742	211	6	,	,	PUNCT
iajs-3742	211	7	li	li	PROPN
iajs-3742	211	8	y	y	PROPN
iajs-3742	211	9	,	,	PUNCT
iajs-3742	211	10	dong	dong	PROPN
iajs-3742	211	11	wg	wg	PROPN
iajs-3742	211	12	,	,	PUNCT
iajs-3742	211	13	luo	luo	PROPN
iajs-3742	211	14	hs	hs	PROPN
iajs-3742	211	15	.	.	PROPN
iajs-3742	211	16	antiproliferative	antiproliferative	ADJ
iajs-3742	211	17	effect	effect	NOUN
iajs-3742	211	18	of	of	ADP
iajs-3742	211	19	octreotide	octreotide	NOUN
iajs-3742	211	20	on	on	ADP
iajs-3742	211	21	gastric	gastric	ADJ
iajs-3742	211	22	cancer	cancer	NOUN
iajs-3742	211	23	cells	cell	NOUN
iajs-3742	211	24	mediated	mediate	VERB
iajs-3742	211	25	by	by	ADP
iajs-3742	211	26	inhibition	inhibition	NOUN
iajs-3742	211	27	of	of	ADP
iajs-3742	211	28	akt	akt	PROPN
iajs-3742	211	29	/	/	SYM
iajs-3742	211	30	pkb	pkb	PROPN
iajs-3742	211	31	and	and	CCONJ
iajs-3742	211	32	telomerase	telomerase	NOUN
iajs-3742	211	33	.	.	PUNCT
iajs-3742	212	1	world	world	PROPN
iajs-3742	212	2	j	j	PROPN
iajs-3742	212	3	gastroenterol	gastroenterol	PROPN
iajs-3742	212	4	 	 	SPACE
iajs-3742	212	5	2003;9(10):2362	2003;9(10):2362	NUM
iajs-3742	212	6	–	–	PUNCT
iajs-3742	212	7	2364	2364	NUM
iajs-3742	212	8	.	.	PUNCT
iajs-3742	213	1	https://doi.org/10.3748/wjg.v9.i10.2362	https://doi.org/10.3748/wjg.v9.i10.2362	PROPN
iajs-3742	213	2	.	.	PUNCT
iajs-3742	214	1	24	24	NUM
iajs-3742	214	2	.	.	PUNCT
iajs-3742	215	1	al	al	PROPN
iajs-3742	215	2	qassab	qassab	PROPN
iajs-3742	215	3	ao	ao	PROPN
iajs-3742	215	4	,	,	PUNCT
iajs-3742	215	5	al	al	PROPN
iajs-3742	215	6	khafaji	khafaji	PROPN
iajs-3742	215	7	zm	zm	PROPN
iajs-3742	215	8	.	.	PUNCT
iajs-3742	216	1	effect	effect	NOUN
iajs-3742	216	2	of	of	ADP
iajs-3742	216	3	different	different	ADJ
iajs-3742	216	4	conditions	condition	NOUN
iajs-3742	216	5	on	on	ADP
iajs-3742	216	6	inhibition	inhibition	NOUN
iajs-3742	216	7	activity	activity	NOUN
iajs-3742	216	8	of	of	ADP
iajs-3742	216	9	enteric	enteric	ADJ
iajs-3742	216	10	lactobacilli	lactobacilli	NOUN
iajs-3742	216	11	against	against	ADP
iajs-3742	216	12	diarrhea	diarrhea	NOUN
iajs-3742	216	13	-	-	PUNCT
iajs-3742	216	14	causing	cause	VERB
iajs-3742	216	15	enteric	enteric	ADJ
iajs-3742	216	16	bacteria	bacteria	NOUN
iajs-3742	216	17	.	.	PUNCT
iajs-3742	217	1	j	j	PROPN
iajs-3742	217	2	agric	agric	PROPN
iajs-3742	217	3	sci	sci	PROPN
iajs-3742	217	4	 	 	SPACE
iajs-3742	217	5	1992;3(1):18–26	1992;3(1):18–26	NUM
iajs-3742	217	6	.	.	PUNCT
iajs-3742	218	1	25	25	NUM
iajs-3742	218	2	.	.	PUNCT
iajs-3742	218	3	fumarola	fumarola	PROPN
iajs-3742	219	1	d	d	PROPN
iajs-3742	219	2	,	,	PUNCT
iajs-3742	219	3	bello	bello	PROPN
iajs-3742	219	4	p	p	PROPN
iajs-3742	219	5	,	,	PUNCT
iajs-3742	219	6	palma	palma	NOUN
iajs-3742	219	7	r	r	NOUN
iajs-3742	219	8	,	,	PUNCT
iajs-3742	219	9	miragliotta	miragliotta	NOUN
iajs-3742	219	10	g	g	NOUN
iajs-3742	219	11	,	,	PUNCT
iajs-3742	219	12	panaro	panaro	NOUN
iajs-3742	219	13	a.	a.	NOUN
iajs-3742	219	14	bacteriocins	bacteriocin	NOUN
iajs-3742	219	15	as	as	ADP
iajs-3742	219	16	cytotoxic	cytotoxic	ADJ
iajs-3742	219	17	agents	agent	NOUN
iajs-3742	219	18	in	in	ADP
iajs-3742	219	19	experimental	experimental	ADJ
iajs-3742	219	20	neoplasms	neoplasm	NOUN
iajs-3742	219	21	:	:	PUNCT
iajs-3742	219	22	considerations	consideration	NOUN
iajs-3742	219	23	on	on	ADP
iajs-3742	219	24	the	the	DET
iajs-3742	219	25	role	role	NOUN
iajs-3742	219	26	of	of	ADP
iajs-3742	219	27	possible	possible	ADJ
iajs-3742	219	28	contaminants	contaminant	NOUN
iajs-3742	219	29	.	.	PUNCT
iajs-3742	220	1	giorn	giorn	VERB
iajs-3742	220	2	bact	bact	PROPN
iajs-3742	220	3	virol	virol	PROPN
iajs-3742	220	4	immunol	immunol	NOUN
iajs-3742	220	5	 	 	SPACE
iajs-3742	220	6	1977;70(1–6):87–93	1977;70(1–6):87–93	PROPN
iajs-3742	220	7	.	.	PROPN
iajs-3742	220	8	26	26	NUM
iajs-3742	220	9	.	.	PUNCT
iajs-3742	221	1	saito	saito	PROPN
iajs-3742	221	2	h	h	PROPN
iajs-3742	221	3	,	,	PUNCT
iajs-3742	221	4	watanabe	watanabe	PROPN
iajs-3742	221	5	t.	t.	PROPN
iajs-3742	221	6	effect	effect	NOUN
iajs-3742	221	7	of	of	ADP
iajs-3742	221	8	a	a	DET
iajs-3742	221	9	bacteriocin	bacteriocin	NOUN
iajs-3742	221	10	produced	produce	VERB
iajs-3742	221	11	by	by	ADP
iajs-3742	221	12	mycobacterium	mycobacterium	PROPN
iajs-3742	221	13	smegmatis	smegmatis	PROPN
iajs-3742	221	14	on	on	ADP
iajs-3742	221	15	growth	growth	NOUN
iajs-3742	221	16	of	of	ADP
iajs-3742	221	17	cultured	cultured	ADJ
iajs-3742	221	18	tumor	tumor	NOUN
iajs-3742	221	19	and	and	CCONJ
iajs-3742	221	20	normal	normal	ADJ
iajs-3742	221	21	cells	cell	NOUN
iajs-3742	221	22	.	.	PUNCT
iajs-3742	222	1	cancer	cancer	NOUN
iajs-3742	222	2	res	re	NOUN
iajs-3742	222	3	 	 	SPACE
iajs-3742	222	4	1979;39(12):5114–5117	1979;39(12):5114–5117	NUM
iajs-3742	222	5	.	.	PUNCT
iajs-3742	223	1	27	27	NUM
iajs-3742	223	2	.	.	PUNCT
iajs-3742	224	1	farkas	farkas	PROPN
iajs-3742	224	2	himsley	himsley	PROPN
iajs-3742	224	3	h	h	PROPN
iajs-3742	224	4	,	,	PUNCT
iajs-3742	224	5	yu	yu	PROPN
iajs-3742	224	6	h.	h.	PROPN
iajs-3742	224	7	purified	purify	VERB
iajs-3742	224	8	colicin	colicin	PROPN
iajs-3742	224	9	as	as	ADP
iajs-3742	224	10	cytotoxic	cytotoxic	ADJ
iajs-3742	224	11	agent	agent	NOUN
iajs-3742	224	12	of	of	ADP
iajs-3742	224	13	neoplasia	neoplasia	NOUN
iajs-3742	224	14	:	:	PUNCT
iajs-3742	224	15	comparative	comparative	ADJ
iajs-3742	224	16	study	study	NOUN
iajs-3742	224	17	with	with	ADP
iajs-3742	224	18	crude	crude	ADJ
iajs-3742	224	19	colicin	colicin	PROPN
iajs-3742	224	20	.	.	PUNCT
iajs-3742	225	1	cytobios	cytobio	NOUN
iajs-3742	225	2	 	 	SPACE
iajs-3742	225	3	1985;42(167–168):193–207	1985;42(167–168):193–207	NOUN
iajs-3742	225	4	.	.	PUNCT
iajs-3742	226	1	28	28	NUM
iajs-3742	226	2	.	.	PUNCT
iajs-3742	227	1	obaid	obaid	PROPN
iajs-3742	227	2	hh	hh	PROPN
iajs-3742	227	3	,	,	PUNCT
iajs-3742	227	4	essa	essa	PROPN
iajs-3742	227	5	rh	rh	PROPN
iajs-3742	227	6	,	,	PUNCT
iajs-3742	227	7	yaseen	yaseen	PROPN
iajs-3742	227	8	ny	ny	PROPN
iajs-3742	227	9	.	.	PROPN
iajs-3742	227	10	cytotoxicity	cytotoxicity	NOUN
iajs-3742	227	11	of	of	ADP
iajs-3742	227	12	non	non	ADJ
iajs-3742	227	13	-	-	ADJ
iajs-3742	227	14	bound	bound	ADJ
iajs-3742	227	15	colicins	colicin	NOUN
iajs-3742	227	16	extracted	extract	VERB
iajs-3742	227	17	from	from	ADP
iajs-3742	227	18	escherichia	escherichia	NOUN
iajs-3742	227	19	coli	coli	NOUN
iajs-3742	227	20	on	on	ADP
iajs-3742	227	21	normal	normal	ADJ
iajs-3742	227	22	white	white	ADJ
iajs-3742	227	23	blood	blood	NOUN
iajs-3742	227	24	cells	cell	NOUN
iajs-3742	227	25	and	and	CCONJ
iajs-3742	227	26	myeloblast	myeloblast	NOUN
iajs-3742	227	27	isolated	isolate	VERB
iajs-3742	227	28	from	from	ADP
iajs-3742	227	29	acute	acute	ADJ
iajs-3742	227	30	myeloid	myeloid	NOUN
iajs-3742	227	31	leukemia	leukemia	NOUN
iajs-3742	227	32	blood	blood	NOUN
iajs-3742	227	33	patients	patient	NOUN
iajs-3742	227	34	.	.	PUNCT
iajs-3742	228	1	iraqi	iraqi	PROPN
iajs-3742	228	2	j	j	PROPN
iajs-3742	228	3	sci	sci	PROPN
iajs-3742	228	4	 	 	SPACE
iajs-3742	228	5	2010;51(4):528–538	2010;51(4):528–538	PROPN
iajs-3742	228	6	.	.	PUNCT
iajs-3742	229	1	https://doi.org/10.24996/ijs.2010.51.4.%g	https://doi.org/10.24996/ijs.2010.51.4.%g	PROPN
iajs-3742	229	2	.	.	PROPN
iajs-3742	230	1	29	29	NUM
iajs-3742	230	2	.	.	PUNCT
iajs-3742	231	1	obaid	obaid	PROPN
iajs-3742	231	2	hh	hh	PROPN
iajs-3742	231	3	,	,	PUNCT
iajs-3742	231	4	essa	essa	PROPN
iajs-3742	231	5	rh	rh	PROPN
iajs-3742	231	6	,	,	PUNCT
iajs-3742	231	7	yaseen	yaseen	PROPN
iajs-3742	231	8	ny	ny	PROPN
iajs-3742	231	9	.	.	PROPN
iajs-3742	231	10	cytotoxicity	cytotoxicity	NOUN
iajs-3742	231	11	of	of	ADP
iajs-3742	231	12	non	non	ADJ
iajs-3742	231	13	-	-	ADJ
iajs-3742	231	14	bound	bound	ADJ
iajs-3742	231	15	colicins	colicin	NOUN
iajs-3742	231	16	extracted	extract	VERB
iajs-3742	231	17	from	from	ADP
iajs-3742	231	18	escherichia	escherichia	NOUN
iajs-3742	231	19	coli	coli	NOUN
iajs-3742	231	20	on	on	ADP
iajs-3742	231	21	human	human	ADJ
iajs-3742	231	22	larynx	larynx	NOUN
iajs-3742	231	23	epidermoid	epidermoid	NOUN
iajs-3742	231	24	carcinoma	carcinoma	NOUN
iajs-3742	231	25	(	(	PUNCT
iajs-3742	231	26	hep	hep	NOUN
iajs-3742	231	27	2	2	NUM
iajs-3742	231	28	)	)	PUNCT
iajs-3742	231	29	cell	cell	NOUN
iajs-3742	231	30	line	line	NOUN
iajs-3742	231	31	.	.	PUNCT
iajs-3742	232	1	third	third	ADJ
iajs-3742	232	2	national	national	PROPN
iajs-3742	232	3	feminist	feminist	PROPN
iajs-3742	232	4	scientific	scientific	PROPN
iajs-3742	232	5	conference	conference	NOUN
iajs-3742	232	6	,	,	PUNCT
iajs-3742	232	7	ministry	ministry	PROPN
iajs-3742	232	8	of	of	ADP
iajs-3742	232	9	science	science	NOUN
iajs-3742	232	10	and	and	CCONJ
iajs-3742	232	11	technology	technology	NOUN
iajs-3742	232	12	;	;	PUNCT
iajs-3742	232	13	2019	2019	NUM
iajs-3742	232	14	.	.	PUNCT
iajs-3742	233	1	30	30	NUM
iajs-3742	233	2	.	.	PUNCT
iajs-3742	234	1	farkas	farkas	PROPN
iajs-3742	234	2	himsley	himsley	PROPN
iajs-3742	234	3	h	h	PROPN
iajs-3742	234	4	,	,	PUNCT
iajs-3742	234	5	cheung	cheung	PROPN
iajs-3742	234	6	r.	r.	PROPN
iajs-3742	234	7	bacterial	bacterial	ADJ
iajs-3742	234	8	proteinaceous	proteinaceous	ADJ
iajs-3742	234	9	products	product	NOUN
iajs-3742	234	10	(	(	PUNCT
iajs-3742	234	11	bacteriocins	bacteriocin	NOUN
iajs-3742	234	12	)	)	PUNCT
iajs-3742	234	13	as	as	ADP
iajs-3742	234	14	cytotoxic	cytotoxic	ADJ
iajs-3742	234	15	agents	agent	NOUN
iajs-3742	234	16	of	of	ADP
iajs-3742	234	17	neoplasia	neoplasia	NOUN
iajs-3742	234	18	.	.	PUNCT
iajs-3742	235	1	cancer	cancer	NOUN
iajs-3742	235	2	res	re	NOUN
iajs-3742	235	3	 	 	SPACE
iajs-3742	235	4	1976;36(10):3561–3567	1976;36(10):3561–3567	NUM
iajs-3742	235	5	.	.	PUNCT
iajs-3742	236	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/271	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/271	PROPN
iajs-3742	236	2	https://doi.org/10.1128/am.21.5.837-840.1971	https://doi.org/10.1128/am.21.5.837-840.1971	PROPN
iajs-3742	236	3	https://doi.org/10.1128/am.21.5.837-840.1971	https://doi.org/10.1128/am.21.5.837-840.1971	PROPN
iajs-3742	236	4	https://doi.org/10.1128/jb.183.13.3958-3966.2001	https://doi.org/10.1128/jb.183.13.3958-3966.2001	X
iajs-3742	236	5	https://doi.org/10.1007/s00253-018-9420-8	https://doi.org/10.1007/s00253-018-9420-8	PROPN
iajs-3742	237	1	https://doi.org/10.3389/fbioe.2020.00450	https://doi.org/10.3389/fbioe.2020.00450	SCONJ
iajs-3742	237	2	https://doi.org/10.1016/s0021-9258(18)99436-6	https://doi.org/10.1016/s0021-9258(18)99436-6	PROPN
iajs-3742	237	3	https://doi.org/10.1016/0003-2697(76)90527-3	https://doi.org/10.1016/0003-2697(76)90527-3	PROPN
iajs-3742	237	4	https://doi.org/10.1128/jb.179.15.4919-4928.1997	https://doi.org/10.1128/jb.179.15.4919-4928.1997	NOUN
iajs-3742	237	5	https://doi.org/10.1590/s0074-02761999000400011	https://doi.org/10.1590/s0074-02761999000400011	PROPN
iajs-3742	237	6	https://doi.org/10.1590/s0074-02762002000400024	https://doi.org/10.1590/s0074-02762002000400024	PROPN
iajs-3742	237	7	https://doi.org/10.3748/wjg.v9.i10.2362	https://doi.org/10.3748/wjg.v9.i10.2362	PROPN
iajs-3742	238	1	https://doi.org/10.24996/ijs.2010.51.4.%25	https://doi.org/10.24996/ijs.2010.51.4.%25	PROPN
iajs-3742	238	2	g	g	NOUN
iajs-3742	238	3	ihjpas	ihjpas	PROPN
iajs-3742	238	4	.	.	PUNCT
iajs-3742	239	1	2025	2025	NUM
iajs-3742	239	2	,	,	PUNCT
iajs-3742	239	3	38(3	38(3	NUM
iajs-3742	239	4	)	)	PUNCT
iajs-3742	239	5	87	87	NUM
iajs-3742	239	6	31	31	NUM
iajs-3742	239	7	.	.	PUNCT
iajs-3742	240	1	farkas	farkas	PROPN
iajs-3742	240	2	himsley	himsley	PROPN
iajs-3742	240	3	h.	h.	PROPN
iajs-3742	240	4	sensitivity	sensitivity	NOUN
iajs-3742	240	5	of	of	ADP
iajs-3742	240	6	various	various	ADJ
iajs-3742	240	7	malignant	malignant	ADJ
iajs-3742	240	8	cell	cell	NOUN
iajs-3742	240	9	lines	line	NOUN
iajs-3742	240	10	to	to	PART
iajs-3742	240	11	partially	partially	ADV
iajs-3742	240	12	purified	purify	VERB
iajs-3742	240	13	bacteriocins	bacteriocin	NOUN
iajs-3742	240	14	:	:	PUNCT
iajs-3742	240	15	inherent	inherent	ADJ
iajs-3742	240	16	and	and	CCONJ
iajs-3742	240	17	proliferative	proliferative	ADJ
iajs-3742	240	18	dependence	dependence	NOUN
iajs-3742	240	19	.	.	PUNCT
iajs-3742	241	1	microbios	microbio	NOUN
iajs-3742	241	2	lett	lett	PROPN
iajs-3742	241	3	 	 	SPACE
iajs-3742	241	4	1988;39(154):57–66	1988;39(154):57–66	NOUN
iajs-3742	241	5	.	.	PUNCT
iajs-3742	242	1	https://doi.org/10.1007/978-3-642-76974-0_47	https://doi.org/10.1007/978-3-642-76974-0_47	PROPN
iajs-3742	242	2	32	32	NUM
iajs-3742	242	3	.	.	PUNCT
iajs-3742	243	1	nes	ne	NOUN
iajs-3742	243	2	if	if	SCONJ
iajs-3742	243	3	,	,	PUNCT
iajs-3742	243	4	brede	brede	PROPN
iajs-3742	243	5	da	da	PROPN
iajs-3742	243	6	,	,	PUNCT
iajs-3742	243	7	holo	holo	PROPN
iajs-3742	243	8	h.	h.	PROPN
iajs-3742	244	1	the	the	DET
iajs-3742	244	2	non	non	ADJ
iajs-3742	244	3	-	-	ADJ
iajs-3742	244	4	lantibiotic	lantibiotic	ADJ
iajs-3742	244	5	heat	heat	NOUN
iajs-3742	244	6	stable	stable	ADJ
iajs-3742	244	7	bacteriocins	bacteriocin	NOUN
iajs-3742	244	8	in	in	ADP
iajs-3742	244	9	gram	gram	NOUN
iajs-3742	244	10	positive	positive	ADJ
iajs-3742	244	11	bacteria	bacteria	NOUN
iajs-3742	244	12	.	.	PUNCT
iajs-3742	245	1	in	in	ADP
iajs-3742	245	2	:	:	PUNCT
iajs-3742	245	3	kastin	kastin	PROPN
iajs-3742	245	4	,	,	PUNCT
iajs-3742	245	5	editor	editor	NOUN
iajs-3742	245	6	.	.	PUNCT
iajs-3742	246	1	handbook	handbook	VERB
iajs-3742	246	2	biol	biol	PROPN
iajs-3742	246	3	active	active	ADJ
iajs-3742	246	4	peptid	peptid	ADJ
iajs-3742	246	5	.	.	PUNCT
iajs-3742	247	1	academic	academic	ADJ
iajs-3742	247	2	press	press	NOUN
iajs-3742	247	3	;	;	PUNCT
iajs-3742	247	4	2006	2006	NUM
iajs-3742	247	5	.	.	PUNCT
iajs-3742	248	1	p.	p.	NOUN
iajs-3742	248	2	107–114	107–114	NUM
iajs-3742	248	3	.	.	PUNCT
iajs-3742	249	1	https://doi.org/10.1016/b978-012369442-3/50020-9	https://doi.org/10.1016/b978-012369442-3/50020-9	ADP
iajs-3742	249	2	33	33	NUM
iajs-3742	249	3	.	.	PUNCT
iajs-3742	250	1	viejo	viejo	PROPN
iajs-3742	250	2	mb	mb	PROPN
iajs-3742	250	3	,	,	PUNCT
iajs-3742	250	4	gargallo	gargallo	PROPN
iajs-3742	250	5	d	d	PROPN
iajs-3742	250	6	,	,	PUNCT
iajs-3742	250	7	ferrer	ferrer	PROPN
iajs-3742	250	8	s	s	PROPN
iajs-3742	250	9	,	,	PUNCT
iajs-3742	250	10	enfedaque	enfedaque	PROPN
iajs-3742	250	11	j	j	PROPN
iajs-3742	250	12	,	,	PUNCT
iajs-3742	250	13	regué	regué	VERB
iajs-3742	250	14	m.	m.	NOUN
iajs-3742	250	15	cloning	cloning	NOUN
iajs-3742	250	16	and	and	CCONJ
iajs-3742	250	17	dna	dna	PROPN
iajs-3742	250	18	sequence	sequence	NOUN
iajs-3742	250	19	analysis	analysis	NOUN
iajs-3742	250	20	of	of	ADP
iajs-3742	250	21	a	a	DET
iajs-3742	250	22	bacteriocin	bacteriocin	NOUN
iajs-3742	250	23	gene	gene	NOUN
iajs-3742	250	24	of	of	ADP
iajs-3742	250	25	serratia	serratia	PROPN
iajs-3742	250	26	marcescens	marcescen	NOUN
iajs-3742	250	27	.	.	PUNCT
iajs-3742	251	1	microbiology	microbiology	NOUN
iajs-3742	251	2	 	 	SPACE
iajs-3742	251	3	1992;138(8):1737–1743	1992;138(8):1737–1743	NUM
iajs-3742	251	4	.	.	PUNCT
iajs-3742	252	1	34	34	NUM
iajs-3742	252	2	.	.	PUNCT
iajs-3742	253	1	farkas	farkas	PROPN
iajs-3742	253	2	himsley	himsley	PROPN
iajs-3742	253	3	h	h	PROPN
iajs-3742	253	4	,	,	PUNCT
iajs-3742	253	5	zhang	zhang	PROPN
iajs-3742	253	6	ys	ys	PROPN
iajs-3742	253	7	,	,	PUNCT
iajs-3742	253	8	yuan	yuan	PROPN
iajs-3742	253	9	m	m	PROPN
iajs-3742	253	10	,	,	PUNCT
iajs-3742	253	11	musclow	musclow	PROPN
iajs-3742	253	12	ce	ce	PROPN
iajs-3742	253	13	.	.	PROPN
iajs-3742	253	14	partially	partially	ADV
iajs-3742	253	15	purified	purify	VERB
iajs-3742	253	16	bacteriocin	bacteriocin	PROPN
iajs-3742	253	17	kills	kill	VERB
iajs-3742	253	18	malignant	malignant	ADJ
iajs-3742	253	19	cells	cell	NOUN
iajs-3742	253	20	by	by	ADP
iajs-3742	253	21	apoptosis	apoptosis	NOUN
iajs-3742	253	22	:	:	PUNCT
iajs-3742	253	23	programmed	program	VERB
iajs-3742	253	24	cell	cell	NOUN
iajs-3742	253	25	death	death	NOUN
iajs-3742	253	26	.	.	PUNCT
iajs-3742	254	1	cell	cell	NOUN
iajs-3742	254	2	mol	mol	ADP
iajs-3742	254	3	biol	biol	PROPN
iajs-3742	254	4	(	(	PUNCT
iajs-3742	254	5	noisy	noisy	ADJ
iajs-3742	254	6	le	le	X
iajs-3742	254	7	grand	grand	ADJ
iajs-3742	254	8	)	)	PUNCT
iajs-3742	254	9	 	 	SPACE
iajs-3742	254	10	1992;38(5–6):643–651	1992;38(5–6):643–651	NOUN
iajs-3742	254	11	.	.	PUNCT
iajs-3742	255	1	https://doi.org/10.1099/00221287-138-8-1737	https://doi.org/10.1099/00221287-138-8-1737	NUM
iajs-3742	255	2	.	.	X
iajs-3742	255	3	35	35	NUM
iajs-3742	255	4	.	.	PUNCT
iajs-3742	255	5	mittelman	mittelman	PROPN
iajs-3742	255	6	m	m	PROPN
iajs-3742	255	7	,	,	PUNCT
iajs-3742	255	8	farkas	farkas	PROPN
iajs-3742	255	9	himsley	himsley	PROPN
iajs-3742	255	10	h	h	PROPN
iajs-3742	255	11	,	,	PUNCT
iajs-3742	255	12	haran	haran	PROPN
iajs-3742	255	13	ghera	ghera	PROPN
iajs-3742	255	14	n.	n.	PROPN
iajs-3742	255	15	recognition	recognition	PROPN
iajs-3742	255	16	of	of	ADP
iajs-3742	255	17	t	t	PROPN
iajs-3742	255	18	cell	cell	NOUN
iajs-3742	255	19	murine	murine	NOUN
iajs-3742	255	20	leukemia	leukemia	NOUN
iajs-3742	255	21	by	by	ADP
iajs-3742	255	22	bacteriocin	bacteriocin	PROPN
iajs-3742	255	23	(	(	PUNCT
iajs-3742	255	24	colicin	colicin	PROPN
iajs-3742	255	25	)	)	PUNCT
iajs-3742	255	26	;	;	PUNCT
iajs-3742	255	27	correlation	correlation	NOUN
iajs-3742	255	28	with	with	ADP
iajs-3742	255	29	transplantation	transplantation	NOUN
iajs-3742	255	30	experiments	experiment	NOUN
iajs-3742	255	31	.	.	PUNCT
iajs-3742	256	1	leuk	leuk	PROPN
iajs-3742	256	2	res	res	PROPN
iajs-3742	256	3	 	 	SPACE
iajs-3742	256	4	1987;11(3):215–222	1987;11(3):215–222	NUM
iajs-3742	256	5	.	.	PUNCT
iajs-3742	257	1	https://doi.org/10.1016/0145-2126(87)90045-2	https://doi.org/10.1016/0145-2126(87)90045-2	PROPN
iajs-3742	257	2	.	.	PUNCT
iajs-3742	258	1	https://doi.org/10.1007/978-3-642-76974-0_47	https://doi.org/10.1007/978-3-642-76974-0_47	PROPN
iajs-3742	258	2	https://doi.org/10.1016/b978-012369442-3/50020-9	https://doi.org/10.1016/b978-012369442-3/50020-9	ADJ
iajs-3742	258	3	https://doi.org/10.1099/00221287-138-8-1737	https://doi.org/10.1099/00221287-138-8-1737	PUNCT
iajs-3742	258	4	https://doi.org/10.1016/0145-2126(87)90045-2	https://doi.org/10.1016/0145-2126(87)90045-2	PROPN